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Regulated exocytosis has been studied mostly in neuronal or chromaffin cells, and
several proteins that are thought to be involved have been identified. In this project
proteins involved in vesicle docking and fusion in the AtT-20 (transformed mouse
anterior pituitary) cell line were studied, as a comparison to these other cell types.
Immunoblotting and immunofluorescence were used to detect and localize SNARE's
(soluble NSF attachment protein receptors) and also cytosolic and cytoskeletal
proteins. These results showed that the proteins present were similar to those in
chromaffin and neuronal cells, with a similar intracellular distribution.
2+Since AtT-20 cells secrete ACTH (adrenocorticotrophic hormone) in a Ca -
regulated manner, secretion could be measured using a radioimmunoassay for
ACTH. This was used with a permeabilised cell system, allowing the introduction of
recombinant proteins, drugs, antibodies and neurotoxins. Little effect was seen on
introduction of some components, such as the synaptotagmin cytoplasmic domain
and aSNAP, however a dramatic reduction in secretion was seen on introduction of
the light chains of the neurotoxins Botulinum D and Tetanus toxin. These toxin
subunits specifically cleave the v-SNARE synaptobrevin demonstrating its
importance in regulated secretion in AtT-20 cells as has been demonstrated in
chromaffin and neuronal cells.
The role of actin in exocytosis has also undergone much scrutiny, particularly in
chromaffin cells. This was studied in AtT-20 cells using phalloidin, cytochalasin and
a combination of the permeabilised cell assay and immunofluorescence. In contrast
to chromaffin cells, the actin did not appear to form a distinct exocytotic barrier in
AtT-20 cells. The introduction of actin-stabilizing and de-stabilizing factors also had
no effect on the rate of exocytosis in AtT-20 cells. We conclude from this that actin
may not have an essential role to play in Ca2+-regulated exocytosis from AtT-20
cells.
Throughout this project ACTH secretion was measured using a rather laborious
radioimmunoassay. It was decided to look at an alternative method of measuring
regulated secretion, by stably transfecting the cells with a vector expressing a
secreted alkaline phosphatase (SEAP) reporter gene, fused to human growth
VIII
hormone (hGH). The logic behind this was that the hGH would direct the SEAP into
the regulated secretory pathway, allowing its release to be measured using
photometric or chemiluminescent methods of detection. The vector was found to be
very efficient in a traditional reporter gene role, but not sensitive enough to measure
the relatively small amounts of ACTH released on stimulation of secretion.
The logical continuation of this project would be to use a molecular approach and
transfect the AtT-20 cells with mutant forms of the proteins thought to be involved in
exocytosis. It would naturally focus on those producing dominant negative
phenotypes, leading to cells deficient in exocytosis.
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1.1 Ca -regulated exocytosis in neuronal and neuroendocrine cells.
Exocytosis is defined as the fusion of the membrane of an intracellular vesicle with
the plasma membrane (Darnell et al., 1990). This project studies the proteins
involved in Ca2+-regulated exocytosis using the transformed mouse anterior pituitary
cell line AtT-20/D16-16 as a model.
1.1.1 Protein Synthesis, secretion and sorting.
(Darnell, et al., 1990; Stryer, 1988; Fox, 1990; Nicholls, 1994)
It has long been known that genes are transcribed into mRNA (messenger
ribonucleic acid), and this is then translated into amino acid sequences by ribosomes.
There are two classes of ribosomes, membrane-attached, thus creating the RER
(rough endoplasmic reticulum) and unattached (cytosolic). Whilst these are
functionally equivalent to one another, they translate different types of proteins, and
this occurs as a result of the amino acid sequence of the protein itself. Most
mitochondrial, chloroplastic, peroxisomal, glyoxisomal, soluble cytosolic and
extrinsic membrane proteins are synthesised on unattached ribosomes. They enter the
cytosol immediately and remain free or attach to other proteins, such as chaperones.
Organelle proteins synthesised in this way undergo active uptake into the correct
organelle by recognition of their signal sequences, which may later be proteolytically
cleaved.
Secretory, integral, ER, Golgi, plasma membrane and lysosomal proteins (any of
which may be glycoproteins) are all synthesised by the attached ribosomes in the
RER. These proteins enter the Golgi at the cis face (directed by their signal
sequences). They are transported through the Golgi stacks by transport vesicles
budding and fusing, and during this time, they can undergo various modifications.
These include modification of amino acid side chains, addition/modification of
oligosaccharide side chains, proteolytic cleavages, disulphide bond formation,
acetylation sulphation and phosphorylation. ER proteins simply stop within the ER,
Golgi within the Golgi and lysosomal proteins travel to the trans Golgi stacks and
are sorted into lysosomes. However secretory proteins enter a complex network of
vesicles called the trans-Golgi reticulum, where they are sorted into continuously-
secreted vesicles or those that undergo regulated secretion. The sorting of the
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proteins at the reticulum stage is now understood to be due to the amino acid signal
sequences of the proteins themselves, which are later cleaved. As the vesicles mature
the proteins are often proteolytically processed into active peptides. Figure 1.1.1
summarises the process of protein synthesis and sorting. Until recent years much less
has been known about the mechanism occurring after this i.e. how the vesicles are
directed to the correct membrane and what physical attributes differentiate
constitutive secretion from regulated secretion. Section 1.1 summarises the most
recent data on exocytosis in neuronal and neuroendocrine cells. First, the main
differences between neuronal and neuroendocrine cell protein synthesis, sorting and
secretion will be summarised.
Neuronal cell synapses can be separated into two types: NMJ (neuromuscular
junctions) and CNS (central nervous system) terminals. One of the main differences
between these is that the NMJ can release several hundred synaptic vesicles on
stimulation with only one action potential, whereas the CNS synapses can require
several action potentials to release one vesicle. The morphology of these synapses
also differ somewhat but the basic principle is the same in that both have a synaptic
cleft, where the presynaptic membrane is juxtapositioned to the post-synaptic
membrane. This means that the action of neurotransmitters tends to be very localised
and there is the possibility of reuptake of neurotransmitters for recycling and further
use. The time gap between stimulation and release of vesicles is often less than 1ms
and in NMJs in particular can often be faster. Exocytosis occurs by the action
• 9 |
potential ultimately causing a Ca influx, which causes vesicle release. CNS
terminals actually contain two types of vesicles: small synaptic vesicles (SSVs,
containing neurotransmitters) and large dense core vesicles (LDCVs, containing
neuropeptides). The main differences between these are that LDCV contents tend not
to be released into a synaptic cleft, meaning their effects are less localised and there
is no reuptake. LDCV exocytosis is perhaps more similar to the release of hormones
by endocrine cells. The overall mechanism of release is still very similar, in that a
stimulus causes a rise in [Ca2+] and this causes exocytosis, however the overall
• 9+ •
cytosolic increase in [Ca ] tends to be larger. The lag time between stimulus and
exocytosis is also longer and often between 50ms to Is. Chromaffin cells from the
adrenal medulla represent an ideal model for this kind of exocytosis, and for
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neuroendocrine cells in general. It is important however, even with this degree of
similarity, to bear in mind certain anatomical and physiological differences within
the classification "neuroendocrine". The ACTH-secreting cell line AtT-20/D16-16,
which is being studied in this project, originates in the anterior pituitary and is a
"neuroendocrine cell line". ACTH secretion is stimulated by hormones from the
hypothalamus and its role is to stimulate the adrenal cortex to release the
glucocorticoids that stimulate gluconeogenesis in the liver. Chromaffin cells are in
the adrenal medulla and are actually innervated by sympathetic neurones. Amongst
other components, they release catecholamines that complement the sympathetic
nervous system in the fear and flight reaction. This is a much faster-acting and less
regulatory role than that seen for ACTH and it requires a completely different
method of stimulation. Differences between systems must be kept in mind when data
from many studies are being correlated to produce a single theory, and one should
never presume that mechanisms will be identical.
1.1.2 The SNARE hypothesis
Protein traffic throughout the cell has long been studied, and many important
findings were obtained using yeast mutants. Proteins were identified using
temperature-sensitive mutants and also the ability of a protein/gene to compensate
for a membrane traffic defect, which otherwise resulted in cell death (Pryer et al.,
1992). In terms of mammalian systems, there was no collection of mutants available
for similar studies, other than the wwc-mutants in the nematode Caenorhabditis
elegans (Clark et al., 1988). The main method of biochemical analysis in mammalian
systems was the characterisation of the synaptic vesicle proteins, which were found
to be abundant in synapses and specific to neuronal and neuroendocrine cells (Jessell
& Kandel, 1993). It was then realised that these proteins were isoforms of the
proteins involved in yeast protein trafficking. The soluble proteins NSF (N-
ethylmaleimide-sensitive factor) and SNAPs (soluble NSF attachment proteins) were
isolated through their ability to restore activity to a mammalian inter-Golgi vesicular
transport assay. Their yeast homologues SEC18 (NSF) and SEC17 (aSNAP) could
replace them in this assay (Wilson et al., 1989). Thus it was postulated that protein
trafficking and vesicle fusion is actually fairly conserved between yeast and man. It
appeared that throughout intracellular protein trafficking in the mammalian cell,
there were specific sets of vesicle proteins that docked with the complementary
target membrane proteins. These were termed SNAREs (SNAP-receptors) and two
types were recognised: t-SNAREs (target SNAREs on the plasma membrane) and v-
SNAREs (vesicular SNAREs on the vesicle). The process also required SNAPs and
NSF, and allowed efficient and accurate targeting of vesicles to the correct
membranes in the cell (Rothman, 1994). More specific studies of the process of
regulated exocytosis were then undertaken.
Two approaches were used to show the involvement of SNAREs in synaptic vesicle
release and regulated exocytosis:
• Binding analysis: Detergent solubilisation of synaptic vesicle membranes and
analysis of their interactions with aSNAP and NSF (Sollner et al., 1993; Wilson et
al., 1992)
• Clostridial neurotoxins: Inhibition of SV fusion and specific cleavage of
syntaxin, synaptobrevin and SNAP-25 by neurotoxins. (Schiavo et al., 1992; Blasi et
al., 1993a; Blasi et al., 1993b).
With regards to the binding/complex studies various detergents were used to
solubilise complexes from rat brain membranes (Bennet et al., 1992). Using CE1APS
to solubilise the membranes they found a large complex, which contained SV2,
synaptotagmin, syntaxin, synaptobrevin, rab 3A and the vacuolar H+-ATPase (proton
pump). On solubilisation with octylglucoside SV2, syntaxin and rab3A were found to
be present; and with TX100 there were two predominant interactions seen, between
synaptotagmin and SV2 and between syntaxin and synaptobrevin. This was taken a
step further when the soluble proteins aSNAP and NSF were introduced and
stepwise binding assays were studied (Sollner et al., 1993). One of these studies used
a recombinant NSF protein with a myc tag attached to it. A TX-100 extract of bovine
brain was also used along with recombinant aSNAP and protein-G beads, with a
monoclonal antibody to myc attached. The membrane extract, protein-G beads and
recombinant aSNAP were mixed together in the presence of a non-hydrolysable
ATP analogue (ATPyS) and EDTA. The beads were then packed into a column and
following washing to remove non-specific binding, specific eluates were examined.
The wash with MgATP, which caused the elution of proteins due to ATP hydrolysis,
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contained aSNAP, syntaxin, synaptobrevin and SNAP-25. A later study (McMahon
& Sudhof 1995) resolved this even further by looking at aSNAP binding to these
various proteins, using a similar affinity-dependent method. It was already known
that syntaxin and SNAP-25 were present as a tight complex on the plasma membrane
(Hayashi et al., 1994). Pevsner et al., 1994 had also shown that synaptobrevin binds
weakly to syntaxin or SNAP-25 but tightly to the syntaxin/SNAP-25 complex. They
showed aSNAP to bind weakly to syntaxin, SNAP-25 or the syntaxin/SNAP-25
complex and not at all to synaptobrevin. However binding was much enhanced when
synaptobrevin was complexed with syntaxin or the syntaxin/SNAP-25 complex. This
lead to a theory of SNAREs and targeted membrane fusion (Sollner,1995) which is
shown diagrammatically in figure 1.1.2. Syntaxin and SNAP-25 were postulated to
be the t-SNAREs and synaptobrevin the major v-SNARE. aSNAP and NSF were
thought to be have a role similar to that in the Golgi, in that aSNAP acts as an
adaptor protein for NSF, which has the ATPase activity to assist vesicle
docking/fusion. Other proteins mentioned will be discussed later.
Tetanus and botulinum toxins are produced by anaerobic bacteria, whose spores can
be found in soil. There is a single type of tetanus toxin (TeTx) and seven
serologically distinct types of botulinum toxins (BoNT/A to BoNT/G). These toxins
are released from bacteria as single chain polypeptides of 150kDa, and are activated
by bacterial or host proteases, which cleave the molecule into two pieces. A 50kDa
light chain peptide (F) remains attached to a 1OOkDa heavy chain peptide (H) by a
disulphide bond. The H-chains allow the entry of the toxin into the cell, where the L-
chain acts specifically to proteolytically cleave the SNAREs (Niemann et al., 1994).
Synaptobrevin is proteolysed by TeTx, BoNT/B, BoNT/D, BoNT/F and BoNT/G,
syntaxin by BoNT/C and SNAP-25 by BoNT/A and BoNT/E (Eisel et al., 1986;
Whelan et al., 1992; Binz et al., 1990; East et al., 1992; Campbell et al., 1993;
Hauser et al., 1990; Poulet et al., 1992). These toxins have now been tested in a
number of different cell types other than strictly neuronal systems. Glenn &
Burgoyne, 1996 showed that the botulinum D light chain could substantially inhibit
exocytosis in permeabilised chromaffin cells, and that C and E light chains showed
partial inhibition. Boyd et al., 1995 showed various botulinum toxins to cause an
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inhibition of insulin secretion from an insulinoma cell line. The above data offered
real proofof the involvement of the t and v-SNAREs in exocytosis.
1.1.3 The alternative SNARE hypothesis
Roth and Burgoyne, 1994 showed SNAP-25 to be enriched in the microsomal
fraction of the adrenal medulla (although less than in brain microsomes).
Immunocytochemistry showed it to be localised to the plasma membrane of
chromaffin cells. Using immunoprecipitation it was demonstrated that SNAP-25 was
in a complex with syntaxin, synaptobrevin, synaptotagmin, NSF, aSNAP and other
unidentified proteins. This, together with the fact that neurotoxins cause inhibition of
exocytosis in chromaffin cells showed that similar mechanisms are occurring in these
cells as in the brain (Glenn & Burgoyne, 1996; Bartels et ah, 1994). Morgan and
Burgoyne, 1995a and 1995b used an entirely different approach to the co-
precipitation assays mentioned so far. They showed that chromaffin cells
permeabilised with digitonin would secrete catecholamines in response to
2"F • * * 2~bmicromolar levels of Ca . However as time increased, their response to Ca
lessened, as soluble proteins necessary for exocytosis were lost through the
digitonin-produced pores. This "cytosolic rundown" could be retarded through the
addition of cytosol, and could thus be used as an assay for specific proteins important
in exocytosis. They used this assay initially to assess the roles of NSF and aSNAP in
a more functional way than previously mentioned. It was found that recombinant
9+
aSNAP could stimulate Ca -dependent exocytosis in these rundown cells, however
NSF could not. Both were shown to leak out of chromaffin cells with a similar time
course, however as much of the NSF appeared to be membrane-bound, this may have
provided a plentiful reservoir for the cell. The aSNAP-stimulated secretion was
2"b
dependent on Ca and Mg-ATP; and Botulinum neurotoxin A inhibited it, thus
confirms it as "real" exocytosis.
Further studies in this laboratory and others separated exocytosis into two stages:
ATP-dependent priming (requiring aSNAP and NSF) and ATP-independent
• 9+
triggering by Ca (Chamberlain et al., 1995; Morgan & Burgoyne, 1995a; Morgan
& Burgoyne, 1995b). Banerjee et al., 1996 did similar experiments on permeabilised
PC 12 cells with similar results. Their priming assay involved a straightforward
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2+incubation of the cell with or without ATP, and stimulation with Ca showed
norepinephrine to be released only in the presence of ATP. The triggering assay
involved extensive washing of ATP pre-primed cells to remove any free ATP, unlike
some of the previously mentioned studies. In this case, a combination of aSNAP and
2_j_
NSF increased Ca -stimulated exocytosis in the presence of ATP, suggesting ATP
hydrolysis to be necessary only in the priming stage. They also showed that both
aSNAP and NSF were necessary to rescue rundown cells and allow exocytosis to
occur. Barnard et al., 1996 showed the C terminus of aSNAP to be the important
feature in recruitment of NSF, as deletion of the first 120 N-terminal amino acids
caused no change in its stimulatory activity.
An additional role for ATP in the priming of exocytosis may be through the lipid
kinases. It has been found that ATP-dependent priming requires the cytosolic
proteins phosphatidylinositol transfer protein (PEP3) and phosphatidylinositol-4-
phosphate-5-kinase (PEP1) (Hay et al., 1995). These act along with the vesicular
membrane phosphatidylinositol-4-kinase to synthesise phosphatidylinositol (4,5)
2+
bisphosphate (PtdIns(4,5)P2), this being necessary for Ca -stimulated exocytosis
(Wiedemann et al., 1996). Thus, ATP appears to act as a substrate in the priming
reaction for NSF and the lipid kinases. CAPS (Ca2+-dependent activator protein for
2+
secretion) is a 145kDa soluble protein which has an essential role in Ca triggering.
It was shown, using the permeabilised/rundown PC 12 cell system, that CAPS was
9+
needed in the ATP-dependent Ca triggering part of exocytosis (Walent et al.,
1996). It binds to phospholipids, particularly PtdIns(4,5)P2. but dissociates and binds
2+
to other phospholipids on binding Ca (Lovett et al., 1997). Antibodies to
PtIns(4,5)P2 or phospholipase C (both of which perturb PtIns(4,5)P2) inhibit
secretion, thus suggesting a role for phospholipids and CAPS.
So far SNAREs, SNAPs and NSF have been discussed, all of which have
2+
homologues in the constitutive yeast trafficking systems. This project studies Ca -
regulated exocytosis, and it follows that some other factor is needed to confer
9+
regulation on the system. This is likely to be a Ca -sensitive fusion clamp(s) that
prevents the fusion of vesicle with plasma membrane, until the influx of Ca2+ occurs.
This may cause a conformational change in the clamp, and would allow fusion to
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proceed. The other alternative is that Ca acts in a positive sense by producing a
conformational change in a protein that then actively causes fusion.
1.1.4 The fusion clamp
The putative fusion clamp has proved highly elusive although the main candidate has
always been synaptotagmin. Synaptotagmin is a 65kDa integral vesicular membrane
protein, and it is now known that at least nine isoforms exist. It has two large, highly
conserved repeats in its cytoplasmic domain that are homologous to the C2 domain of
protein kinase C (Perin et al., 1990). These C2 domains appear to give synaptotagmin
2_|_its Ca - and phospholipid-binding properties, and purified synaptotagmin binds 4
moles Ca2+ per mole protein (Brose et al., 1992). It demonstrates Ca2+-dependent
PtdIns(4,5)P2 binding and inositol hexakisphosphate (an inhibitor of neurosecretion)
will compete with its binding to the synaptotagmin C2 domain (Schiavo et al., 1996;
Ohara-Imaizumi et al., 1997). This may suggest that PtdIns(4,5)P2 is part of a
2+
clamp, restraining fusion, and that synaptotagmin acts as a Ca sensor that binds the
former thus allowing fusion to proceed. Eaton Myasthenic Syndrome (EMS) is an
autoimmune disease of the NMJ. IgG fractions from EMS patients co-precipitate co-
9+
conotoxin sensitive Ca channels and synaptotagmin, suggesting synaptotagmin
forms complexes with these channels (Leveque et al., 1992). Synaptotagmin also
binds to syntaxin and a putative a-latrotoxin receptor (neurexin) which will be
discussed later (Petrenko et al., 1991).
Again it is important to remember that many of these studies on synaptotagmin used
in-vitro precipitation methods rather than functional assays. Other studies of
synaptotagmin, in particular genetic experiments, have yielded sometimes
contradictory results. Microinjection of a peptide from the cytoplasmic domain of
synaptotagmin inhibited exocytosis in PC12 cells (Elferink et al.,1993). However the
stable transfection of AtT-20 cells with a truncated cytoplasmic domain of
9+
synaptotagmin had no effect on Ca -regulated secretion (Wendland & Scheller,
1994). Synaptotagmin gene knockouts in Drosophila can be fatal (Littleton et al.,
1993) or may still allow synaptic transmission to occur (Diantonio et al., 1993).
Gene knockouts in mice have been shown to be fatal (Geppert et al.,1994b) but in C.
elegans resulted only in an impairment of synaptic function (Nonet et al., 1993).
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Much conflicting data now exists and the explanation may be variations in the
experimental systems used, or multiple pathways within the cell allowing bypassing
of the fault. There is also a possibility with genetic knockouts that functional
isoforms still exist. The most recent results postulate that synaptotagmin is a v-
SNARE which interacts with the t-SNARE SNAP-25, bringing the core complex in
close proximity with itself (i.e. the Ca2+ sensor) (Schiavo et al., 1997). This result
was used to explain why the docking of synaptic vesicles still occurred after
neurotoxin proteolysis (Sweeney et al., 1995).
Although much research has concentrated on synaptotagmin, other fusion-clamp or
fusion-activator candidates have been put forward, the main one being the a-
latrotoxin receptor, a-latrotoxin is the active component of black widow spider
venom, which causes massive Ca2+-independent exocytosis at the NMJ (Rosenthal &
Meldolesi., 1989). The concept of a Ca2+"sensitive fusion clamp would mean that on
2"bits becoming non-functional exocytosis would occur in the absence of Ca , thus the
mechanism of the toxin was of great interest.
The first proteins to be isolated through their binding to a-latrotoxin were the
neurexins, which are a family of polymorphic neuron-specific cell surface receptors.
Neurexin I was thought to bind both a-latrotoxin and synaptotagmin (Ushkaryov et
al., 1992; Hata et al., 1993). More recent experiments have identified a new protein
which binds a-latrotoxin, perhaps more convincing as it does so in the absence of
2+Ca , unlike neurexin I. This protein, termed a-latrophilin, is a single N-glycosylated
polypeptide chain which is enriched in synaptosomes (Davletov et al., 1996;
Krasnoperov et al., 1997). The area of interest now is the action of a-latrotoxin, of
2~b 2"l"which it appears to have two: Ca -dependent and Ca -independent. On binding to a
presynaptic receptor a-latrotoxin appears to form large non-selective cation channels
that allow Ca2+ entry, hence triggering exocytosis (Rosenthal & Meldolesi, 1989).
Other studies show massive exocytosis occurring in the absence of Ca2+ (Ceccarelli
et al., 1979), thus it may be that there are two receptors: Ca2+ independent and
dependent.
Figure 1.1.3 summarises the alternative SNARE hypothesis and fusion-clamp
mechanism. This section has reviewed the findings on the two main fusion clamp
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candidates, but as with the SNARE hypothesis, nothing is clear-cut and the real
answer has not yet been obtained. The sheer complexity of the pathway, and the
involvement of a number of different proteins, are what continue to cloud the issue.
The following section will briefly discuss other proteins that may also have a role in
exocytosis, in order to complete and summarise a very complex story.
1.1.5 Other proteins involved in exocytosis
Cytoskeletal proteins are one of the most important new groups of proteins to
emerge as having a role in exocytosis. There is substantial evidence that in some
cells the bulk of secretory vesicles are inhibited from fusion with the plasma
membrane by interactions with the cytoskeleton. The fact that certain synaptic
vesicle proteins, such as synapsin I, interact with the cytoskeleton seem to back up
this theory. Synapsin I is a synaptic vesicle protein that is phosphorylated on cell
depolarisation (Browning et al., 1985), and interacts with various elements of the
cytoskeleton including F-actin (Bahler & Greengard, 1987). It is possible that
vesicles interact with an actin network and are localised at the plasma membrane, but
prevented from fusion. The role of actin in secretory cells may also be connected
with the two distinct time phases of vesicle release. Superfusion of the dendritic
• ™f" 2d™
areas from rat hippocampal neurons, with solutions containing increased K and Ca
concentrations, produced a distinct trend in post-synaptic excitatory events (Stevens
& Tsujimoto, 1995). It was shown that the initial release rate was approximately 20
quanta per sec per synapse, however this rapidly declined to a much lower rate. This
readily-releasable pool, as it is described, could be replenished with a time constant
of approximately 10s. Morphological studies on chromaffin cells shows around
30,000 vesicles that lie well below the area of cortical actin. There are however 500
vesicles which appear to lie outside this cortical actin, and are docked at the plasma
membrane (Morgan, 1995). Permeabilised chromaffin cells appear to release 4% of
their total vesicle content, on stimulation with Ca2+, and in the absence of ATP. A
much larger percentage is released in the presence of ATP (Holz et al., 1989). Patch
2™b
clamp capacitance studies showed that Ca -regulated exocytosis in chromaffin cells
which had been washed to remove ATP, corresponded to approximately 800
'docked' vesicles. The readily-releasable pool of vesicles appear to be those vesicles
docked in close proximity to the plasma membrane, which are available for
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immediate Ca2+-triggered ATP-independent release. Functional studies have shown
that inhibitors of myosin light chain kinase will inhibit ATP-dependent secretion in
permeabilised adrenal cells (Kumakura et al., 1994). The reverse can also be shown
9+
in that F-actin depolymerising agents increase Ca -regulated exocytosis by causing
an increase in the readily-releasable pool of vesicles (Roth & Burgoyne 1995; Vitale
et al., 1995a). The former study also implicated the 14-3-3 proteins in having a role,
as they increased the secretion of catecholamines in permeabilised chromaffin cells.
This property was abolished on addition of the F-actin stabilising drug phalloidin.
Recombinant scinderin (an F-actin severing protein) has been shown to increase the
9-F •
Ca -stimulated release of seretonin from platelets (Zhang et al., 1996) and many
9-F
studies have shown actin-stabilising factors increase Ca - regulated exocytosis in
chromaffin cells (Sakurai, et al., 1997).
These studies all suggest an additional role for ATP, other than in aSNAP/NSF-
dependent priming of vesicles already discussed. ATP may also be required in the
recruitment of vesicles to the plasma membrane, by assisting with cortical actin
rearrangement, perhaps by being utilised by an ATP-dependent motor such as
Myosin II.
A second major category of proteins implicated in exocytosis are the rab proteins.
These are small GTP-binding proteins which are active in their GTP-bound form and
inactive in their GDP-bound form. They have been found to be required in various
stages of intracellular membrane trafficking (Pfeffer, 1992) and rab3A is abundant in
synaptic vesicles. It is anchored to membranes by two geranyl moieties (Ngsee et al.,
1990) when it is in its GTP-bound form. Upon GTP hydrolysis it dissociates and is
maintained in the cytoplasm by a regulatory protein called GDI (GDP dissociation
inhibitor) (Araki et al., 1990). Rabphilin is an 86 kDa protein which appears to
maintain rab3A in its active form by promoting exchange of GDP for GTP (Kishida
et al., 1993). Studies have shown rab3A to play a role in exocytosis in chromaffin
cells (Holz et al., 1994) and in neurones (Geppert et al., 1994a). The fact that
clostridial neurotoxins inhibit exocytosis stimulated by non-hydrolysable analogues
of GTP (GTP-y-S) indicates a definite convergence of the GTPase and
SNAP/SNARE pathways (Glenn & Burgoyne, 1996). It has also been suggested that
9-F
rabphilin3A is a Ca sensor in exocytosis. The most commonly expressed
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2+ • r*
synaptotagmin isoform, synaptotagmin I, binds syntaxin at Ca concentrations of
9+
200-500p.M (Geppert et al., 1994b). In neurones localised Ca concentrations of this
level are thought to occur, however in neuroendocrine cells often only 10p,M is
2d"
required. Rabphilin 3A has the required Ca - and phospholipid-binding domains and
2+
has a Ca dissociation constant of 1-lOp.M (Yamaguchi et al.,1993). It is possible
9+
that synaptotagmin is a low-affinity Ca receptor for fast neurotransmission, whilst
2+
rabphilin (and its interaction with rab 3) acts as a high-affinity Ca receptor in the
slower release of LDCVs. Certainly the overexpression of rabphilin 3A in
2_|_chromaffin cells enhances Ca -regulated exocytosis (Chung et al., 1995).
There are many other proteins put forward as having roles in exocytosis, too many to
review fully, but a very brief summary can be offered, in the form of table 1.1.
2+
Diagram 1.1.4 shows the various proteins which may be involved in Ca -regulated
exocytosis.
As shown in the table and discussed above, there are now a vast number of proteins
which may be involved in exocytosis. Taking all of these studies into consideration,
do we assume that the synaptic vesicle contains a huge fusion complex
(secretosome), with many different binding reactions occurring, and would this in
fact be spatially possible? It seems unlikely that all of these proteins play such a
similar role and care should be taken on the interpretation of in vitro binding studies.
Whilst they offer a good method for the identification of proteins which bind the
synaptic vesicle and therefore may be involved, it should not be automatically
assumed that they are all involved in exocytosis. Cell assays and genetic
manipulations are the ways by which we will be able to fully elucidate actual roles
9-i_
for these proteins and the mechanism for Ca -regulated exocytosis, and this
promises to be a lengthy and complex process. The next section will be a review of
the AtT-20 cell line that was studied in this project.
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Figure 1.1.1 Protein processing and sorting
Continuously secreted proteins e.g. albumin (liver)
Regulatory secreted proteins e.g. insulin (pancreatic-p-islet cells)
Lysosomal proteins
Sorting up to this point is controlled by amino acid signal sequences
within the proteins themselves. There must therefore be mechanisms
to target the vesicles to the correct membrane and to distinguish
regulated and constitutive secretion.
14
Figure 1.1.2 The SNARE hypothesis
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Docking of vesicle and
recruitment of aSNAP and
NSF.
ATP hydrolysis causes a
conformational change in
the SNARE complex, thus
priming has occurred.
Ca2+ enters and causes a
conformational change to
occur in the fusion clamp,
thus allowing close the
membranes to come into
close proximity, and fusion
to occur.
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aSNAP 36kDa; cytosolic adaptor to NSF.
NSF 76kDa; cytosolic
(trimer)














Binding partner of rab3.









SNARE interactions, binds to
synaptobrevin and prevents
synaptobrevin binding to other
SNAREs. A major component of
SVs, with unknown function (Sudhof
et al.t 1987; Edelmann et al., 1995).
Doc-2 44kDa; vesicle
(integral)
A SV protein with two C2 domains,
which bind Ca2+ and phospholipids.
Co-localises with synaptophysin and
is another candidate for the Ca2+
sensor (Orita et al., 1995).
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CAPS 145kDa; vesicle and
plasma membrane
(associated)
Vesicle and plasma membrane
aggregation (Ca2+ triggered stage).
Munc-18 67kDa; vesicle
(associated)
SNARE interactions: interacts with
syntaxin and interferes with its
binding to synaptobrevin. On
phosphorylation ofmunc-18, its
binding to syntaxin is inhibited
(Fujita et al., 1996).








Peripheral membrane proteins of
SVs, function unknown. Shown to



















A family of Ca - and phospholipid
binding proteins, enriched in SVs and
bind synapsin I (Inui et al., 1994).
Complexins 18kDa, cytosolic Enriched in neurons and compete
with aSNAP for binding to the









SV2 82kDa; vesicle A SV trans-membrane protein which
(integral) resembles other plasma membrane
proteins involved in protein transport
across the membrane. Possible role in
concentration of neurotransmitters
within the vesicle. Also reported to
bind synaptotagmin (Jahn & Sudhof
1994).
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1.2 The AtT-20 cell line
The AtT-20 cell line is derived from the mouse anterior pituitary, and these cells
synthesise and secrete adrenocorticotrophic hormone (ACTH), p lipotropin and
related opioid peptides (endorphins). They represent a useful model for a number of
studies as they are a homogeneous population of cells, unlike their in vivo
counterparts which represent only a small fraction (2-5%) of the total cells within the
anterior pituitary (Sabol, 1980).
In vivo the hypothalamus releases corticotrophin-releasing hormone (CRH) which
stimulates the anterior pituitary to release ACTH. This travels to the adrenal cortex
and releases glucocorticoids that go on to stimulate gluconeogenesis in the liver
(Fox, 1990). Glucocorticoids are steroid hormones and therefore exert their effect
through modulating mRNA synthesis. Their role is to increase blood glucose
concentrations by increasing the rate of glucose production by the liver. One of the
major glucocorticoid hormones is Cortisol and it is ACTH that controls the rate of its
synthesis and secretion, mainly by binding to adrenal cortex plasma membrane
receptors and increasing adenylate cyclase activity. The anterior pituitary gland is
therefore under the indirect control of the central nervous system (CNS) through the
negative control of blood Cortisol and the positive control of hypothalamic CRH. The
physiological role of Cortisol is to prepare the body for physical and metabolic
activity thus it produces an increase in blood glucose concentration along with fatty
acid mobilisation and an increased sensitivity to thyroxine and adrenaline. It is
thought that this mainly occurs by Cortisol changing the response of tissues to other
hormones and regulators. This role means that every individual has a unique daily
rhythm of Cortisol with the most important peak being just prior to waking. It also
guarantees this pathway a role during times of physical and emotional stress
(Newsholme & Leech, 1992).
Figure 1.2.1 shows the hypothalamic-pituitary-adrenal axis
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At present AtT-20 cells have been used in the study of two main areas:
• Intracellular signalling events
AtT-20 cells have been used extensively to study the signalling pathways that are
activated on stimulation with CRH.
• Prohormone processing and sorting
Much of the information available on these cells represents the slightly earlier stages
of the pathway than those involved in this study. This project is more concerned with
the events closer to the plasma membrane and the proteins involved i.e. the actual
docking and fusion of the vesicle with the plasma membrane.
9+
This study will compare Ca -regulated exocytosis in AtT-20 cells with the data
already available for other cell types, predominantly neuronal and chromaffin cells. It
will then correlate this data with the information already known about the signalling
pathways.
Current findings in AtT-20 cells will now be reviewed under the following headings:
• Basal/ constitutive secretion and pro-hormone processing
• Intracellular signalling
2+
• Molecular mechanisms of Ca -regulated exocytosis
1.2.1 Basal/constitutive secretion and pro-hormone processing
AtT-20 cells have been extensively used in the study of the constitutive and regulated
secretory pathway, and particularly in the analysis of the signals which direct
proteins into the regulated pathway (Stahl et al., 1996; Castle et al., 1995). They
have also frequently been used in the study of intracellular trafficking and pro¬
hormone processing, often using methods of transfection to insert exogenous pro¬
hormones into the cell line (Brakch et al., 1994; Eskeland et al., 1996). POMC itself
(see figure 1.2.2), the peptide precursor from which ACTH, a-MSH, P-endorphin
and other related peptides are produced, has also been studied in great detail. The
maturation of the pro-hormone begins by the signal sequence being cleaved in the
ER (Walter et al., 1984). The identity of this signal sequence has been investigated
by Cool & Loh, 1994. The first 10, 26, 50 and 101 N terminal amino acids of
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POMC were fused to a reporter gene, and the localisation of the fusion protein
studied. Immunofluorescence and subcellular fractionation showed that all the
sequences, except for the first 10 amino acids, were able to direct the reporter gene
into secretory granules, which forskolin (a secretagogue) could then go on to release.
Binding studies with the first 76 amino acids of POMC also showed it to bind to the
luminal side of granules in a pH-dependent manner. Similar binding was not
obtained when CLIP and (3-lipotropin were used. Thus it appears that the first 26
amino acids are necessary to target POMC to the regulatory pathway, and that this
occurs via a pH-dependent binding mechanism. POMC is then transported through
the Golgi complex where further maturation takes place including glycosylation,
sulphation and phosphorylation (Huttner, 1988; Eipper & Mains, 1982). Proteolytic
processing i.e. POMC cleavage, begins in the trans-Golgi network (TGN) and
continues as the secretory granules mature (Tanaka & Kurosumi, 1992; Tooze et al.,
1987). AtT-20 cells express the pro-hormone convertase PCI at 20% of the molar
levels of POMC (Zhou & Mains, 1994) and PCI has been shown to be involved in
POMC cleavage at paired basic sites (Seidah et al., 1991). Tanaka et al., 1996
confirmed this co-localisation of PCI with POMC in secretory granules. They also
concluded that, whilst an acidic pH is favourable for proteolytic POMC processing, it
is not a necessity, and more important is the efficient sorting of the POMC into
secretory granules.
The AtT-20 cell line exhibits a high basal level of secretion that is often as much as
40% of stimulated secretion. There has been speculation as to the nature of this basal
secretion, and in particular whether it occurs by the same pathway as constitutive.
Matsuuchi & Kelly, 1991 studied a variant AtT-20 cell line, deficient in regulated
secretion, and postulated that basal secretion (i.e. a spontaneous release of regulated
proteins occurring in the absence of stimulation) is not via the constitutive pathway.
This is important when estimates are being made of the efficiency of sorting into the
regulated pathway. It may also have an important physiological role, allowing the
cells to respond to both positive and negative stimuli. Other data however appear to
contradict this. Surprenant, 1982 showed the direct link between increased electrical
activity and secretory activity in AtT-20 cells. 82% of the cells showed spontaneous
electrical activity that was increased on application of a depolarising current. On
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removal of external calcium, the spontaneous action potentials were abolished and it
was proposed that the mechanisms causing regulated secretion are different from
those causing basal release. They postulated that basal secretion is due to release of
ACTH from cellular components other than secretory granules. As yet, it appears
that the real identity of basal secretion remains somewhat indistinct and it would be
interesting to analyse it further.
1.2.2 Intracellular signalling in AtT-20 cells
ACTH secretion is stimulated by a 41-residue peptide called corticotrophin releasing
hormone (CRH) ( Hook et al 1982). It has been established for many years that
9+
increasing intracellular Ca concentration causes exocytosis in various cell types
(Douglas, 1968), and this has been shown to be true for AtT-20 cells (Surprenant,
1982). However, the link between CRH stimulation and Ca2+ influx remains poorly
defined. In the AtT-20 cell system, there is also the added complication of
understanding how the negative inhibition of the glucocorticoids fits into this
complex signalling pathway.
cAMP and cAMP-dependent Protein Kinase (PKA) have been shown to be involved
in the control of ACTH release from anterior pituitary cells and AtT-20 cells
(Axelrod & Reisine, 1984). Miyazaki et al., 1984 showed that whilst PKA will
phosphorylate several macromolecules in AtT-20 cells, this does not appear to be
directly linked to the ACTH secretion event. He suggested that cAMP-dependent PK
9+ 9+
was involved in the regulation of the intracellular Ca concentration and this Ca
influx followed the PKA activation. AtT-20 cells have a type-1 CRH receptor that is
linked to adenylate cyclase by the stimulatory G protein Gs, (Pozzoli et al., 1996) and
CRH stimulates both ACTH secretion and biosynthesis of the ACTH precursor pro¬
opiomelanocortin (POMC) via this receptor (Lundblad, 1988). Litvin et al., 1984
used the cyclic nucleotide phosphodiesterase inhibitor MIX (3-
methylisobutylxanthin) to increase intracellular cAMP levels to 10 times that seen
during CRH stimulation, (which caused a two-fold increase). This caused no increase
over the ACTH secretion seen with normal CRH-stimulated cAMP levels. This
demonstrated the need for only small changes in intracellular cAMP concentrations
in order to mediate ACTH secretion. This twofold cAMP rise was also accompanied
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by activation of only a small fraction of the cAMP-dependent protein kinase within
the cell. Guild & Reisine, 1987 showed that CRH, forskolin (a direct adenylate
cyclase activator; Heisler & Reisine 1984) and K+-induced depolarisation stimulated
ACTH secretion and a rise in intracellular Ca2+ concentrations. Protein kinase
inhibitors have been introduced (via liposomes) into intact AtT-20 cells and shown to
produce a subsequent large decrease in forskolin or CRH-stimulated, but not K+-
stimulated, ACTH release (Reisine et al., 1986; Reisine & Guild 1985). This directly
demonstrated the essential role of adenylate cyclase (acting via the cAMP-dependent
9+
protein kinase, PKA) in increasing intracellular Ca and causing ACTH release. It
also enforced the idea that K+ causes ACTH release by transiently opening voltage-
gated Ca2+ channels and not by increasing cAMP levels. The same method was used
to show the necessity of PKA in increased POMC gene expression (Reisine et al.,
1985).
Permeabilised AtT-20 cells have been used extensively to study the later stages in the
2+
signalling cascade and have proved useful in resolving the Ca -dependent and
independent parts of the pathway. This is done mainly by the use of Ca2+-EGTA
buffers, which maintain a constant free Ca2+ concentration, which can effectively be
2"b
zero. From such studies it appears that cAMP has a role in Ca -evoked ACTH
2_j_release (as well as in causing the initial Ca influx) as it will increase the amount of
9+ 9+
ACTH released in response to varying Ca concentrations (Guild, 1991). Ca -
EGTA buffers ensured that the cAMP-mediated rise in ACTH secretion could not be
occurring via a further Ca2+ influx. Thus the cAMP appears to be playing an
2"badditional regulatory role at a site distal to that of Ca entry.
Protein kinase C (PKC) may also play a role in ACTH secretion from AtT-20 cells
(Reisine & Guild, 1987). Activators of PKC such as phorbol-12-myristate-13-acetate
2"b
(PMA) increase cytosolic Ca concentrations and stimulate ACTH release from
intact cells in a dose-dependent manner thereby suggesting the involvement of PKC,
possibly via the phospholipase C cascade. Rane and Dunlop, 1986 first suggested a
91
link between PKC activity and modulation of Ca channel function. Reisine and
9+
Guild, 1987 took this a step further by suggesting that this Ca influx was mediated
by K+ channel blockage. Depolarisation of intact AtT-20 cells prevents PMA from
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causing any further increase in Ca2+ levels whilst TEA (tetraethylammonium), which
blocks K+ channels, prevents PMA but not CRF from causing Ca2+ influx. Thus it
appears that PMA-activated ACTH secretion may work via TEA-sensitive K+
2"b
channels that depolarise the cells and cause a Ca influx. PKC may directly
phosphorylate either the K+ channels or a protein that will interact with these, thus
causing a blockage. A biphasic pattern of ACTH release is obtained on stimulation
with PMA, the cells quickly becoming unresponsive to further stimulation with K+,
CRF or forskolin. It is possible that the phosphorylation events causing K+ channel
blockage could at a slightly later time cause a blockage of Ca2+ channels.
CRF stimulation of ACTH secretion via the adenylate cyclase/cAMP-dependent
protein kinase system is unlike this as the response is maintained for as long as the
stimulus is present and no biphasic pattern is seen. This, together with the fact that
9+
PKA inhibitors block [Ca ] increase and ACTH secretion mediated by forskolin or
CRH but not by PMA, demonstrates the distinct pathways of PKC and PKA (Reisine
& Guild, 1987; Reisine et al., 1985). It is also important to note that TEA has no
2_|_ . . 2+effect on CRH-stimulated [Ca ] increase and ACTH secretion. Possibly, the Ca
channels are directly stimulated as the TEA-sensitive K+ channels are obviously not
involved. Luini et al., 1985 have shown that 8-bromo-cyclic-AMP (a membrane
2+
permeant form of cAMP) can increase the frequency of Ca channel opening in
voltage-clamped patches of intact AtT-20 cells, therefore the cAMP appears to
stimulate Ca2+ channels via PKA phosphorylation events. Heisler and Reisine., 1984
9+
supported this by showing that the Ca channel blocker nifedipine inhibited
forskolin and 8-bromo cAMP-mediated ACTH secretion. Loechner et al., 1996
9 i
identified the presence of three different Ca channel types in AtT-20 cells:
dihydropyridine-sensitive (nimodipine, L-type channel), co-Agatoxin-sensitive (PQ-
type channel) and co-conotoxin MVIIC-sensitive (N-type channel). They showed that
only the nimodipine-sensitive channels were involved in KC1 and CRH stimulation
of ACTH secretion. Thus it appears that although the mechanisms of KC1 and CRH
9_l_
evoked release vary, the Ca channels involved are the same ones.
2_|_
In permeabilised cells chelerythrine blocks PMA-mediated enhancement of Ca -
stimulated ACTH release but not the Ca2+ evoked secretion itself. Again Ca2+-EGTA
2+buffers were used to ensure no rise in the Ca concentration therefore the PKC was
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acting at a distal site and had a regulatory role. However unlike PKA, PKC has the
ability to evoke ACTH secretion in the absence of Ca2+, although at a lower level
than that conferred by Ca . Thus we see the regulatory roles ofPKA and PKC to be
distinct (Mcferran & Guild, 1994). It has also been shown that PKC has a number of
isoenzymes (Hug & Sarre, 1993) and that these are involved at different stages of
the signalling pathway. McFerran., et al 1995, using the permeabilised AtT-20 cell
• • 2"b
system, showed that the a and s isozymes of PKC act at a site distal to Ca entry to
9+
regulate Ca -mediated ACTH secretion. The p isozyme could act at a much earlier
stage in the pathway to actually regulate the cytosolic Ca2+ concentration.
To summarise these findings: PKA activators will not cause ACTH secretion in the
absence of Ca whereas PKC activators will. The PKA pathway is the one by which
CRH appears to mediate ACTH secretion. It also has a synergistic effect distal to
Ca2+ entry where it appears to have a regulatory role. As yet, there is no direct link
between CRH-mediated ACTH secretion and PKC. The effects of PKC and its
2+activators on CRH and Ca -mediated ACTH secretion are purely additive, thus
suggesting that the two pathways are effectively independent and that the PKA
pathway is the one involved in the Ca2+ messenger system (and CRH-mediated
ACTH secretion). As yet the role ofPKC remains unclear.
• 9+
Events have been discussed which occur prior to the Ca influx and which regulate
9+
at a point distal to Ca entry in the pathway. As yet this section has not touched on
2+the mechanisms after the Ca influx, which are of course much closer to the topic of
this thesis. While there are many proteins that are possible candidates for having
roles in later events, only one has been shown to have a direct involvement in ACTH
9+
secretion at a site distal to Ca entry. This effector appears to be a G protein.
Guanosine 5'-0-3-thiotriphosphate (GTP-y-S) is a non-hydrolysable GTP analogue
9_L
which stimulates AtT-20 cells to secrete ACTH in the absence of Ca or ATP
(Guild, 1991). This demonstrates a specific difference in the two levels of the
pathway in that Ca2+-stimulated ACTH secretion requires ATP whilst GTP-y-S
mediated secretion does not. In the absence of ATP, levels of secretion were slightly
reduced at lower concentrations of GTP-y-S, however at higher concentrations of
GTP-y-S the ATP had little effect. In fact the omission of ATP actually caused a
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significant drop in basal ACTH secretion, which it has been suggested, is due to the
added ATP generating GTP via nucleoside diphosphate kinase (Gomperts, 1990).
Obviously the effect of this GTP analogue points to the involvement of a guanosine
5'-triphosphate binding protein. It appears that G-proteins may have a role in
mediating the effects of Ca2+ in various secretory cell systems (for review see
Gomperts 1990) and at present the specific G protein involved has been given the
term Ge- Ge may be a member of one of two families of G proteins: heterotrimeric G
proteins, with three distinct sub units (a, (I and y) or small monomeric ras-like G
proteins (Gilman, 1987; Taylor, 1990; Hall, 1990). In AtT-20 cells rab3 (a
monomeric G protein) seems to play a role in localisation, sequestration and storage
of secretory vesicles (Ngsee et al., 1993), and within this rab 3 family are isoforms
which have different cellular distribution thus suggesting slightly varying roles
(Martelli et al., 1995). Luini & Dematteis, 1988 identified an inhibitory form of Ge
(GeO which mediates somatostatin inhibition of ACTH secretion and may be
heterotrimeric. Mastoparan is an amphiphilic tetradecapeptide that can form a helical
structures in the phospholipid membrane. These appear to mimic the cytosolic loops
of G protein- coupled receptors and therefore to activate heterotrimeric G proteins
(Higashijuma, 1988; Weingarten, 1990). However it should be noted that other
diverse effects have also been seen with mastoparan (Malenick andAnderson, 1983).
McFerran & Guild, 1995 showed that mastoparan could stimulate ACTH secretion
in permeabilised cells in a time- and dose-dependent manner, mirroring the
• • • • •
stimulation obtained with GTP-y-S and Ca , and thus suggesting a specific effect on
Ge. They postulated that mastoparan acts specifically on Ge in this system. Their use
of the mastoparan analogues Mas-7 (which can stimulate heterotrimeric G proteins)
and Mas-17 (which is unable to do so) points towards Ge being heterotrimeric, as the
former stimulates ACTH secretion whilst the latter does not. They also show that the
absence of ATP causes a large decrease in ACTH secretion (unlike the small
decrease seen with GTP-y-S mediated ACTH secretion). Again this may support the
theory that the added ATP simply increases available GTP as opposed to having a
direct role. The residual activity seen in the absence of ATP may then be due to the
mastoparan activating nucleoside diphosphate kinase (Kikkawa et al., 1992), or it
could be due to a non-Gn mediated form ofACTH secretion.
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At present this is the level of understanding that has been reached in ACTH secretion
from AtT-20 cells. However there is also another important physiological aspect in
the pathway that we must look at, that of inhibition of ACTH secretion. The main
physiological inhibitors of ACTH secretion in AtT-20 cells are the glucocorticoids
(such as Cortisol) and these have a typical negative feedback role (see figure 1.2.1)
There are two distinct mechanisms by which glucocorticoids exert their inhibitory
effect (Shipston et al., 1995):
• EARLY (<3hours; within 10 minutes)
This involves de novo protein synthesis and subsequent decrease in ACTH secretion
(Keller-Wood et al., 1988).
• LATE (>6 hours to days)
This involves an actual suppression of cell function by inhibiting ACTH biosynthesis
and down-regulating CRH signalling pathways (Lundblad & Roberts, 1988).
As this review covers the intracellular signalling pathways of AtT-20 cells the area
focused on will be the early inhibition of ACTH secretion by glucocorticoids.
Phillips & Tashjian, 1982 showed dexamethasone to cause a decrease in ACTH
secreted on stimulation by hypothalamic extract, by phorbol esters, or by 8-bromo-
cAMP but not by high K+. It also had no effect on the basal levels of ACTH
secretion. They showed that there was no decrease in intracellular levels of ACTH
and used cycloheximide (an inhibitor of protein synthesis) to conclude that the
inhibition was due to the synthesis of new protein. The molecular mechanism of this
glucocorticoid-induced protein (GIP) remains under scrutiny.
Clark & Kemppainen, 1994 showed dexamethasone to inhibit ACTH secretion but
not that stimulated by K+ or maitotoxin (which stimulates a Ca2+ influx by Ca2+-
dependent membrane depolarization). They used the Ca indicator fura-2 to measure
intracellular [Ca2+] and show that its increase was necessary for ACTH secretion.
However on treatment with dexamethasone and stimulation of ACTH secretion there
was no decrease in the intracellular Ca2+ rise, but a decrease was seen in the ACTH
secretion. This led to the theory that the inhibitory effect of the GIP must occur distal
to Ca2+ entry, although it is difficult to reconcile this with the fact that
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glucocorticoids do not have an effect on high K+-mediated ACTH secretion. Link et
al, 1993 reported a similar result in rat anterior pituitary cells stimulated to secrete by
oxytocin.
There are however results which contradict this theory. Other groups have found that
the inhibition of ACTH secretion by dexamethasone does in fact cause a decrease in
the stimulated intracellular rise of calcium ions (Antoni et al., 1992). Such results
suggest a role for the GIP in preventing or decreasing the influx of calcium ions.
Shipston et al., 1996 showed that PKA activation (by CRF or 8-bromo-cAMP)
caused (in addition to Ca2+ influx via L-type Ca2+ channel activation) an inhibition of
the Ca2+-activated BK-type K+ channel. Thus CRH stimulation usually prevents the
Ca2+-induced feedback hyperpolarization mediated by these channels, thereby
allowing a greater Ca2+ influx. Iberiotoxin specifically blocks the BK channel, and
abolishes glucocorticoid inhibition of CRF-stimulated ACTH secretion. They
therefore postulate that glucocorticoids cause the synthesis of GIP, which in turn
blocks PKA-activated inhibition of the BK channel, thus preventing the intracellular
[Ca2+] rise.
Another theory (Castellino et al., 1992) suggests a role for glucocorticoids in
inhibiting ACTH secretion by stabilisation of the actin barrier. It was shown that
cytochalasin D destabilised plasma membrane actin and that dexamethasone partially
protected the cells against these effects, and thickened the actin bundles. However
electron microscopy showed the actin filaments not to intervene as a direct barrier
between secretory droplets and the plasma membrane. They concluded that the role
of actin in exocytosis in AtT-20 cells was to hold the granules away from, but close
to their discharge sites, as opposed to acting as a direct barrier. A difficulty in
interpreting these data is that the total increase of actin cross-linking proteins is
actually very small and can only be reliably detected after 6 hours.
This brings to a conclusion the review of intracellular signalling in At-20 cells.
Figure 1.2.3 summarises this very complex, if fairly well characterised pathway.
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1.2.3 Molecular mechanisms of exocytosis in AtT-20 cells
As mentioned before, little work has been done in AtT-20 cells on the molecular
mechanisms of exocytosis which occur slightly further down the pathway. The
following section reviews the work that has been undertaken at this present time.
Rab proteins (ras-like GTP-binding proteins) have been the most extensively studied
proteins in AtT-20 cells, in terms of their role in exocytosis. Many monomeric small
G proteins (20-25 kDa) have been implicated in acting as molecular switches in
regulated membrane trafficking (see section 1.1; Bourne et al., 1991). Of these rab
proteins, rab3 is of particular interest due to its localisation to synaptic vesicles in
neurons (Fischer von Mollard et al., 1990). Ngsee et al.t 1993 transfected AtT-20
cells with an elasmobranch homologue of endogenous rab3A (o-rab3) and showed it
to be localised exclusively at the tips of the cell processes (where regulated secretory
proteins accumulate). Two mutations, affecting GTP binding and hydrolysis, blocked
the localisation of o-rab3 to the tips of the cell processes. These same mutations also
caused less efficient targeting of ACTH-containing vesicles to the processes, but had
no effect on ACTH secretion (basal or stimulated). These results suggest that the
rab3 proteins are important in vesicle transport to the process tips, but do not have a
role in the actual release of vesicles in a regulated manner. However without actually
removing all functional rab-3, it is very difficult to have absolute confidence in this
statement.
Martelli et al., 1995 identified rab3D in AtT-20 cells and showed it to have a diffuse
vesicular distribution in the cytoplasm of the cell body, the processes and the tips,
unlike rab3A. They put forward the possibility that it defines a regulatory secretory
pathway which functions independently of cell polarity, however it is important to
note that, as yet, there is no experimental evidence to back up this finding.
Wendland and Scheller, 1994 investigated the effects on secretion in AtT-20 cells of
stable transfection with soluble fragments of synaptotagmin, a putative calcium
sensor. If the synaptotagmin were acting in this manner, the soluble, non-functional
synaptotagmin should create a dominant negative phenotype, by interfering with the
secretory machinery. Subcellular fractionation analysis showed that the fragments
were localised to both soluble and membrane fractions, possibly by protein-protein
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interactions. Neither basal nor regulated secretion was affected in the stable mutants,
suggesting either that another pathway is present which is able to bypass the
synaptotagmin stage, or that synaptotagmin is simply not a requirement of regulated
secretion in AtT-20 cells.
1.3 Project aims
This chapter has reviewed two main areas:
• The molecular mechanisms of exocytosis
• Secretion from AtT-20 cells
The purpose of this project is to bring these two areas together and to elucidate
whether similar mechanisms of exocytosis are involved in these cells, as are present
in other cell types.
Increasingly it becomes apparent that considerable variation can be seen between
different cell types and particularly different experimental systems. It is important to
remember the very different physiological roles which neuronal and chromaffin cells
(the best studied exocytosis systems) have, in comparison to AtT-20 cells.
• The first aim was to completely characterise the AtT-20 cells using western
blotting and immunofluorescence, to assess which of the many proteins thought to be
involved in exocytosis, were actually present in this cell line.
• The second aim was to explore the role of these proteins in more detail by setting
up a permeabilised cell system and RIA (to measure ACTH secretion). This would
allow the entry into the cells of various recombinant proteins, antibodies, drugs and
toxins and subsequent measurement of their effect on exocytosis.
• A third aim of this project was to look at a possible alternative to the complex
and time-consuming RIA presently used for measurement of regulated secretion in
AtT-20 cells.
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Figure 1.2.1 Hypothalamus-Pituitary-Adrenal Axis
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Figure 1.2.2 Structure of pro-opiomelanocortin
(Nakanashi et al., 1979)
Abbreviations: MSH, melanocyte-stimulating hormone; ACTH,











































General Chemicals for biochemical techniques were obtained from BDH Chemicals
and Sigma Chemical Co., as were all photographic reagents.
Radiochemicals were all obtained from Amersham International pic.
Molecular Biology reagents were generally from Promega, Qiagen, GibCo BRL or
BioLabs. The plasmidmini-prep kit, Qiaex II Gel Extraction Kit, mRNA extraction
kit and Ni2+-agarose were all from Qiagen. The Great Escape Genetic Reporter kit,
containing the SEAP plasmid and the chemiluminescent detection method, was from
Clontech. All growth medium materials (yeast extract, tryptone and bact-agarose)
were from DIFCO. Reverse transcriptase superscript II was from GibCo BRL. Taq
polymerase, lkb DNA ladder and dNTPs were all from Promega. Vent DNA
polymerase and restriction enzymes were from BioLabs. IPTG was from BDH. All
primers were from Oswell or Cruachem and nucleic acid sequencing was done by
Oswell.
Cell Culture Reagents were from GibCO BRL, and plasticware was from Greiner.
The Lipofectamine™ reagent was from GibCO BRL. The Alkaline Phosphatase
Leukocyte Cytochemical stain Kit and the trypan blue stain were from Sigma.
Normal AtT-20 cell culture used GibCO DMEM (4500 mg/ml glucose), containing
10% v/v FCS and 100 IU/ml penicillin/streptomycin. Cells were frozen in GibCO
freezing medium. Transfections were made using GibCO Optimem™ medium,
incomplete DMEM (i.e. DMEM with no FCS or antibiotics) or selective complete
DMEM (with 2.5mg/ml G418). Incubations in the absence of 5% CO2 (for KC1 or
CRF stimulation assays) used a powdered form of DMEM which was supplemented
with Hepes/NaOH (pH 7.4) and BSA.
Radioimmunoassay materials were from NIDDK (National Institute of Diabetes
and Digestive Kidney Diseases). Human ACTH (1-39 synthetic peptide,
AFP6328031) and Human anti-ACTH rabbit antiserum (AFP2938C) were both
obtained from NIDDK. Radioimmunoassay tubes were from Luckam. PEG (average
molecular weight 8000) and BSA (high purity) were from Sigma Chemical Co.
Donkey anti-rabbit antiserum and normal rabbit serum were from SAPU (Scottish
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Antibody Production Unit). Digitonin was from Calbiochem. CRF, 8-bromo-cAMP,
dexamethasone, cytochalasin D and phalloidin were all from Sigma Chemical Co.
Antibodies were from various different sources. Secondary antibodies used for the
detection of immunofluorescence microscopy or western blots were from SAPU,
except for anti-mouse and anti-rabbit antibodies conjugated to rhodamine, which
were from Sigma Chemical Co. Anti-syntaxin HPC-1 antibody was also from Sigma
Chemical Co. All other antibodies used in western blotting and immuofluorescence
were kindly donated by various laboratories and are acknowledged in context, as are
various recombinant proteins.
METHODS
2.1 Cell culture of AtT-20 cells
AtT-20 cells were grown in a similar way to that described by Sabol, 1980. AtT-20
cells (clone D16-16, obtained from F. Antoni, Dept. of Pharmacology, Edinburgh
University) were grown in high glucose (4500mg/ml) DMEM medium with 10% v/v
FCS and 100 IU/ml penicillin/streptomycin until a confluency of approximately 80%
5 2
(approximately 5X10 cells per 25cm flask) was reached, at which point the cells
were passaged at a 1:3 dilution. This was done by first washing the cell monolayer
with 5ml of PBS and then adding 2ml of trypsin/EDTA. Having ensured complete
coverage of the monolayer the majority of the trypsin/EDTA was decanted off. The
cells were left in the residual trypsin/EDTA for 5min at room temperature and were
then resuspended in 6ml medium. This 6ml medium was distributed between three
25cm flasks and an additional 3ml fresh medium was added to each. These flasks
were then passaged in 3-5 days time, when the cells reached approximately 80%
9 9
confluency. This same protocol was carried out for 75cm - 500cm flasks/dishes and
for 6-24 well plates with the appropriate scale up according to surface area. Cells
were grown at 37°C with 5%C02.
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2.1.1 Freezing AtT-20 cells
'j
Cells were grown until they reached 80-90% confluency in a 75cm flask at which
point they were removed from the flask surface with 0.25% w/v trypsin/ 0.1% w/v
EDTA as detailed above. They were then resuspended in approximately 10ml of
medium and centrifuged at lOOOrpm for 5min using a bench centrifuge. The medium
was decanted from the tube and the cells were resuspended in 3ml of ice-cold
freezing medium, 1ml of which was aliquoted per freezing vial. The vials were kept
overnight at -70°C and transferred, after 24 hours, to liquid nitrogen where they were
stored until needed. The cells were taken up from liquid nitrogen by thawing the vial
quickly in a 37°C water bath and re-suspending in 10ml medium. They were then
centrifuged at lOOOrpm using a bench centrifuge for 5min (to remove them from
toxic dimethylsulphoxides, in the freezing medium) then resuspended in 5ml fresh
medium in a 25cm2 flask.
2.1.2 Large scale harvesting of cells




50mM KC1, lOmM EGTA, 50mM Hepes, 1.92mM MgCl2.
PIC (protease inhibitor cocktail) - used at 1:1000 (stored in DMSO)
Aprotinin lmg/ml, Leupeptin lmg/ml, Pepstatin lmg/ml, Antipain lmg/ml,
Benzamidine 1M, PMSF 40mg/ml.
Complete KHEM buffer (KHEM plus the following added):
ImM DTT, lpM cytochalasin B, 1 pl/ml PIC (see above).
TEA/KC1
Triethanolamine (TEA) lOmM, KC1 150mM.
All solutions used were at pH 7.4.
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2.1.2.2 Method
Cells were grown in 500cm2 Petri dishes until 80% confluent, at which point the
dishes were placed on ice, in the cold room. The plates were washed twice with 50ml
KHEM buffer, and were then incubated for 45min with 20ml complete KHEM
buffer. This was then removed and stored for later use, and the cells were swollen
with 50ml TEA/KC1 for lOmin, after which time they were again incubated in
complete KHEM buffer for 2-5min. This was decanted and the dishes placed on their
sides to drain until no more buffer was collected, at which point the cells were
scraped off using a sliced rubber bung. Approximately 0.8-lml cells were collected
per dish and these were then ruptured with approximately 30 down strokes in a small
Dounce homogeniser (2ml at a time). Cell breakage was assessed using 0.4% w/v
trypan blue solution and was found to be greater than 80-90%. To remove nuclear
material the homogenate was centrifuged at 2000rpm for 5min using a microfuge,
and the post-nuclear supernatant (PNS) was stored in liquid nitrogen (unless used
immediately).
2.1.3 Fractionation of post-nuclear supernatant
This method was similar to that detailed by Wendland & Scheller,1994 except that a
continuous sucrose gradient was used and the fractions collected were not TCA
precipitated. A 12ml continuous linear sucrose gradient was produced using a
gradient maker and peristaltic pump. The sucrose solutions were made up in lOmM
Hepes pH7.4 and 2mM EGTA, and were 0.4M and 1.925M. In later experiments
slightly varying sucrose gradients were tested and these are detailed in Chapter 3.
lml of PNS was carefully layered onto the top of each gradient and the tubes were
centrifuged (in a Beckman SW41 rotor, on an L8-55 Beckman, 55,000g) for 2 hours
at 4°C. lml samples were then removed using a peristaltic pump and a needle placed
at the bottom of the tube, and stored at -70°C, until needed.
2.1.4 Estimations of sucrose concentrations
A refractometer and refractive index conversion tables were used to estimate the
actual sucrose concentration in each fraction from the gradient.
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2.1.5 Protein estimations
Protein estimations were made of each cell fraction using the methods detailed
below. These methods were also used throughout the project.
2.1.5.1 Peterson's assay
A simplification of the method of Lowry et al., 1977 was used here.
A standard curve was produced using duplicates of 0-60pg bovine serum albumin
which were made up to 400pl with water, as were all samples. 40pl of 10% w/v
sodium deoxycholate was added to each and they were left to stand for lOmin at
room temperature. 40pi of 72% v/v trichloroacetic acid (TCA) was then added to
each tube. Samples were incubated at room temperature for 5min, and centrifuged at
6000rpm for lOmin using a microfuge, and the supernatants were then discarded.
This step allowed the removal of any substances that might interfere with the protein
assay.
CTC: 10% sodium carbonate, 0.1% w/v copper sulphate (pentahydrate), 0.2% w/v
potassium sodium tartrate. Sodium carbonate was made up first and then slowly
added to a solution of the latter two compounds.
Reagent A: was made up using equal amounts of: CTC, 0.8N NaOH, 10% w/v SDS,
water.
Reagent B: One volume of Folin-Ciocalteu phenol reagent was mixed with five
volumes water.
The sample was brought to a volume of 400pl with water, and 400pl of reagent A
was added, and incubated for lOmin at room temperature. 200pl of reagent B was
then added and the absorbance read at 750nm after 30min.
2.1.5.2 Bradford's assay
The following protocol is a modification of the protocol detailed below: Bradford,
1976.
25 mg of Coomassie Brilliant Blue G was dissolved in 25ml 96% v/v ethanol with
stirring overnight, and 50ml of 85% v/v orthophosporic acid was then added. This
was made up to 100ml with water to produce a 5 X stock solution of dye.
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The standard curve was obtained using BSA samples of 0-100pg. All samples were
made up to 1 OOpil in 150mM NaCl and 1ml of 1 X Bradford reagent (diluted in
150mM NaCl) was added to each sample. Having vortexed well, these were
incubated at room temperature for 30min, and the absorbance read at 595nm.
2.1.6 Galactosyl transferase assay
The transfer of galactose from [3H]-UDP-galactose to the glycoprotein acceptor
ovomucoid (Bretz & Staubli, 1977) was assayed, as a method of identifying the
position of the Golgi apparatus in the sucrose gradient during cell fractionation.
Assay mix: 40mM sodium cacodylate pH6.6, 17.5mg/ml ovomucoid, 40mM
mercaptoethanol, 0.2% v/v Triton X-100, 2mM ATP pH7.0, 40mM MnCh,
0.5p.Ci/ml [3H]-UDP-gal (specific activity 10-25 Ci/mmol; 370-925 GBq/mmol).
20|fr samples were incubated with 80ptl of the above assay mix at 37°C for 30min.
The reaction was stopped using 1ml of ice-cold 0.5M phosphotungstic
acid/hydrochloric acid (PTA/HC1) and the samples centrifuged at 2000rpm for 4min
in a microfuge. The supernatant was aspirated and the pellets washed 3 times with
lml PTA/HC1 as detailed above, and then given a last wash with 96% v/v ethanol
before being solubilised with 50ml of 2M Tris base and 200ml of 1% w/v SDS. The
samples were mixed on a shaker for lOmin and lml of Beckman (cocktail T)
scintillation fluid was added to each sample. These were then loaded into Beckman
5ml scintillation vials and counted.
2.1.7 Biotinylation of cell surface antigens
In order to detect plasma membrane proteins in the gradient fractions a large scale
AtT-20 cell preparation was done in the presence of a biotinylating reagent (i.e.
biotinylation of whole cells). The protocol is as in 2.1.3, except for the additional
steps detailed below.
Biotinylation buffer pH7.5: 137mM NaCl, 5mM KC1, 5mM glucose, ImM MgCh,
ImMCaClj, 6mMNaHC03.
500cm dishes were placed on ice in the cold room and washed twice with 20ml PBS
per dish. 35ml of biotinylation buffer, containing N-hydroxysuccinimidyl-biotin
(NHS-biotin) at a concentration of 300p,g/ml, was added to each dish and incubated
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for 30min. 175pl lysine (O.lmg/ml stock solution) was added per dish and mixed, in
order to remove unreacted NHS-biotin and so prevent biotinylation of intracellular
proteins on homogenisation. The biotinylation buffer was then decanted and the
cells then harvested exactly as detailed in 2.1.3.
After blotting, and blocking free protein sites, the biotinylated cell surface antigens
were detected using streptavidin-peroxidase at a concentration of 1/4000 in the
normal secondary antibody buffer.
2.1.8 Triton Fractionation of cell pellet
AtT-20 cells were grown until eight confluent 450cm" flasks were obtained, and the
cells were then removed using trypsin/EDTA. The cells were centrifuged for 5min, at
lOOOrpm, on the bench centrifuge to obtain a pellet that was used in the protocol
detailed below.
2.1.8.1 Pre-condensation of TX-114
This procedure is similar to that detailed by Bordier, 1981 and its purpose was to
remove any contaminants from the Triton X-l 14.
20g of Triton X-l 14, and 16mg of butylated hydroxytoluene (dissolved in lOOpl
ethanol) was added to 980ml of lOmM Tris-salt pH7.4/ 150mM NaCl. This mixture
was left on ice for 8 hours, during which time the solution became clear. It was then
transferred to a separating funnel and warmed overnight at 30°C, which caused
separation into an aqueous phase and a detergent phase, the former of which was
discarded. The discarded aqueous phase was then replaced with fresh buffer, and the
process repeated twice more, finally recovering the detergent phase.
2.1.8.2 TX-114 phase separation of integral membrane proteins
The protocol used here was adapted from that described in Pryde & Phillips, 1986
and Pryde, 1986. The AtT-20 cell pellet, described above, was resuspended in 4ml of
Tris-salt buffer (lOmM Tris pH7.6, 150mM NaCl). TX-114 was then added to a
concentration of 2% at 4°C, and the solution left on ice for 2 minutes. This was then
centrifuged at 100,000rpm (TL 100.3 rotor, TL-100 centrifuge) for lOmin, after
which the supernatant was removed and kept on ice, whilst the pellet was
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resuspended in Tris-salt buffer. This was centrifuged as before, and resuspended
400pl of Tris-salt buffer. This fraction was the phospholipid-rich fraction (PI).
1.6ml of the supernatant was then loaded on to a 1.4ml sucrose cushion mix (0.25M
sucrose, lOmM Tris pH7.6, 0.15M NaCl, 0.06% TX-114), in a conical test tube and
incubated at 30°C for 3 minutes. The samples were then centrifuged for 10 minutes at
4000rpm in a bench centrifuge, and the top aqueous layer removed and kept on ice.
The sucrose cushion was removed, leaving behind a thick detergent-rich phase,
which was diluted by adding a small volume of Tris-salt buffer. The process of phase
separation was repeated and the final detergent phase diluted with an equal volume
of Tris-salt buffer. This was the P2 fraction.
To the aqueous layer from the above phase separation had TX-114 was added to a
concentration of 0.5%. This was overlayed on a sucrose cushion and the phase
separation repeated, again keeping the aqueous layer. TX-114 was then added to a
concentration of 2% and phase separation repeated, taking the final aqueous layer as
the end product. This was the hydrophilic fraction (S2).
2.2 Gel electrophoresis and western blotting
Separation of proteins was achieved by electrophoresis through polyacrylamide gels
following the basic procedure of Lammili, 1970, using the Hoeffer "Tall Mighty
Small" apparatus.
2.2.1 SDS-PAGE
2.2.1.1 Solutions for SDS-PAGE
Separating gel: 0.1% w/v SDS, 330mM Tris HC1 pH8.8,10-15% w/v acrylamide:
bis-acrylamide, 0.1% w/v APS, 0.1% v/v TEMED.
Stacking gel: 0.11% w/v SDS, 0.14mM Tris HC1 pE16.5, 4.5% w/v Acrylamide:Bis-
acrylamide, 0.1% w/v APS, 0.1% v/v TEMED.
The acrylamide:bis-acrylamide was at a ratio of 30:0.8.
Electrophoresis buffer (5 X stock): 0.248M Tris-base, 1.92M Glycine, 0.5% w/v
SDS, ImM EDTA.
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Sample buffer (4 X stock): 0.2M Tris-HCl pH6.5, 20% w/v SDS, 8mM EDTA,
40% v/v glycerol, 40mM DTT, 0.2mg/ml bromophenol blue. Samples were usually
heated to 100°C although variations of this were used, and these are detailed in the
results chapters.
Molecular weight markers: DaVII (14-66kDa) and High MW markers (29-
205kDa), both ofwhich were from Sigma Chemical Co.
2.2.1.2 Assembly of gel cassette and pouring of gels
The alumina backing plate, glass plate and plastic spacers were cleaned with
methanol. The cassette was then assembled with the alumina plate first, spacers and
glass plate; all flush with the back reservoir base. These were held in place with 4
clips and then the apparatus placed on a glass plate in some molten 1.5% agar to seal
it. The appropriate volumes of 10% APS and TEMED were then added to the
separating gel mix, this was mixed and then pipetted in between the alumina and
glass plates up to a level that allowed room for the separating gel and comb. Until
set, this gel mixture was overlayed with water-saturated butan-2-ol Once this was set
the top was washed the stacking gel mix was pipetted on top of the separating gel,
and a 10 or 15 well comb inserted. Once this had set, the gel cassette was inserted
into a bottom tank and electrophoresis buffer added to the bottom and top tanks.
Samples were loaded and the gel was run at 20mA (constant current) for
approximately 1.5 hours.
2.2.1.3 Solutions for coomassie staining of gels:
Gel fix: 10% v/v acetic acid, 20% v/v methanol.
Gel stain: 0.125% w/v Coomassie blue R, 50% v/v methanol, 7.5% v/v acetic acid.
Destaining solution: 7% v/v acetic acid, 10% v/v methanol.
2.2.1.4 Fixing, staining and destaining of gels
Having run the gels, the apparatus was disassembled and the gels transferred to fix
for 10-30min, where they were incubated with gentle shaking. They were then
transferred into stain for lOmin and then into destain overnight, again with gentle
shaking. Finally they were then dried down or vacuum-sealed until they were
scanned.
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2.2.1.5 Densitometric scanning of gels
Quantitation of recombinant toxins was done using a combination of Bradford
protein assays and a Densitometer Raster scan, using a Joyce-Loebl computer
program for analysis.
2.2.2 Western blotting
2.2.2.1 Solutions for western blotting
Transfer Buffer: 20mM Na2HPC>4, 20% v/v methanol, 0.02% w/v SDS.
TBS X 10: 200mM Tris HC1 pH7.4, 1.5N NaCl.
Blocking buffer: 0.5% Tween20, 0.05% sodium azide, 5% Marvel (in TBS).
Washing buffer: 0.05% Tween-20 in TBS.
Primary antibody solution: 5% v/v normal horse serum, 5mg/ml BSA, 0.05% w/v
sodium azide, 0.5% v/v Tween-20 (in TBS). The primary antibody was usually used
at 1/1000 dilution (details of the antibody and concentrations are given in the
appropriate chapter).
Secondary antibody solution: 0.05% v/v Tween-20 in TBS. Secondary antibody
was either anti-rabbit conjugated to HRP or anti-mouse IgG conjugated to HRP. Both
were used at a dilution of 1/4000 and were from SAPU.
Ponceau S (10 X stock): 2% w/v Ponceau S, 30% v/v TCA, 30% v/v sulphosalicylic
acid.
2.2.2.2 Western blotting protocol
A cassette was set up in transfer buffer with a layer of sponge, and four pieces of
filter paper at either side. The gel to be blotted was carefully lifted onto this and a
piece of nitrocellulose was placed on top. The cassette was closed and placed into the
blotting apparatus, which was already full of transfer buffer. The proteins were
transferred onto the nitrocellulose for 3 hours at 1.5amp or overnight at 0.5amp.
The nitrocellulose was removed from the tank and stained with Ponceau S in order to
assess the position of the marker bands. This was done by incubating the blot in
Ponceau S for lOmin and then washing with water until the bands appeared. These
were marked on the nitrocellulose with pen and then the blot was transferred into
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blocking solution for 3hours or overnight. The blocking solution was then removed
and the primary antibody solution added and incubated for 3 hours or overnight.
Having removed this the blot was washed 3 times for 15min with wash solution and
the secondary antibody solution was added for 45-60min. This was removed and the
blot was washed 3 times for 20min. All incubations were done with gentle rocking
and washing with more vigorous shaking. The blot was then well covered with ECL
solution for 2min, and having poured this off, the blot was wrapped in cling-film.
This was then exposed to Amersham X-ray film, which was subsequently developed
using an automatic developer.
2.2.2.3 Positive controls for Western Blotting
Various positive controls were used during the Western blotting section of this
project. Chromaffin granule membranes (CGM) and mitochondria were obtained
from Dr. David Apps (Dept. of Biochemistry, University of Edinburgh) and
synapotsomes from Leonora Ciufo (Dept. of Biochemistry, University of
Edinburgh). Golgi-apparatus and microsomal preparations were done as follows.
Golgi Preparation: Rat liver homogenate was made up to a sucrose concentration of
1.6M and then 1ml loaded at the bottom of a 0.5M-1.3M sucrose gradient (in lOmM
Hepes pH 7.4). This was centrifuged at 41K in a swinging bucket rotor (SW41), in a
Beckman L8-55 centrifuge at 41,000rpm, for 60min at 4°C. The middle band of
membranes was removed and diluted to 0.25M sucrose, and centrifuged in a SW45
rotor/ Beckman L8-55 centrifuge, for 30min at 4°C/45K. The pellet was then
removed and the sucrose concentration made up to 1.6M and 2.0M KC1 and 1ml
loaded at the bottom of a continuous 0.5-1.3M sucrose gradient. This was centrifuged
for 30min at 41K in an SW41 rotor/Beckman L8-55 centrifuge at 4°C. The band in
the centre was removed, and shown to have a sucrose concentration of 0.988M,
which was around the expected level for Golgi-apparatus.
Microsomal preparation: The microsomal preparation was done using a discarded
fraction from a chromaffin granule preparation. The first supernatant was removed
and spun at 50,000rpm in the 50.2Ti rotor (L8-55 centrifuge), for 60 min at 4°C. The
pellet was then resuspended in lOmM Hepes (pH7.4), 2mM EDTA.
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2.3 Indirect immunofluorescence microscopy
2.3.1 Solutions for immunofluorescence microscopy
PBS (phosphate buffered saline) pH 7.4: 137mM NaCl, 2.7mM KC1, 4.3mM
Na2HP04, 1.47mM KH2P04.
Fix solution: 3% v/v p-formaldehyde in PBS containing ImM CaCl2 and ImM
MgCl2.
Quench solution: 50mMNH4Cl in PBS.
Permeabilisation solution: 0.2% v/v Triton-X-100 in PBS.
Block solution: 0.2% v/v fish skin gelatin in PBS.
Moviol mounting medium: 25% v/v glycerol, 10% w/v Moviol 4-88, lOOmM Tris
HC1 pH 8.5. If the secondary antibody being used was conjugated to FITC, anti-fade
would also be added to this solution (this was n-propyl-gallate at 5mg/ml).
Hoescht dye: 2pg/ml Hoescht dye in PBS. This was only used periodically, as it
stains DNA and therefore the nucleus. It was also used on a regular basis to check for
mycoplasma contamination of the cells, of which there was none throughout this
project.
2.3.2 Protocol for indirect immunofluorescence microscopy
AtT-20 cells were plated onto sterilised coverslips in 6-well plates, and grown for 3
days until approximately 60-70% confluent. The cells were then washed three times
with 2ml PBS containing ImM CaCl2 and ImM MgCl2. 2ml of fix solution was then
added for lOmin, after which the cells were washed three times with 2ml PBS. 2ml
quench solution was added for lOmin, the cells were washed as in the last step, and
2ml permeabilisation solution was added for 4min. Washing from this point on
consisted of the permeabilised cells being washed three times with 2ml blocking
solution (over 5min), and a further three washes with 2ml PBS.
The primary antibodies are detailed in the results chapters but were usually at 1/100
dilution and were always made up in blocking solution. lOOpl droplets were placed
onto parafilm and the coverslips were inverted onto the drops and left there for
20min. They were then returned to the 6-well plate and washed, after which the same
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procedure was used for the secondary antibody incubation. Secondary antibodies
were generally anti-rabbit or anti-mouse IgG conjugated to rhodamine, although for
double labelling the same antibodies were often used linked to FITC, as detailed in
the Chapter 3. Following this incubation the cells were washed, rinsed in distilled
water, dried and mounted on glass slides with a 20pl drop of Moviol mounting
medium. They were stored at 4°C overnight, to allow the Moviol to set, and then
viewed on a fluorescence microscope using the appropriate filter. Before mounting
with moviol the cells could also be stained with Hoescht stain, by incubation with
2ml for lOmin and washing afterwards in the normal way. Other directly-conjugated
fluorescent tags were used to stain the cells (e.g. phalloidin conjugated to coumarin
to stain actin), and these simply required a single incubation stage, and were done as
detailed above.
2.3.3 Immunofluorescence photography of cells
2.3.3.1 Developing films
Photographs were taken using a Leica camera system attached to a similar
microscope. Kodak 400 T-max films were used and the speed was set at 1600 ASA
instead of 400 ASA in order that minimal exposure times were obtained. This meant
that the development times for the film were increased slightly (7min to llmin).
When pictures of non-fluorescent cells were taken the same film was used, but the
speed was set at 400 ASA and development times were as stated on the instructions
(7min). Photographs were generally taken using a 63X oil-immersion lens.
The film was inserted into a developing tank in the dark room, in complete darkness.
400ml water was added per film, left for 2min, and on removal, 400ml of developing
solution was added. This was agitated every 2min, up to the desired development
time. The developer was replaced with 5% v/v acetic acid (stop solution), incubated
for 2min, and then replaced by fix solution for a further 15min. On removal of this
the film was rinsed in water for 5min, the final wash containing a drop of 10% v/v
Triton-X-100. The film was then dried and stored until ready to print.
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2.3.3.2 Printing negatives
The film was printed on Illford photographic paper (high resolution), and the stop
solution and fix solution were as detailed in 2.3.3.1. Exposure times ranged from 10-
30 seconds, after which the paper was placed into a tray of Sigma photographic
paper developer and rocked gently for l-2min. It was then transferred into stop
solution for 30sec-lmin, fix for 5-10min, and the photographs were then rinsed with
water for at least lOmin, before being dried.
2.3.4 Affinity purification of antibodies for use in immuonfluorescent staining of
AtT-20 cells
Thisprotocol was obtainedfrom Alan Boyd (Department ofBiochemistry, Edinburgh
University; unpublished work)
SDS-PAGE was used as described in section 2.2.1 with a single lane comb, to obtain
a band of the appropriate recombinant protein. This was transferred to nitrocellulose
using the western blotting protocol detailed in section 2.2.2, and stained with
Ponceau S to identify the band of interest. A strip was cut from the nitrocellulose,
containing this band, and was washed with TBS to remove residual Ponceau S. The
antigen-bearing face of the nitrocellulose was marked and incubated in blocking
buffer for 90min. As much antiserum (against the recombinant protein) as would stay
on by capillary action was loaded onto the strip, and incubated at room temperature
for 2 hours. The depleted serum was removed, the strip washed 3 times with TBS,
and 0.2M glycine/HCl pH2.8 added for 20min to elute specific antibodies. This
eluate was neutralised using 0.2M Tris/HCl pH8.5, and the solution stored at 4°C
with NaN3.
2.4 ACTH radioimmunoassay
This protocol was obtained from John Bennie (Royal Edinburgh Hospital) and is
based on that detailed by Woods, et al., 1992.
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2.4.1 Iodination of ACTH
A 1ml SEP-PAK CI8 (octodecasilica) column was attached to a 5ml syringe and was
primed with two 1ml washes of 80% v/v acetonitrile, 0.1% v/v TFA, followed by
three 1ml washes of 0.1% v/v TFA. 1 pg ACTH peptide, stored in lOpl 0.0IN HC1 at
-70°C, was radio-iodinated using 125I (specific activity 569.8MBq/pg of iodine; 15.4
niCi/pg of iodine). This was done by adding 40pl of 0.5M sodium phosphate buffer
(pH8.0), 5pl of Na125I and 5pl of 2mg/ml chloramine T to the lpg of ACTH. After
60 seconds the reaction was stopped by the addition of 1ml of 0.1% v/v TFA, and
was also added to the column. The liquid was gently pushed through the column and
the reaction vial washed out with another 1ml 0.1% TFA, which was also transferred
onto and through the column. These eluates (El and E2) were collected in 3ml tubes
and a stepwise elution of the radio-iodinated ACTH was begun. Steps of 10, 20, 30,
40, 50, 60, 70 and 80% v/v acetonitrile (in 0.1% v/v TFA) was used (1ml washes),
and it was found that the ACTH was eluted at the 40 or 50% fraction. 0.8ml
methanol was added to these tubes to prevent freezing (which would have damaged
the iodinated ACTH), and they were stored at -20°C for 3-4 weeks with no loss of
biological activity.
2.4.2 Measurement of ACTH by radioimmunoassay
2.4.2.1 Materials
Radioimmunoassay buffer: 8.94g Na2HPC>4 (anhydrous), 4.84g Na2EDTA.2H20,
0.2g NaN3 was warmed to dissolve, in 800ml water. 400KIU/ml or 0.15 TlU/ml of
aprotinin was added and the buffer was made up to 1000ml. All stages of assay used
this buffer with various detailed additions, and it could be stored at 4°C and used as
needed. The final pH was pH7.4
2.4.2.2 Method
All manipulations were done on ice or in the cold room. The standard curve was
produced using 0 (B0), 0.02, 0.04, 0.08, 0.156, 0.312, 0.625, 1.25, 2.5, 5, 10, 20, 40
and 80ng/ml ACTH samples, and all points were measured in triplicate. NSB (non¬
specific binding) samples had the appropriate buffer volume in place of ACTH
antiserum. TC (total count) samples were 50pl untreated samples of iodinated
ACTH. Standards were made up in radioimmunoassay buffer containing 0.25% w/v
high-purity BSA. 50pl of standard or unknown samples were added to 3ml tubes,
along with 5Opt of 125I-ACTH diluted in radioimmunoassay buffer with 0.1% v/v
TX-100 (the iodinated ACTH having been diluted to 10000 cpm per 50pl aliquot).
Anti-ACTH was diluted 1/60,000, in radioimmunoassay buffer (containing 1% NRS
and 0.1% TX-100), and added to the same 3ml tubes which were vortexed well and
incubated in the cold room overnight. 250pl of a 1/25 dilution of donkey anti-rabbit
antiserum (in radioimmunoassay buffer containing 0.01% v/v TX-100) was added
and the tubes incubated on ice for a further 3 hours after vortexing well. 600pl of
8.7% w/v PEG (in radioimmunassay buffer with 0.25% BSA) was added, the tubes
vortexed and then centrifuged for 1 hour at 4,200rpm in a J6B centrifuge (i.e.
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4000g). The supernatants were carefully aspirated the I content of the tubes
measured for 3 minutes per sample, using a Nuclear Enterprises NE1612 turbo
gamma counter.
2.5 Cell assays
2.5.1 Non-permeabilised cell assays
All incubation times and concentrations are typical; where variations were used these
are detailed in the appropriate results chapter.
2.5.1.1 Ba2+ stimulation of cells
(Hurtley, 1993 Journal ofCell Science 106, 649-656)
All incubations were done at room temperature. Cells were grown in 24-well dishes
to 80% confluency and washed with 1ml Locke's buffer (154mM NaCl, 5.6mM KC1,
5.6mM glucose, 1.2mM MgCl2, 2.2mM CaCl2, 5mM Hepes, pH 7.0). They were
then allowed to equilibrate in 1ml Mg-Locke's buffer (154mM NaCl, 5.6mM KC1,
5.6mM glucose, 3.4mM MgCl2, 5mM Hepes, pH 7.0) for lOmin followed by a
lOminute incubation with 1ml Ba-Locke's buffer (154mM NaCl, 5.6mM KC1,
5.6mM glucose, 5mM BaCl2, 1.2mM MgCl2, 5mM Hepes, pH 7.0). Control cells
(giving non-stimulated basal rates of secretion) were at this last stage treated in
parallel with Locke's buffer.
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2.5.1.2 CRF stimulation of cells and inhibition with dexamethasone
Cells were grown in 24-well plates until 80% confluent and then washed with 1ml of
serum-free (SF) DMEM (pH 7.4; obtained in powder form, supplemented with 0.6%
w/v Hepes/NaOH and 0.25% BSA per 100ml made up). 250pl of this SF DMEM
was added to each well and the plate was incubated at 37°C for 30min (without CO2),
after which any wells requiring incubation with dexamethasone were treated with
250pl of SF medium containing dexamethasone at twice the required concentration.
This was added without removal of the 250pl SF medium, and control cells were
treated in the same way with 250pl SF medium, minus the dexamethasone. The
plates were then incubated for 90min at 37°C, however if no dexamethasone was
being used this step was omitted, although the 30 minute incubation with SF medium
was still included. The medium was then aspirated, the appropriate concentration of
CRF added, and the plates incubated for 30min at 37°C.
2.5.1.3 Stimulation of cells with 8-bromo-cAMP
As before cells were grown to 80% confluency in 24-well plates, and then washed
with 1ml of SF medium. They were then incubated for approximately 15min at
37°C/5% CO2 with the appropriate concentration of 8-bromo-cAMP in 1ml SF
medium.
2.5.1.4 Stimulation of cells with high potassium concentration
KC1 solution: A solution (total volume 25ml) was made up containing 20.5ml of
1.15% w/v KC1, 0.6ml of 1.18% w/v CaCl2, 0.2ml of 3.82% w/v MgCl2, 0.2ml of
0.5M Hepes/NaOH pH 7.4, 50mg glucose. This was diluted with two parts SF
DMEM to make a high K+ (50mM) solution which would de-polarise AtT-20 cells.
Cells were grown to 80% confluency in 24-well plates and then washed with 1ml SF
DMEM (normal liquid form without FCS or penicillin/streptomycin). They were
then incubated with 1ml of a 50mM KC1 solution at 37°C, for 30min.
2.5.1.5 Removal of samples in assays of non-permeabilised cells
Immediately after the final incubation, the plates were placed on ice and 300pl
samples removed and centrifuged for 5min at 13.000rpm (4°C) using a microfuge.
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Samples of the supernatant were then removed and stored at -70°C, until the ACTH
concentrations were measured by radioimmunoassay.
2.5.2 Permeabilised AtT-20 cell assay
All incubations are done at room temperature. 24-well plates were incubated with
200pl 0.1% w/v poly-L-lysine per well for 5min, washed with 1ml sterilised
distilled water and left to dry for 3-5 hours. Cells were plated and grown until 80%
confluent as usual. They were then washed with 1ml permeabilisation buffer pH 6.6
(139mM potassium glutamate, 20mM PIPES, 5mM EGTA, 2mM MgCl2, 2mM
NaaATP) and then incubated with 1ml permeabilisation buffer containing 20pg/ml
2_j_
digitonin for lOmin. The digitonin was aspirated off and a 15min pre-Ca
stimulation stage was used to allow the entry of recombinant proteins, antibodies or
drugs into the cells. This involved the dilution of the various factors in the
permeabilisation buffer and the addition of 500pl of this per well, control cells being
• • ... • • 24-treated in parallel with permeabilisation buffer only. Having done this 500pl of Ca
stimulation buffer (at double the required concentration of Ca2+) was added directly
to the wells, to the 500pl buffer already present. This was incubated for lOmin at
which point the plate was placed on ice, 300pl samples removed and centrifuged for
5min at 13,000rpm (4°C) using a microfuge, and the supernatants were kept at -70°C
2~buntil the ACTH concentration was measured by radioimmunoassay. The Ca
stimulation buffer contained 20pM free Ca2+, giving a final concentration of 10pM
free Ca2+, as calculated using the computer program "ca.calc" (kindly donated by
Richard Ashley, Dept. of Biochemistry, Edinburgh University). In this buffer 20pM
94-
Ca was given by adding CaC^ to a final concentration of 6.4mM. Control cells
94-
were treated in parallel with Ca -free permeabilisation buffer.
2.5.3 Buffer replacement
Various toxins and recombinant proteins that were used were obtained in buffers
other than the permeabilisation buffer. Because of the importance of maintaining the
precise Ca2+ concentration it was often necessary to transfer these factors into the
correct buffer. Biorad Biogel (P6-DG) was swollen in distilled water and
approximately 1.5ml was added to an Eppendorf tube, with a small hole in the base
and a plug of packed glass wool. The gel was allowed to settle and the resin then
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equilibrated by slowly dripping 5ml permeabilisation buffer through the Eppendorf
tube, which was then centrifuged for 2min at lOOOrpm using a bench centrifuge. Up
to 250pl of the protein/toxin solution was then placed on the top of the column,
which was then incubated for 5min and centrifuged as before. The concentration of
protein/toxin before and after ion exchange was assessed using gel electrophoresis or
A280-
2.5.4 Total lysis ofAtT-20 cells
This protocol was taken from Sambrook et al., 1989. Total ACTH content was
measured by lysing the cells with a triple detergent lysis buffer, containing 50mM
Tris.HCl (pH 8.0), 150mM NaCl, 0.02% w/v NaN3, 0.1% w/v SDS, lOOpg/ml
PMSF, lpg/ml aprotinin, 1% v/v Nonidet P-40 and 0.5% w/v sodium deoxycholate.
The cells were washed with 1ml of PBS, containing ImM CaCl2 and ImM MgCl2,
and then 1ml of lysis buffer added, and the plate incubated on ice for 20min. The
buffer was then removed and treated as with any other radioimmunoassay sample,
however on assaying these samples a separate Bo sample was used containing 50pi
of lysis buffer in place of the 50pl RIA standard buffer usually used.
2.5.5 Lactate dehydrogenase (LDH) assay on permeabilised cells
AtT-20 cells were permeabilised as described in section 2.5.2, with variations being
detailed in chapter 5. LDH concentrations were measured in the digitonin solution
and in the permeabilisation buffer used in subsequent stages. Samples were assayed
for LDH activity using a Roche Cobas Fara automated centrifugal analyser, and LDH
assay kit (Sigma Chemical Co. 340-LD).
2.6 Production and purification of toxins
2.6.1 Production of toxins
The plasmids used were a kind gift from H. Niemann (Tubingen, Germany) and were
based on the Quigen expression vector pQE with the light chain genes of
botulinum D or tetanus toxin inserted. The toxins were expressed as His6-tagged
55
fusion proteins which allowed purification using a Ni-agarose system. Maps and
details of these plasmids can be found in the Appendix.
2.6.1.1 Competent NM522 cells
These were made using a method based on that described by Sambrook et al., 1989.
This same reference also details the basic protocol for the transformation of the cells
(section 2.6.1.2).
5ml of L broth (0.5% w/v NaCl, 0.5% w/v yeast extract, 1.0% w/v tryptone) was
inoculated with NM522 E. coli cells and grown at 37°C overnight with shaking. 50ml
of L broth was then inoculated with 1ml of this culture and grown under the same
conditions until the A6oo reached between 0.4 and 0.7. The cells were harvested by
centrifugation at 5000rpm (4°C, 5min) and resuspended in 20ml of 0.1M MgCl2,
after which they were again harvested in the same way. This pellet was resuspended
in 10ml cold CaCl2 and the cells stored on ice for 1 hour, before being stored at -70°C
until needed for transformation with the toxin and other plasmids.
2.6.1.2 Transformation of NM522 cells with toxin-expressing plasmids
2pl of plasmid was added to 200pl of competent NM522 cells and left on ice for 1
hour, before heat-shocking the cells at 42°C for 2-3min. 800pl of 2YT medium
(0.5% w/v NaCl, 1.6% w/v tryptone, 1.25% w/v yeast extract) was then added and
the cells incubated at 37°C for 1 hour. A 200pl aliquot was spread on to selective
agar (2YT medium with 1.5 % w/v agarose and lOOpg/ml ampicillin). The plates
were incubated overnight at 37°C in order to obtain toxin-expressing clones, which
were subsequently used to inoculate 5ml of selective 2YT medium containing
lOOpg/ml ampicillin. These cultures were grown overnight at 37°C with shaking and
were used for the purposes of a large-scale toxin preparation.
2.6.1.3 Large scale production of crude toxin
500ml of 2YT medium containing lOOpg/ml ampicillin was inoculated with a 5ml
culture, prepared as detailed above. This was grown at 37°C until the A6oo reached
0.6-0.7 at which point the cells were induced to produce protein by the addition of
0.5mM IPTG (for BoNTD) or 0.2mM IPTG (for TeTX). The culture was grown
under the same conditions for a further 2.5 hours at which point the cells were
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harvested by centrifugation at 4000g for 20min at 4°C. The bacterial pellet was then
resuspended in 10ml sonication/elution buffer (SE buffer; 50mM NaE^PC^ pH8.0,
300mM NaCl) containing 5mM benzamidine, 0.5mM PMSF and lpg/ml pepstatin
A. The bacteria were disrupted by pulse sonication on ice for two lmin periods of
sonication. The lysate was then cleared by centrifugation at 7000rpm for 20min using
a 50Ti rotor, (L8-55 Beckman centrifuge) at 4°C, the supernatant removed and
further purification of toxins carried out.
2.6.2 Purification of toxins
2.6.2.1 Purification of botulinum D light chain toxin (BoNTD-LC)
The final protocol used is detailed here, however before selecting this various
washing stages were tried and these are detailed in Chapter 5. All washes were done
on ice and involoved re-suspending the Ni-agarose gel and centrifuging briefly at
lOOOrpm on a bench centrifuge. 1ml Ni-NTA-agarose (50% slurry) was placed in a
conical glass tube and washed 5 times with 4ml SE buffer (pH 8.0), after which 9ml
of the lysate supernatant was added. The tube was incubated on a roller mixer in the
cold room overnight to allow the his-tagged light chain toxin to bind to the Ni-
agarose gel. The Ni-agarose gel was centrifuged as above and the supernatant
removed by aspiration, followed by ten 4ml washes with SE buffer pH 8.0. The Ni-
agarose was then washed ten times with 4ml washes of lOmM imidazole, in SE
buffer pEl 8.0, and then 10 times with 4ml washes in 30mM imidazole, in SE buffer
pH 8.0. Elution of the toxin was brought about by washing with 0.5ml of lOOmM
imidazole in SE buffer pH 8.0, and the yield was slightly improved by incubating
them together on the roller mixer at 4°C for 30min. This 0.5ml toxin preparation was
then transferred into permeabilisation buffer after buffer exchange using the Biogel
system already described. A control preparation was done with untransformed
NM522 cells grown in non-selective medium, which was fractionated and eluted in
parallel to the BoNTD-transformed NM522 cells.
2.6.2.2 Purification of tetanus toxin light chains (TeTX-LC)
The binding of the his-tagged TeTx to the Ni-agarose was done as described above
for BoNTD, however the washing and elution steps differed as follows. Having
removed the first supernatant the Ni-agarose was washed 5 times with 4ml of SE
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buffer pH8.0, followed by 5 washes with 4ml of SE buffer pH6.5. Elution was
achieved with 10 washes of 0.5ml SE buffer at pH5.0. The highest protein
concentration was in fraction 10, and the yield was improved by a 30minute
incubation at 4°C on the roller mixer. Again this 0.5ml toxin preparation was buffer
exchanged using the Biogel system described above and a similar control cell
preparation (using untransformed NM522 cells) was done in parallel.
2.7 Transfection of AtT-20 cells
2.7.1 Lac-Z assay
A lac-Z reporter assay was used to assess whether the lipofectamine method of
transfecting AtT-20 cells with plasmids was suitable, and also for examination of
varying transfection conditions. The plasmid used is detailed in the Appendix.
Transient transfection of cells was examined by detecting expressed P-galactosidase
in cells using histochemistry.
2.7.1.1 Transfection of AtT-20 cells with lac-Z expressing plasmid
Ratios of DNA:lipofectamine were varied and are as detailed in Chapter 6. Cells
were plated in 6-well plates and grown until 60-70% confluent. The transfection
mixture was prepared in polystyrene tubes by mixing varying amounts of DNA with
lOOp.1 of Optimem™ serum free (SF) medium, and then varying amounts of
lipofectamine with lOOpl Optimem™ SF medium. The two solutions were then
combined, gently mixed and left at room temperature for 30min. The cells were
rinsed with 2ml of Optimem™ SF medium, and a further 0.8ml of Optimem™ SF
medium added to the transfection mixture. Having removed the wash, the
transfection mixture was added to the cells (approximately 1ml per well), and left for
5 hours at 37°C in 5%C02. This was then replaced with complete DMEM (DMEM
with penicillin/streptomycin and 10% FCS) for 24 hours, at which point the cells
were tested for p-galactosidase activity using the method detailed below.
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2.7.1.2 P-galactosidase staining of cells transfected with lac-Z plasmid
PEM buffer: lOOmM potassium phosphate buffer (pH7.4), 5mM EDTA, 2mM
MgCl2.
Fix: 0.2% v/v glutaraldehyde, in PEM buffer.
Wash solution: 0.01% w/v Na deoxycholate, 0.02% v/v Nonidet P-40, in PEM
buffer.
Stain: 0.5mg/ml X-gal, lOmM K3[Fe(CN)6], lOmM K4[Fe(CN)6], in wash solution.
The cells were washed twice in PBS containing lmMCaCl2 and ImM MgCl2, and
then in 2ml fix solution for 5min. This was aspirated off and the cells washed another
three times with wash solution. 2ml of stain was then added to the cells and they
were incubated in the dark at room temperature for 3 hours, after which time the cells
were again washed twice with wash solution, transfected cells stained blue and the
plates were photographed.
2.7.2 Transfection of AtT-20 cells with SEAP or HGH-SEAP plasmid
Two types of vectors were used in these experiments, both based on the Clonetech
(pSEAP-control) plasmid. The first is a simple reporter vector which causes the
transfected cells to secrete alkaline phosphatase, which itself can be assayed in a
number of ways. The second construct was made by Alan Colley (Department of
Biochemistry, University of Edinburgh) and involved the attachment of the human
growth hormone gene to the alkaline phosphatase gene. The idea was that the cells
would secrete the fusion protein in a Ca2+-regulated manner, as opposed to
constitutively. This secreted alkaline phosphatase could then be assayed in a number
of ways, and the system would offer an alternative method of measuring regulated
exocytosis, that is much quicker and simpler than the ACTF1-RIA currently used.
The plasmid maps and details can be found in the Appendix. All DNA/lipofectamine
concentrations are detailed in the Chapter 6, as different concentrations were tried.
2.7.2.1 Preparation of plasmid DNA
Plasmid DNA was made by transfecting competent NM522 cells (as detailed in
section 2.6.1.2 but using L broth) with the original plasmid DNA (constructed and
purified by Alan Colley. The cells were spread on selective L broth agar ( containing
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ampicillin) and placed at 37°C overnight, after which a colony was picked to
inoculate a 5ml L broth culture, which was grown at 37°C overnight with shaking.
This 5ml culture was then processed to pure plasmid DNA using the Qiagen mini-
prep system. DNA concentration and purity was calculated using A260/280 values and
the plasmid obtained was checked by undertaking the appropriate restriction enzyme
digests (see below and Chapter 6). A260/280 ratios were always above 1.8 and the
DNA was therefore deemed to be pure enough to use for transfection.
2.7.2.2 Gel electrophoresis of DNA
TBE buffer: 1.08% w/v Tris base, 0.55% w/v Boric acid, 2mM EDTA pH 8.0.
TE buffer: lOmM Tris HC1, ImM EDTA (pH 8.0).
Blue Juice (6 X): 0.5mg/ml bromophenol blue, 40% v/v sucrose (made up in TE
buffer).
Agarose gels were set up. The sides were taped and 1-1.5% molten agarose (in TBE)
poured in to the correct level. The spacer was inserted and the gel left to set, after
which the tape was removed and the gel placed in a tank, which was filled with
enough TBE to cover the gel completely. 10-15jul samples in 'blue juice' were then
loaded, and the gel was run at 120mV for 45min-lhour. It was then stained with 2-
5mg/ml ethidium bromide (in TBE), viewed using UV light, and photographed.
2.7.2.3 Restriction enzyme digests
The precise restriction (RE) enzyme digests used are detailed in the Chapter 6. In
general 1 pg DNA was mixed with 40U of the restriction enzyme (2pl) in the
corresponding RE buffer, in a total volume of 15pl. This was incubated for 1 hour at
37°C and then 10pl run on a 1-1.5% agarose gel, which was stained with ethidium
bromide as above.
2.7.2.4 Transfection of AtT-20 cells with SEAP/HGH-SEAP plasmids and
selection of stable transfectants
Cells were plated in 6-well plates and grown as described previously until 60-70%
confluent. The method of transfection was as described for the lac-Z plasmid, in that
after 5 hours the transfection mixture was removed and replaced with complete
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DMEM medium. Again the DNAdipofectamine ratios varied and are described in
Chapter 6. After 24 hours of incubation with complete DMEM, this was aspirated off
and replaced with selective medium, which was complete DMEM containing G418
(2.5mg/ml). The G418 caused acidification of the medium, which was titrated to
pE17.4 using 20mM Hepes/NaOEl. Transiently-transfected or non-transfected cells
died and lost attachment to the plate after 2-5 days, leaving small foci of cells which
displayed G418 resistance. The medium was changed every 3-6 days until the foci
were deemed large enough to be cloned (visible by the naked eye). They were picked
off using sterile 20pl tips, placed in 96-well plates and resuspended in 200pl
selective complete DMEM. This process was repeated with foci within the 96 well
plates being moved in the same way to new 96 well plates to ensure that clones had
been obtained. At this stage, when 40-50% confluency was reached, lOOpl trypsin-
EDTA solution was added for 30sec and then the majority of it removed. The nearly
-detached cells were then resuspended in 500pl of complete selective DMEM and
placed in 24-well plates until 50-60% confluent, at which point the same process was
used to dislodge them, with increased quantities of trypsin-EDTA. The cells were
placed in 6-well plates, then the process repeated, and the cells plated in a 25cm
flask, after which cell passaging was as described before (section 2.1). The stable cell
lines were grown up and frozen down as previously described (section 2.1), and
could be plated and used for experiments. To ensure that there was no loss of DNA
or gene expression, the cells were maintained in G418 containing selective complete
DMEM.
Many of the experiments were done using transiently-transfected cells. This was
done by plating the cells in 24-well plates and transfecting them with the
appropriately scaled volume of transfection mixture (as described in this section).
After 5 hours it was removed, replaced with complete DMEM, and the cells were
assayed after 24-72 hours.
2.8 Assay of alkaline phosphatase (SEAP) activity
Stable or transiently-transfected cells were plated or left in 24 well plates and grown
until 70-80% confluency or for a further 24-72 hours. The medium the cells were
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grown in could then be assayed for constitutively-secreted HGH-SEAP or for SEAP
(depending on which plasmid had been used). Cells transfected with the HGH-SEAP
plasmid could also be stimulated to secrete in a regulated manner by any of the
methods detailed in section 2.5.1, and the levels of alkaline phosphatase then
measured. In all cases samples were removed and centrifuged at 13000rpm (4°C) for
5min,in a microfuge, then assayed immediately or stored at -70°C.
2.8.1 Chemiluminescence method for detection of SEAP or HGH-SEAP
This method used the Clontech Great Escape Detection Kit and was carried out as
detailed in the instructions. A chemiluminescent substrate (CSPDIM) was used, along
with an enhancer to produce a light reaction detectable by exposure to X-Ray film
and subsequent development.
2.8.2 Cytochemistry of alkaline phosphatase
The Sigma alkaline phosphatase cytochemistry kit was used and the protocol was as
detailed in the instructions. In this case the cells were plated onto coverslips in 6-well
plates, and then examined microscopically.
2.8.3 Spectrophotometric detection of SEAP or HGH-SEAP
The method used here was as reported by Cullen & Malim, 1992. The samples were
processed in 96-well plates and absorbances read at 405nm using a Dynatech 700006
automated plate reader. The only variation was that the substrate was obtained in
tablet form (pNPP; from Sigma Chemical Co.) and due to poor solubility, each tablet
was dissolved in 1ml (instead of 633pi) of SEAP buffer.
2.9 Reverse-transcriptase polymerase chain reaction (RT-PCR)
This method was used as an alternative to Western blotting, in an attempt to identify
the mRNAs for synaptobrevin and syntaxin in AtT-20 cells. The first method tried
was the purification of mRNA from AtT-20 cells and subsequent RT-PCR. As
difficulties were encountered using this method a total RNA preparation was then
used, with subsequent RT-PCR. The nucleotide sequences for mouse synaptobrevin
and syntaxin genes were not available, therefore the primers were designed using rat
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syntaxin A and rat synaptobrevin 1. The gene sequences and primers are detailed in
the Appendix. Western blotting had already been used successfully to identify the
presence of synaptotagmin, therefore this was used as a positive RT-PCR control.
Primers for this were designed and kindly donated by Leonora Ciufo (Department of
Biochemistry, Edinburgh University)
2.9.1 mRNA preparation
This was done using a Qiagen kit and following the manufacturer's protocol. All
apparatus and solutions were RNAase-free. However since only a very small fraction
of the RNA in a cell is mRNA its detection was difficult. After an unsuccessful RT-
PCR, it was impossible to assess whether this negative result was due to faliure of
the RT-PCR or an initial lack ofmRNA. Thus a total RNA preparation, which could
be measured spectrophotometrically, was used.
2.9.2 Total RNA preparation
The method used here was that detailed in the RNAzol™ B Tel-Test Bulletin no.2
• • 2
(Biogenesis Ltd). 5ml of RNAzol was used per 75cm flask, and all other steps The
solution was stored at -20°C, or -70°C for long term storage.
2.9.3 RT-PCR reaction
Two methods were used for the initial production of the cDNA (i.e. the RT part of
the reaction). The first used the syntaxin, synaptobrevin or synaptotagmin primers to
specifically produce the corresponding cDNA only, and the second used random
primers to produce total cell cDNA.
2.9.3.1 RT production of cDNA
The following components were added to a nuclease-free Eppendorf tube: 2pl
random primers or specific 3' primer, 1.5pl total RNA or messenger RNA (i.e. lpg
total RNA or 60ng mRNA), 7.5pl water and 1 pi RNAsin (Promega). The contents of
the tube were mixed gently and then heated to 70°C for lOmin, after which the tube
was chilled on ice. The following additional components were then added: 4pl of 5 X
RT buffer, 2 pi DTT (stock 0.1M) and lpl dNTP mix (stock concentration of lOmM
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each). The contents of the tube were gently mixed, lOOpl of mineral oil layered on
top, and then incubated at 25°C for 2min, after which 1 pi of reverse transcriptase was
added and the 25°C incubation continued for lOmin. The tube was then
immediumtely incubated at 42°C for 50min, followed by 70°C for lOmin.
2.9.3.2 PCR amplification of specific cDNA product
The following components were added to a sterile Eppendorf tube: lOpl of 10 x PCR
buffer, 6pl MgCl2 (25mM stock), 2pi dNTP mix (stock concentration of lOmM
each), lpl 5'primer, lpl 3'primer, 2pl Taq DNA polymerase, 74pl water and 2pl
cDNA from RT reaction. These were gently mixed and lOOpl mineral oil layered on
top. They were then incubated at: 95°C for 1.5min, 45°C for 2min and 72°C for lmin.
This was done for 30 cycles and then incubated at 10°C until the samples were
removed and run on agarose gels as detailed above.
2.10 Site-directed mutagenesis of NSF
A vector containing the cloned CHO (chinese hamster ovary) cell line NSF gene,
tagged with 6 histidine residues, was kindly donated by Professor R. Burgoyne
(University of Liverpool). The aim was to use site-directed mutagenesis (Ho et al.,
1989) to mutate a single amino acid residue (Thr373 to Pro373), and the reasons behind
this are explained in Chapter 6. The flanking and mutagenic primers were designed
using the gene map provided, and both these and the plasmid maps, can be seen in
the appendix, along with a brief description of the technique, which involves the
production of two amplified pieces of cDNA at the 5' and 3' ends of the gene. At the
3' end of the former and the 5' end of the latter, is the mutated amino acid and an
overhang of approximately 12 bases. The next step would therefore be to join the two
mutated pieces of DNA together using another PCR step and the two flanking non-
mutagenic primers. Plasmid mini-preps were done using the same technique
described in section 2.7.1.1 and the plasmid was examined using restriction enzyme
digests, as detailed in section 2.7.1.3. In this case all primers were obtained from
Cruachem.
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2.10.1 Site-directed mutagenesis by PCR
Both VENT polymerase and Taq polymerase were used in these experiments and are
detailed in Chapter 6.
Taq polymerase PCR The following components were added to an Eppendorf tube:
lOpl of 10 X PCR buffer, 8pl of MgCl2 (25mm stock), 2pl dNTPs (stock of lOmM
each), 2pl Taq polymerase, 74pl water and 2pl NSF template. For production of the
5'fragment the primers added were 5' and 3'M, and for the 3' fragment the primers
5'M and 3' were used. All were added at 1 pi per PCR reaction. The tubes were then
incubated at: 95°C for 1.5min, 50°C for 1.5min and 72°C for lmin. This was done for
30 cycles and then incubated at 10°C until the samples were removed and run on
agarose gels as described above.
Vent PCR: The same reaction mixture was used except lpl VENT was used, the
MgCl2 excluded, and the appropriate 10 x PCR buffer used. MgSCE was added to a
concentration of 2mM or 4mM, as detailed in Chapter 6.
2.10.2 Purification of 5' and 3' fragments
To ensure that none of the original un-mutated template would be present in the next
part of the reaction, lOOpl of the reaction mixtures were run on a 1.5% agarose gel.
The correctly sized fragments were then purified using a Qiagen gel extraction kit
and the included protocol.
2.10.3 Production ofmutated cDNA
The following components were added to a sterile Eppendorf tube: 2pi of 5'
fragment, 2pl of 3' fragment, 2pl VENT, lOpl of 10 X PCR buffer, 81 pi water, 2pl
dNTP (stock of lOmM each), lpl 5' primer and lpl 3' primer. MgSCE was added to
a concentration of 2mM or 4mM, as detailed in Chapter 6. The tubes were then
incubated at: 95°C for 1.5min, 50°C for 1.5min and 72°C for lmin. This was done for
30 cycles and then incubated at 10°C until the samples were removed and run on
agarose gels as detailed above.
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The above figure shows the Qiagen QLAexpress™ expression vector that was used to
express the cloned light chains of the toxins BoNTD and TeTX. Two lac operator
sequences ensured tightly-controlled repression of the powerful T5 promoter present.
There are 6 histidine residues tagged onto the expressed proteins, to enable efficient
affinity purification, and two transcriptional terminators to prevent read-through
transcription. The P-lactamase gene (bla) confers ampicillin resistance, and allows
selection of the transformed E.coli.
The plasmids were a generous gift from Dr. Heiner Neimann (Tubingen, Germany)
and the constructs are as detailed in Hayashi et al., 1994.
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(B) NSF expression vectors and design of primers
The plasmid used as a template for the NSF mutagenesis reaction was based on the
pQE plasmid detailed in (A). This was also used for propagation of the plasmid in
order to obtain enough DNA for experiments, by transforming NM522 cells and using
a Qiagen mini-prep kit. The NSF was cloned from a Chinese Flamster Ovary cell line
and details of the plasmid can be found in Whiteheart et al., 1993. Flanking primers
and mutagenic primers were designed using the CHO cell gene sequence, as obtained
from the Swiss-prot website. Below is a brief description of how this 4 primer method
of mutagenesis works. The primers are then shown, along with the relevant areas of
the NSF gene.
Schematic diagram of site-directed mutagenesis by overlap extension
Mutated NSF gene
The method used was based on that described by Ho et al., 1989. Two separate PCR
reactions were used (1 &2) to generate two DNA fragments: PCR 1 used primers 5"
and 5'M; PCR 2 used primers 3" and 3'M. The resulting DNA products were purified
from an agarose gel using a Qiagen gel DNA extraction kit, to ensure that none of the
original template was present in the final reaction. PCR 3 was used to extend the two
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mutated pieces of DNA, to obtain a whole mutated gene. This reaction used only the



































The primers used were as shown above. The 5" and 3' primers were designed using
the 5" and 3" ends of the NSF gene, with additional sites added on to allow for cloning
into a mammalian expression vector. * Denotes additional nucleotides which were
added to improve the efficiency of cutting by the restriction enzymes. The mutational
primers contained a single point mutation (ACC to CCC), in the centre. The 5" primer
was not shown as it was simply complementary to the 3'M primer.
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The SEAP-Control plasmid was obtained from Clontech laboratories, Inc. It has an
SV-40 promoter and enhancer which allow the expression of SEAP in most
mammalian cell types. The SV-40 intron and SV-40 polyadenylation signal ensure
proper processing of the transcript in eukaryotic cells. There is a pUC19 origin of
replication (along with an ampicillin resistance gene) for propogation in E.coli. The
sequence can be obtained in GenBank, and further information can be found in the
following references: Berger et al., 1988; Araki et al.,1988; Chen & Okayama, 1988;
Sambrook, 1989.
The SEAP-HGH plasmid was kindly donated by Alan Colley (Biochemistry Dept.,
University of Edinburgh). The pSEAP-control plasmid was used as a source of DNA
from which the SEAP gene was cloned as a Hindlll/NotI fragment, and inserted into
the pRc/CMV2 plasmid shown below. Cloned HGH gene (including the leader
sequence) was then fused to the beginning of the SEAP gene as a Notl/Xbal fragment.
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PRc/CMV2 expression vector
The pRc/CMV2 plasmid was obtained from Invitrogen, and its full sequence can be
obtained from the Invitrogen website. It has a CMV promoter to allow for efficient
expression of the protein in mammalian cells. It also has a T7 promoter, polylinker,
BGH polyA signal, fl origin, SV40 promoter, SV40 origin of replication, Neo ORF,
SV40 polyA, ColEl origin and ampicillin resistance gene. The above diagram shows
the original expression vector, along with the hHG/SEAP fusion gene and its position
of insertion into the vector. Neomycin denotes the gene which expresses the G418
resistance of the plasmid.
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(D) RT-PCR PRIMER DESIGN
The following shows the primers which were used in an attempt to detect the presence
of synaptobrevin and syntaxin in AtT-20 cells using RT-PCR. The RT part of the
reaction was done using random primers, but the second PCR amplification of the
cDNA used the primers detailed below.
Syntaxin Primers
5' primer
5' A T »A A G*G A C*C G A*A C C*C A G*G A G«C T C»C GC3'
3" primer
3'TC C*T T C*T T C*T A G*T A C*T A G*T A G*T A A*A C G* A C A 5'
These were designed using the 5' and 3' ends of rat syntaxin A, the gene sequence of
which was obtained from the internet DNA database.
Synaptobrevin primers
5' primer
5'AT G*T C T*G C T*C C A*G C T*C A G3'
3' primer
3TA C*C A T*C A A»T A A*C A T*T A G*A T G*A A A*A A A*T GA5'
These were designed using the 5' and 3" ends of human synaptobrevin 1, the gene
sequence ofwhich was obtained from the internet DNA database.
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BstXI 4363Plasmid name: pPHC AGGS-BstXI-LacZ
Plasmid size: 10182 bp
Constructed by : Hitoshi Niwa
Construction date: Sep. 1994
Comments/References : Notl fragment from pSVlacZ cloned into pPHCAGGS-BstXI
(HN68) using BstXI adapters
The lacZ plasmid was a generous gift from Nick Gilbert (Dept. of Biochemistry,








Many proteins have been identified, mainly in chromaffin and neuronal cells, that are
thought to be involved in Ca2+-regulated exocytosis. However definite functional
evidence has not yet been obtained for all such proteins, and many have implicated
through their interactions with synaptic vesicles or synaptic vesicle proteins. The aim
of this project was to examine the exocytotic machinery in AtT-20 cells, and to
assess whether similar mechanisms were at work. The starting point for this project
was therefore to fully characterise the cells, and to discover whether these proteins
were present and what their intracellular distribution was. Due to the huge number of
putative exocytotic proteins that have now been discovered, it was decided to
concentrate on several well-established ones, for which there was definite functional
evidence. These were synaptobrevin, SNAP-25, syntaxin, aSNAP, NSF, rab3A,
synaptotagmin and CAPS. It was also decided to study the role of actin in exocytosis
from AtT-20 cells, therefore western blotting was used to look for two actin-
depolymerising proteins, ADF (actin-depolymerising factor) and cofilin.
Wendland & Scheller, 1994 have previously shown the presence of synaptotagmin,
VAMP and synaptophysin in AtT-20 cells, by subcellular fractionation and
immunoblotting, while Martelli et al., 1995 showed the presence of both Rab3A and
Rab3D by similar methods.
3.2 Fractionation ofAtT-20 cells
AtT-20 cells were grown, harvested and homogenised, as described in section 2.1,
after which they were fractionated using various sucrose density gradients, as
detailed in 2.1.3. The fractions were run on 10-12% or 10%, 12% and 13%
polyacrylamide gels (section 2.2) and then stained with Coomassie blue R. Each
fraction was assayed for protein (section 2.1.5), and sucrose concentrations were
estimated using a refractometer (section 2.1.4). In order to monitor the distribution of
organelles and proteins, various marker proteins were utilised. Preparations of the
various organelles were normally used as positive controls and are detailed in
Chapter 2.
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• Golgi were identified using an assay for the enzyme galactosyl transferase and
the assay described in 2.1.6. The unique ability of Golgi fractions to transfer
galactose from sugar nucleotide precursors to N-acetylglucosamine residues lead
to the identification of galactosyl transferase as a marker for this organelle
(Fleischer & Fleming, 1970). It is now known to be present on the trans-
cisternae of the Golgi-complex, its active site being at the luminal side (Strous et
al., 1983).
• The endoplasmic reticulum was detected using the a subunit of the signal
recognition particle receptor (SRPRa or 'docking protein') as a marker protein
specific to the ER. An antiserum raised against the 60,000kDa fragment of the
docking protein of dog pancreas microsomes (gift from David Meyer, EMBL,
Heidelberg), was used to localise the ER by western blotting of the cell fractions.
• The mitochondria were localised by detection of the Fi sector of the
mitochondrial ATP-ase, containing the subunits a,(3 and y. Rabbit anti-bovine Fi
serum was obtained from David Apps (Dept. of Biochemistry, Edinburgh
University) and was used to localise the mitochondria by western blotting of the
cell fractions.
• Secretory vesicles were initially detected using the 57kDa subunit B of V-
ATPase as a marker protein. Rabbit antiserum was raised against the 57kDa
subunit of Kalanchoe tonoplast V-ATPase by Dr. Mark Warren (Department of
Biochemistry, Edinburgh University) and was used to localise vesicles by
western blotting of the cell fractions.
• The plasma membrane was detected by biotinylating the plasma membrane
proteins (section 2.1.7) prior to harvesting and homogenisation (section 2.1.2).
Western blotting was then used to detect labelled plasma membrane proteins,
using streptavidin-conjugated HRP, in place of antibodies, and subsequent
detection by ECL.
• Cytosol was assumed to remain in the lightest sucrose fractions and blots using
antibodies against soluble proteins such as ADF showed this to be true.
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In all blots 20pl of the cell fractions were run on 10-12% or 10%, 12% and 13%
polyacrylamide gels and then western blotting was done using the technique
described in section 2.2. Equal amounts of proteins were not used in each lane as
certain fractions contained very little protein and this would greatly lower the
chances of being able to detect the desired proteins. A total of four gradient
fractionations were done throughout this project, some with slightly varying
conditions. The results of these will now be detailed and discussed with respect to
protein and sucrose concentrations, and organelle localisation in the gradients. These
preparations were also used for the localisation of the exocytotic proteins, which will
be discussed in section 3.3. Gradient 1
A gradient of 0.4-1.8M sucrose was used and protein concentrations were estimated
by Bradford's assay (section 2.1.5.2), the standard curve of which can be seen in
figure 3.1. Results of the protein and sucrose estimations are shown in table 3.1. 20pl
of the fractions were run on 10-15% gradient gels which were stained using
Coomassie blue, and these are shown in figure 3.2. The protein estimations and gels
show the majority of cellular proteins to be distributed over two main areas: fractions
4-5 (1.33 & 1.25M sucrose) and fractions 11-13 (0.18, 0.4 & 0.6M sucrose). These
probably represent membrane proteins and cytosolic proteins respectively. Secretory
vesicles were identified using an antibody against V-ATPase (see figure 3.3), and
were shown to be localised in fractions 4-5. However the subunit used as a marker
was not an integral one, and it appeared that much of it had dissociated from the
integral segment, and was found in the cytosolic fractions (11-13). Synaptotagmin is
also a good vesicle marker and was found to co-localise to the V-ATPase proteins
and give better results, therefore future fractionations used synaptotagmin as the
vesicle marker. An example of a synaptotagmin blot can be seen in figure 3.10.
The various fractions were tested for a number of proteins involved in exocytosis,
which will be discussed in section 3.4. Further analysis of the various organelles was
done in a repeat of this experiment (see fractionation 2 below).
3.2.2 Gradient 2
The sucrose gradient used was as above, however protein concentrations were
estimated by Peterson's assay (section 2.1.5.1), as there was a possibility that sucrose
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may have interfered with the Bradford's assay. Table 3.2 details the protein and
sucrose concentrations, whilst figure 3.4 shows the Peterson's assay standard curve.
The protein distribution is very similar to that obtained previously. Slightly lower
protein concentrations were found, due to the fact that slightly less PNS was loaded
onto the sucrose gradient (0.7ml instead of 1ml), rather than interference of sucrose
in the last protein assay. Since fractions were collected manually, 1ml being
estimated by eye, there were also only 12 fractions collected this time.
This gradient was further analysed by the localisation of some of the organelles,
using the techniques detailed above. Figure 3.5 shows the blots obtained for
mitochondria, and figure 3.6 the blots obtained for ER. Figure 3.7 shows the
galactosyl transferase assay results. Secretory vesicles were identified in fractions 4-
5 using synaptotagmin as a marker (data not shown).
3.2.3 Gradient 3
The method used for this fractionation was the same as for fractionations 1 and 2, but
the sucrose gradient was changed to 0.6-1.6M. This was to try and separate out the
membrane proteins which up until this point had clustered in the same area. The
protein and sucrose concentrations are shown in table 3.3. The results obtained from
the mitochondria, ER and secretory vesicle blots have been summarised in table 3.4,
as have the Golgi assay results. Identification of the vesicles was again by use of the
anti-synaptotagmin antiserum.
3.2.4 Gradient 4
As the separation of membrane fractions showed no great improvement with the
altered range of sucrose concentrations, the gradient used here was 0.4-1.8M (as in
fractionations 1 and 2). The major aim in this experiment was to locate the plasma
membrane, so intact cells were biotinylated using the method detailed in section
2.1.7. Table 3.5 details the sucrose and protein concentrations, whilst table 3.6 again
summarises the results obtained for the mitochondria, vesicle, ER and Golgi
localisation. Figure 3.8 shows the results obtained for plasma membrane localisation,
as shown by blotting with streptavidin-peroxidase.





Protein estimations of samples from this gradient showed that there were two main
regions where many proteins were equilibrating: fractions 4-5 and fractions 12-13.
These had respective sucrose concentrations of 1.33-1.25M and 0.40-0.18M, and
they would be expected to represent membrane and cytosolic proteins respectively.
This gradient was used to detect the presence of various exocytotic proteins, detailed
in section 3.4. The secretory vesicle fraction was identified as being in fractions 4-5,
using the V-ATPase as a marker. However the subunit recognised by the antiserum is
not an integral one and thus appeared also in cytosolic fractions (11-13), presumably
as a result of dissociation from the V-ATPase. Thus in subsequent experiments the
secretory vesicle fraction was identified using the secretory vesicle marker
synaptotagmin.
Gradient 2
In this gradient the same procedure was used, however fewer fractions were
collected. This meant that the two main regions of protein accumulation were
fractions 3-4 and 11-12, with sucrose concentrations of 1.33 & 1.25M sucrose and
0.50 & 0.12M sucrose respectively. The protein concentrations were also slightly
lower, but this was due to the fact that the homogenate was slightly more dilute and
therefore less protein was actually loaded on each sucrose gradient. In gradient 2 ER,
mitochondria and secretory vesicles were located in fractions 3-4 (1.33 & 1.18M
sucrose). The ER showed the majority of SRPR to be in the degraded form, however
similar bands also appeared in fractions 11-12. It is probable that these are high
concentration cytosolic proteins that are reacting non-specifically with the antiserum,
as synaptotagmin is integral. The mitochondrial blot shows (unlike the V-ATPase
57kDa subunit) that no dissociation has occurred, although the Fi subunits are not
integral. The Golgi membranes equilibrated in fractions 4-5 (1.18 & 1.14M sucrose),
showing slight membrane separation. There was also a peak of this marker in
fraction 10, which may have been due to disruption of the Golgi apparatus. Since
most membrane proteins were clustered in the same fractions, it was decided to use a
sucrose gradient of narrower range in the hope that this would cause some separation
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of the membranes and therefore achieve greater enrichment of the secretory vesicle
fraction.
Gradient 3
Although the concentration of the sucrose gradient was adjusted, there was little
change in the protein distributions, although there was further distribution of the
Golgi into fraction 6 (1.06M sucrose), as well as 10. Secretory vesicles, mitochondria
and ER remained in fractions 3-4 (1.37/1.22M sucrose). As a final experiment a
fractionation was done in which the plasma membrane proteins were biotinylated, to
detect whether they were also equilibrating in these middle fractions.
Gradient 4
In this experiment only 1 pg from each fraction was loaded per lane of an acrylamide
gel, and the biotinylated proteins were detected using streptavidin-HRP. The reason
for loading similar quantities of protein here is that the detection method was very
sensitive, and the gradient was not screened for a single specific protein, but for all
biotinylated proteins. In all other cases, in which detection of particular proteins was
required, it was better to load as much as possible, in order to exceed the threshold of
detection by the antibody. The sucrose gradient used was 0.6-1.8M and the protein
and sucrose estimations of the various fractions showed very similar distributions to
previous fractionations. Secretory vesicles, mitochondria and ER equilibrated in
fractions 4-5 (1.37 & 1.22M sucrose), and Golgi membranes were also found here, as
well as in fraction 10 (0.77M sucrose). Biotinylated proteins were located in
fractions 4-5, showing that little separation of plasma membranes was occurring.
Whilst this fractionation method did not achieve separation of the various organelles,
it concentrated membrane and cytosolic proteins in quite different areas. These
results could be used to assess whether the proteins were cytosolic (and soluble in the
cell) or membrane bound or associated. Whether they are specifically bound to
plasma membrane, vesicles or other organelles was determined using
immunofluorerscence micrsocopy (see chapter 4), and data on these proteins
obtained in other studies. The results of the blots obtained for the various exocytotic
proteins are shown in the figures section at the end of this chapter. The gradient
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number used in each study is quoted, in order that protein and sucrose concentrations
can be obtained from the tables.
3.4 Identification of proteins involved in exocytosis
2"bAntibodies against various proteins thought to be involved in Ca -regulated
exocytosis, were tested against the AtT-20 cell fractions discussed above. Figures
3.10 to 3.22 show the results of the blots, and details of the antibodies (and source)
can be found in the appropriate figures. The fractionation number and dilution of the
antibody have also been detailed here. Chromaffin membrane granules were usually
run beside the AtT-20 cell fractions as a comparison. Whilst these do not always
represent ideal positive controls (e.g. for cytosolic/plasma membrane proteins), they
serve to show whether differences could be seen in the two cell types. Antibodies
were usually tested and titrated using rat brain synaptosomes (for plasma membrane
proteins) and rat brain cytosol (for cytosolic proteins), however the data for this is
not shown. The following list summarises the proteins examined:
Figure 3.10 synaptotagmin (65kDa; integral vesicle protein)
Figure 3.11 syntaxin (36kDa; integral plasma-membrane protein)
Figure 3.12 SNAP-25 (25kDa; plasma membrane associated protein)
Figure 3.13 aSNAP (36kDa; cytosolic protein)
Figure 3.14 NSF (76kDa; cytosolic protein)
Figure 3.15 ACTH precursors (various molecular weights; major secretory peptide in
the dense granules)
Figure 3.16 synaptotagmin (detected using a monloclonal antibody; details as above)
Figure 3.17 Normal rabbit serum (negative control)
Figure 3.18 synaptobrevin 2 (18kDa; integral vesicle protein)
Figure 3.19 Rab 3A (17kDa; vesicle-associated/cytosolic protein)
Figure 3.20 CAPS (145kDa; phospholipid/vesicle associated protein)
Figure 3.21 ADF (20kDa; cytosolic protein)
Figure 3.22 cofilin (17kDa; cytosolic protein)
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3.5 Discussion
Synaptotagmin (figures 3.10 & 3.16)
Synaptotagmin was identified in the membrane-rich fractions 4-5, peaking in 4. A
degradation product of around 52kDa can also be seen in these fractions as well as in
fractions 12-13. However it is unlikely that this is the same product, as a protein of
this size would still be an integral membrane component. It is more likely that this is
a highly-concentrated cytosolic protein that shows non-specific reactivity with the
synaptotagmin antibody. Synaptotagmin has been shown to be present in synaptic
vesicles, catecholaminergic granules and peptidergic granules (Wendland & Scheller,
1994). AtT-20 cells contain two distinct types of vesicles: small clear synaptic
vesicles and dense-core peptidergic vesicles. The small clear synaptic vesicles
contain acetylcholine (ACh), which has been shown to be released in response to
lOOmM potassium {Matsuuchi et al, 1988). However these must not be directly
equated to the rapid neuronal communication, as it is thought that the ACh release
from AtT-20 cells actually mediates paracrine actions (Reetz et al., 1991). The dense-
core peptidergic vesicles contain ACTH. Synaptotagmin is presumably a marker for
both of these, although as yet we cannot separate them.
Syntaxin (figure 3.11)
Syntaxin is an integral plasma membrane protein, and was positively identified
(although the band was faint) in the membrane fraction of AtT-20 cells (fraction 4).
In agreement with the marker protein results this indicated that all membranes
equilibrate around this region. It can also be seen in the chromaffin granule
membranes, which suggests contamination with plasma membrane or that syntaxin is
also found on vesicle membranes, about which there has been some debate.
Kretzschmar et al., 1996 reports the existence of syntaxin and SNAP-25 on synaptic
vesicles, whilst Tagaya et al., 1995 showed the presence of syntaxin on chromaffin
granules only.
SNAP-25 (figure 3.12)
SNAP-25 is a t-SNARE that is anchored to the plasma membrane via multiple
palmitoylation of its C-terminal cysteine residues. It therefore appears in the
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membrane fractions (4 & 5), and the cytosolic fractions (11-13), where it exists due
to dissociation from the plasma membrane. However SNAP-25 can also be
recognised (at lower concentrations) in fractions 6-10, where previously no
organelles have been localised. Possibly this is simply due to the fractionation
process, in that SNAP-25 travels down the gradient to fraction 4 where it
equilibrates. It may be that the nature of its linkage to the vesicles causes dissociation
from them as it moves down the gradient, thus producing a trail of SNAP-25 protein.
Interestingly SNAP-25 can also be seen in the chromaffin granule membranes, which
as for syntaxin, could suggest contamination of the granules with plasma membrane,
or the existence of a vesicle-bound form (as reported by Tagaya et al.t 1996).
aSNAP (figure 3.13)
aSNAP is a 36kDa cytosolic protein that associates with the SNARE complex,
although at which stage is still under debate. It has been shown that permeabilisation
of chromaffin cells causes a run down in the exocytotic response to Ca2+, which can
be rectified by the introduction of aSNAP (Morgan & Burgoyne, 1995). This in
itself suggests that in a normal cell situation it exists in a soluble form, however this
blot shows it to be present in the membrane fractions (4-5). Thus it must be
associated with the membranes, or most likely to an integral/associated membrane
protein (a SNARE). This is in contrast to the chromaffin granule membranes where it
cannot be seen at all. It is also present in the expected cytosolic fractions (11-13),
where bands of 66 kDa can alse be seen. It is unlikely that this band represents a
SNARE complex of any sort, as this is an SDS-containing gel and the band is not
seen with any of the other SNARE proteins. Again it is likely that this is due to the
high protein concentration of the cytosolic fractions and non-specific binding as a
result of this.
NSF (figure 3.14)
NSF is a cytosolic protein, which binds to the SNARE complex and has ATPase
activity. It was identified in the membrane fractions (4-5) and the cytosolic fractions
(11-13). Like aSNAP it is therefore associated with membranes, or more likely to
integral/associated membrane proteins. In this instance the NSF can also be seen in
the chromaffin granule membranes which is interesting with respect to the
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aforementioned permeabilisation assay. In this assay, whilst aSNAP rescued the
cells from rundown, NSF had no effect, and this was postulated to be because it
existed in a membrane-bound form which provided the cell with a plentiful supply
(Morgan & Burgoyne, 1995). An association with synaptic vesicles was also reported
by Hong et al.,1995 who described co-localisation of NSF with the SV marker
synaptophysin.
ACTH propeptides (figure 3.15)
ACTH is one of several peptide hormones derived from the precursor POMC, which
gets processed into a 4.5kDa mature ACTH peptide before release on Ca2+
stimulation. Tanaka et al., 1991 showed that the mature form of the hormone is
processed to POMC within the Golgi cisternae and RER. The POMC is then
processed as the granules mature and move to the periphery of the cell, and much of
the cleavage of the POMC into mature ACTH will actually occur within the mature
dense core granules. A true marker of the mature dense core granules would be
mature 4.5kDa ACTH, however the resolution of the 12% polyacrylamide gel was
not great enough to show this band accurately. Subsequent attempts using a tricine
based gel system (Schagger & Jagow, 1987) also failed to provide accurate
identification (data not shown). Thus the propeptides were located in the membrane
fractions (4-5) and also in the cytosolic fractions (11-13), probably due to lysis of the
granules. However, in a similar way to the synaptotagmin blot, we can assume that
the POMC would be present in both immature and mature dense-core vesicles, thus
again suggesting a general clustering of the membranes. It is concluded that the
ACTH-containing dense-core vesicles are in the membrane fractions, along with
many of the other proteins involved in exocytosis.
Normal Rabbit Serum (figure 3.17)
This was simply used as a negative control, to identify any false positives, and show
up any major cross-reactive proteins. Little reactivity was seen in fractions 1-8, with
an increasing density of bands in fractions 9-11, and slightly less in 12. This shows
the potential of the cytosol for giving non-specific reactive bands, some of which
have been mentioned previously. In general a band has been considered to be a
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positive result only when it is the major and most dense band present.
Synaptobrevin 2 (figure 3.18)
Synaptobrevin is an integral vesicular membrane marker, and has been shown to be
present on SVs (Trimble et al., 1988), catecholaminergic granules (Papini et al.,
1995) and peptidergic dense core vesicles (Halpern et al., 1990). It localised to the
membrane fraction 4 in AtT-20 cells, however some very strong bands were seen in
fractions 10-12 at around 116kDa. High molecular weight bands have been seen in
this region in previous blots, and could be attributed to a complex that was not
dissociated by SDS. Different loading conditions were therefore tried, such as
increased or decreased SDS and DTT concentrations and heating of the sample to
25°C, 37°C or 90-100°C, however no difference was seen. As the high-molecular
weight bands varied between blots it is doubtful that it is a SNARE complex, and
probably represents non-specific reactivity. Previously mentioned was that a positive
result was inferred by the existence of a band of the expected mobility, and the
highest density. However the different amounts of protein loaded must also be taken
into account, as 3-5 times the amount was loaded in fractions 11-13 (cytosolic
fractions) compared to fractions 4-5 (membrane fractions).
Rab 3A (figure 3.19)
This protein is vesicle-associated in its GTP bound form, and cytosolic in its GDP
bound form. It is thus found in membrane fractions (3-4) and cytosolic fractions (11-
13).
CAPS (figure 3.20)
This protein has been shown to bind phospholipids, and has been postulated, from
cytosolic rundown experiments in PC 12 cells, to be involved in late stage triggering
of fusion (Walent et al., 1992). In AtT-20 cells all of the protein was identified in the
... .. 2,~h
cytosolic fractions (11-12), perhaps indicating a later role for it in Ca -regulated
exocytosis. The degraded form (seen around 85kDa) is common and can also be seen
in the references cited above.
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ADF (figure 3.21)
ADF and cofilin are very similar actin-depolymerising proteins, and have been found
to be abundant in neuronal and secretory tissues. Both sever actin filaments in a
Ca -independent manner, are pH-dependent (Hawkins, 1993), and transients in
intacellular pH have been noted in various cells on stimulation of exocytosis (Stella,
1995). This and the relatively recent suggestion that actin acts as a barrier to
exocytosis prompted the study of these two proteins. ADF was found in cytosolic
fractions 11-12 only.
Cofilin (figure 3.22)
Cofilin was located in the cytosolic fractions only, and was most concentrated in
fraction 12.
3.6 Triton X-114 fractionation
The results obtained using conventional fractionation of AtT-20 cells followed by
SDS-PAGE and Western blotting show the presence of the majority of exocytosis-
related proteins tested, however they could only be separated into membrane-bound
and cytosolic fractions. In addition, the blots obtained for certain proteins, in
particular syntaxin and synaptobrevin, gave very weak signals. RT-PCR and
immunofluorescence were used as alternative methods of further characterising the
AtT-20 cell line, and these results are presented in chapter 4. It was also decided to
use fractionation with Triton X-114, in the hope that it would yield more information
about the proteins, and give more definite results in western blotting. The technique
used is detailed in section 2.1.9.2, and each gel had 15pg protein loaded per lane. All
antibodies used were as described in the gradient blots (figures 3.10-3.22). However
the antibodies to synaptobrevin and syntaxin were new, and were obtained from
Timothy Whalley (Stirling University). Both were rabbit antisera, raised against the
recombinant cytoplasmic domains of the proteins, and they were used at a dilution of
1/1000. The fractionation was performed on the pellet from 6 x 150cm confluent
flasks, which corresponds to approximately 4 x 106 cells.
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Integral membrane proteins, in order that they can exist as such, have hydrophobic
domains that anchor them within the lipid bilayer. Non-ionic detergents with
polyoxethylene heads such as Triton-X-100, can replace the lipid environment of
these proteins. Triton-X-114 has the added advantage of having a low 'cloud-point',
thus on warming a solution of TX-114 to 30°C it forms two phases: detergent rich
and aqueous. Intrinsic proteins partition into the lower phase, whilst extrinsic and
soluble proteins partition into the upper phase (Pryde, 1986).
TX-114 was homogenised with the cell pellet at 0°C, in order to solubilize the
membranes. Having centrifuged, a TX-114 insoluble fraction was obtained,
containing membrane proteins in their original phospholipid environment that the
TX-114 was unable to solubilise. The supernatant was then warmed, allowing the
separation into 2 phases: aqueous and detergent-rich. These generated two more
fractions: the aqueous layer (S) containing the hydrophilic proteins, and the
detergent-rich fraction (P2) containing the hydrophobic integral membrane proteins.
The proteins which were tested for using this technique were synaptobrevin,
syntaxin, aSNAP, NSF, SNAP-25 and synaptotagmin. The results are shown in
figure 3.24 and are discussed in section 3.7. All blots included chromaffin granule
membranes (C) and the various fractions are labelled S, PI and P2. Molecular weight
markers are shown in kDa. A Coomassie-stained gel was also run to show the
general protein concentrations and distributions (figure 3.23).
3.7 Discussion
The majority of syntaxin was found in fraction S, which is expected to contain the
soluble, hydrophilic proteins. Only a small fraction of syntaxin was detected in the
expected P2 fraction (hydrophobic membrane proteins). A similar result was
obtained for synaptobrevin and synaptotagmin, in that the main bands were in the
S fraction, with minor bands detected in the P2 fraction. Possibly these proteins have
very hydrophilic domains, outside their hydrophobic membrane spanning domains,
which cause them to fractionate in this way (Fischer-Colbrie et al., 1982). Another
explanation may be that multimeric complexes may form, which shield the
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hydrophobic domains, thus causing the protein to behave in a more hydrophilic
manner (Tanford & Reynold, 1976). Another possibility is that the traces of TX-114
remaining in the S fraction were sufficient to maintain the proteins in solution. This
problem can be overcome on removal of the detergent by dialysis against XAD-2
resin (Pryde & Phillips, 1986), but this approach was not practical in such a small-
scale fractionation. In contrast SNAP-25 was found in fraction P2 only presumably
by virtue of its behaving as a typical membrane protein.
The soluble proteins NSF and aSNAP were both found in the membrane fraction P2,
as was also observed in the previous fractionation by sucrose density gradient. The
TX-114 fractionation may also suggest their binding (in non-stimulated cells) to
membrane components, however not via synaptobrevin, synaptotagmin or syntaxin.
The other possibility is that they are binding to SNAP-25 and co-localising with it,
although most evidence has suggested the need for a SNARE complex, before
aSNAP/NSF binding will occur (Goda, 1997). It must be remembered that the TX-
114 fractionation does not produce a realistic cellular environment, and the soluble
proteins could be dissociating and re-associating with other membrane proteins, after
solubilzation.
3.8 Conclusions
The presence of the proteins synaptotagmin, syntaxin, synaptobrevin, SNAP-25,
NSF, aSNAP, ADF cofilin, CAPS and rab3A has been cofirmed in AtT-20 cells.
Syntaxin, synaptobrevin, synaptotagmin, SNAP-25, NSF, aSNAP and rab3A were
all found to be membrane-bound, with NSF, aSNAP, rab3A and SNAP-25 also
being found in the cytosolic fractions. ADF, cofilin and CAPS were found only in
the cytosolic fraction. These results demonstrate that aSNAP, NSF and rab3A are
associated with membranes or membrane-bound proteins in AtT-20 cells that have
9+
not been stimulated with Ca . This may suggest a much earlier role for them in
Ca2+-regulated exocytosis, in that they attach to the SNARE complex before the
influx of Ca2+.
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TX-114 fractionation was useful in showing more positive bands in Western blots for
many of the proteins, particularly synaptobrevin and syntaxin. These same
antibodies, when used with the original sucrose density gradient fractions gave no
definite bands. Thus the TX-114 fractions provided an enrichment of proteins, which
the previous approach was unable to match. However TX-114 fractionation does not
really provide any additional information as to the localisation of the proteins in the
cell.
Table 3.7 summarises the results obtained using these two techniques (sucrose
density gradient sedimentation and TX-114 fractionation), and gives details of the
fractions in which the proteins were found.
Chapter 3 shows the presence in AtT-20 cells ofmany of the proteins believed to be
involved in exocytosis, in neuronal and chromaffin cells. The next aim was twofold:
(1) Further characterisation of AtT-20 cells (especially with respect to actin and the
cytoskeleton). (2) To assess the role (if any) of these proteins in exocytosis from
AtT-20 cells.
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Figure 3.1 Bradford assay standard curve for protein determination
(gradient 1)
A standard curve was constructed using BSA standards ranging from 0 to 20jag and
the absorbance was read at 595nm. The cell fractions were diluted until on the scale
of the graph and the protein concentrations calculated accordingly, using the standard
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Table 3.1 Protein and sucrose concentrations in gradient 1
Protein concentrations were estimated using Bradford's assay and calculated using



















Figure 3.2 10-15% gradient gels of fractions from gradient 1
20pl of each cell fraction were run on 10-15% gradient gels (labelled 1-13), along
with DaVII/SDS-6H markers, chromaffin granule membranes (CGM), rat brain
synaptosomes (S) and cytosol (C). Approximately 20pg of each of these were run per
lane. 20pl of each cell fraction correlates to the following total quantity (pg) of
protein per fraction loaded onto the gel: (1) 3.0, (2) 3.0, (3) 3.4, (4) 61.0, (5) 44.2, (6)














Figure 3.3 Localisation of secretory vesicles in gradient 1
The diagram below shows the blots obtained when using the anti-V-ATPase antibody
(at a dilution of 1/2000), as described previously. The molecular weight of the V-
ATPase antigen is 57kDa, the positive control used here is chromaffin granule
membranes (labelled as C). H represents AtT-20 cell homogenate, and the various





Figure 3.4 Peterson's assay standard curve for protein
determination (gradient 2)
A standard curve was constructed using BSA standards ranging from 0 to lOOpg and
the absorbance was read at 750nm. Appropriate volumes of the cell fractions were
diluted, until on the scale of the graph, and the protein concentrations calculated
accordingly, using the standard curve. The standard curve was plotted as A750 against
pg BSA.
1.6
0 20 40 60 80 100 120
BSMng)
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Table 3.2 Protein and sucrose concentrations in gradient 2
Protein estimations were done using a Peterson's assay and calculated using the




















Figure 3.5 Localisation ofmitochondria in gradient 2
The diagram below shows the blots obtained using the anti-F i antibody (at a dilution
of 1/1000), as described previously. The Fi sector of the mitochondria contains 3
subunits: a and P having a molecular weight of 55 and 51kDa and y of 30kDa.
Molecular weights are shown in the centre of the two gels. The positive control
(bovine heart mitochondria) is labelled M and the various fractions are labelled 1-12.
H represents a sample ofAtT-20 cell homogenate.
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Figure 3.6 Localisation of endoplasmic reticulum in gradient 2
The diagram below shows the blots obtained when using the anti-SRPR antibody (at
a dilution of 1/1000), as described previously. The molecular weight of the docking
protein is 72kDa, however it is very easily degraded to a smaller (60kDa) product
which is what is detected in the AtT-20 cell fractions. This degradation can also be
seen in the microsome preparation that was used as a positive control, labelled M.
AtT-20 cell fractions are shown 1-12 and AtT-20 cell homogenate is shown as H.
< ♦ * *
MW markers
M 1 2 3 4 5 6 (koa) H
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Figure 3.7 Localisation of Golgi membranes in gradient 2
Galactosyl transferase was assayed in order to identify Golgi membranes in the AtT-
20 cell fractions. The presence of galactosyl transferase (and hence Golgi) was
indicated by the transfer of galactose from [ H]-UDP-galactose to ovomucoid, and
a .
this was expressed in dpm. The graph below shows [ H] measured as dpm (i.e.
presence of galactosyl transferase) plotted against sucrose concentration.







Table 3.3 Protein and sucrose concentrations in gradient 3
Sucrose concentrations were estimated by refractometry, and protein concentrations




















Table 3.4 Localisation of organelles in gradient 3
Mitochondria, secretory vesicles, ER and Golgi were localised using methods
previously described. Their position is summarised below in a table using - to show
a negative finding in that fraction, and a scale of + , ++ and +++ to show the
presence of the organelle, and its increasing concentration.
Fraction Golgi Vesicle ER Mitochondria
number
1 .
2 - + ++ ++
3 - +++ +++ +++
4 - ++ ++ ++
5 - + - -
6 ++ + - -







Table 3.5 Sucrose and protein concentrations in gradient 4
Sucrose and protein concentrations were determined using refractometry and




















Figure 3.8 Localisation of plasma membrane in gradient 4
The plasma membrane was localised in this final fractionation by biotinylating the
cell surface antigens. Biotinylated proteins were detected using streptavidin-HRP, at
a dilution of 1/4000. Unlike all the other blots so far, lpg of protein was loaded on
each lane, due to the sensitivity of the detection method. The AtT-20 cell fractions
are labelled 1-12, and molecular weight markers are shown at the side.
1 2 3 4 5 6 7 8 9 10 11 12
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Table 3.6 Localisation of organelles in gradient 4
The following table summarises the results obtained for gradient 4 in the same
manner as table 3.4 (gradient 3).
Fraction
number
golgi vesicle ER mitochondria
1 - - -
2 - - -
3 - - -
4 +++ +++ +++ +++
5 +++ ++ +++ +++
6 ++ + ++ ++
7 - - -
8 - - -
9 - - -
10 ++ - -
11 - - -
12 - - -
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Figure 3.9 Summary of protein estimations and sucrose estimations
of gradients 1-4
This summarises the organelle localisation results and the sucrose/protein
concentrations for gradients 1-4 (the compositions of which are shown in the table).
The fractions marked are the ones with the highest concentration of organelle.
gradient golgi ER vesicle mitochondria Plasma-membrane
1 (0.4-1.8M) 4,5
2 (0.4-1.8M) 4, 5, 10 3,4 3,4 3,4
3 (0.6-1.6M) 6, 10 3,4 3,4 3,4




















Rabbit anti-synaptotagmin serum was raised against a recombinant fusion protein,
consisting of the cytoplasmic domain of bovine synaptotagmin I linked to protein A,
and was kindly donated by Leonora Ciufo (Dept. of Biochemistry, Edinburgh
University). It was used at a dilution of 1/1000, and the positive control used was
bovine adrenal chromaffin granule membranes (CGM). Synaptotagmin is a 65kDa
integral vesicular membrane protein. C represents CGM, H is homogenate (with H/2
representing a 1:2 dilution of homogenate), and gradient fractions are shown as 1-12
(high to low sucrose concentration). The gradient used here was Fl. Molecular
weight markers are shown in the centre in kDa.
C 1 2 3 4 5 6 7
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3.11 Syntaxin
The antibody used in this case was an ascites mouse monoclonal (HPC-1) available
from Sigma. The immunogen used was a synaptosomal plasma-membrane fraction
from adult rat hippocampus, and the monoclonal recognizes an epitope in the
extracellular domain of the 36kDa membrane protein syntaxin. The antibody was
used at 1/2000 and chromaffin granule membranes were also blotted (denoted by C).
AtT-20 cell fractions are shown 1-13, with homogenate and 1:2 diluted homogenate
shown as H and H/2 respectively. Molecular weight markers are shown in the centre
in kDa, and this blot used fractions from gradient 1.
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3.12 SNAP-25
The rabbit anti-SNAP-25 serum used was a gift from Prof. R. Burgoyne (University
of Liverpool), and was raised against a synthetic peptide of SNAP-25. The antibody
was used at a 1/1000 dilution, and chromaffin granule membranes were also run. 1-
13 represent the various fractions, C the chromaffin granule membranes and H and
H/2 the homogenate and homogenate diluted 1:2. Fractions from gradient 1 were
used for this blot.
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Figure 3.13 aSNAP
The rabbit anti-aSNAP serum was kindly donated by Dr. Tim Levine (ICRF,
London). It was raised against the his-tagged aSNAP recombinant protein, and then
affinity-purified against the same protein. aSNAP is a 35kDa cytosolic protein. The
antibody was used at a dilution of 1/1000, and again gradient 1 was used. 1-13
denotes the AtT-20 cell fractions, H and H/2 are AtT-20 cell homogenates neat and
diluted 1:2, and C is chromaffin granule membranes.
C 1 2 3 4 5 6 7 H H/2 8 9 10 11 12 13
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3.14 NSF
The rabbit anti-NSF serum was donated by Prof. R. Burgoyne (University of
Liverpool), and was raised against his6-tagged recombinant NSF (cloned from a
Chinese hamster ovary cell line). The antibody was used at a dilution of 1/1000, and
again gradient 1 was used in these blots. C denotes chromaffin granule membranes,
H and H2 show AtT-20 cell homogenate neat and at a dilution of 1:2, and AtT-20
cell fractions are numbered 1-13.
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3.15 ACTH propeptides
Anti-human ACTH serum, developed in rabbit using ACTH(18-39)-KLH as the
immunogen, was obtained from Sigma. This gel will not detect the mature form due
to its acrylamide concentration, however it shows the various stages of processing,
which are labelled below. Chromaffin granule membranes were run as a negative
control (C), AtT-20 cell homogenate is shown as H (neat) and H/2 (1:2 dilution),
fractions are labelled 1-13 (gradient 1 again having been used). The antiserum was
used at a dilution of 1/1000.
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The antiserum used here was a mouse monoclonal (hybridoma culture medium)
which recognised an epitope near the C terminus of synaptotagmin. It was raised by
Dr. Bulent Tugal (Department of Biochemistry, Edinburgh University) and was used
as neat, sterile filtered culture medium. CGMs (C) were used as a postivive control
and AtT-20 homogenate was run at a dilution of V2 (H/2). Fractions are labelled 1-12,
and gradient 2 was used in this case. The positions of the molecular weight markers
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Figure 3.17 Normal Rabbit Serum
Normal rabbit serum (NRS) was obtained from Sigma, and was used at a dilution of
1/100, as a negative control. In particular it was hoped that this would show up any
major proteins (present at high concentrations) which which showed non-specific
reactivity. It should also help to verify that results obtained for exocytotic proteins
were true and specific. Chromaffin granule membranes were run (C) and neat AtT-20
cell homogenate (H), as well as AtT-20 cell fractions 1-12 (labelled as such, from
gradient 2). The positions of molecular weight markers are shown in the centre
labelled as kDa.



















Figure 3.18 Synaptobrevin 2
This rabbit antiserum was raised against recombinant synaptobrevin 2, and was
donated by Cliff Shone (Porton Down). Synaptobrevin 2 is an integral vesicular
protein of 18kDa. The antiserum was used at a dilution of 1/1000 against fractions
from gradient 2. Chromaffin granule membranes (C) acted as a positive control,
AtT-20 cell homogenate was run neat (N), and fractions were labelled 1-12. The
positions ofmolecular weight markers are shown in the centre labelled as kDa.



































Rabbit antiserum was raised against recombinant human Rab3A, and was specific in
that it did not cross react with Rab3B, however its cross-reactivity with Rab3C and
3D had not yet been determined. It was donated by Dr. Francois Darchen (Institute of
Biology and Physiology, Paris), and was used at a dilution of 1/500. Chromaffin
granule membranes (C) were also run, as well as rat brain synaptosomes (S).
Fractions are from gradient 3 and are labelled 1-12. The position of molecular weight
markers are shown in the centre labelled as kDa.
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Figure 3.20 CAPS
This rabbit antiserum, raised against the CAPS protein, was donated by Dr. Thomas
Martin (University of Wisconsin, Madison, USA) and was used at a dilution of
1/1000. A PC 12 cell pellet was used as a positive control, and fractions were from
gradient 3, and are labelled 1-12. The position of molecular weight markers are
shown in the centre labelled as kDa.
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Figure 3.21 ADF
Rabbit antiserum was raised against recombinant human cytoplasmic ADF, and was
donated by Dr. Sutherland Maclver (Department of Biochemistry, Edinburgh
University). The antibody was used at a 1/500 dilution and a cell pellet of the human
T-cell line (hsp2) was used as a positive control (L), Chromaffin granule membranes
were also run (C), and the AtT-20 cell fractions used were from gradient 4 and are
labelled 1-12. The position of molecular weight markers are shown in the centre
labelled as kDa.
C 1 2 3 456 L 7 8 9 10 11 12
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Figure 3.22 Cofilin
Rabbit antiserum was raised against human recombinant cytoplasmic cofilin, and
was donated by Dr. Sutherland Maciver (Department of Biochemistry, Edinburgh
University). It was used at a dilution of 1/1000, against AtT-20 cell fractions from
gradient 4 (labelled 1-12). A pellet of cells from the human T-cell line (hsp2) was
run as a control (L), and chromaffin granule membranes were also run (C). The
position ofmolecular weight markers are shown in the centre labelled as kDa.
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Figure 3.23 Coomassie stained gel of Triton X-114 fractions
lOpl samples of the TX-114 fractionation detailed in 2.1.8 were run on an
acrylamide gel. The fractions are displayed as PI, P2 and S, details of which can be
found in 2.1.8.2. Molecular weights are displayed on the left hand side in kDa.
PI P2 S
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Figure 3.24 Blots of TX-114 fractions










































Table 3.7 Summary of fractionation results
The table below summarises the results obtained using the different methods of
fractionation. The presence of the protein in a fraction is shown by +, and its absence
by A blank space has been left when it has not been tested in a particular fraction.
The fraction where the protein was most concentrated (for that particular
fractionation) is marked *. If no asterisk is present, the distribution between the two
or three fractions is similar.
PROTEIN
Sucrose gradient fractionation TX-114 fractionation results
Membrane Cytosolic PI P2 S
Synaptotagmin + - - + +
Syntaxin + - - + +*
Synaptobrevin + - - + +
SNAP-25 +* + - + -
aSNAP + + - +* +





ACTH propeptides +* +
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Chapter 4
Further characterisation of AtT-20 cells using indirect
immunofluorescence microscopy and RT-PCR
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4.1 Introduction
Chapter 3 reported the presence in AtT-20 cells ofmany of the proteins thought to be
involved in exocytosis (Martin, 1997) however it was only possible to localise them
to the extent of being cytosolic or membrane-bound. Indirect immunofluorescence
microscopy was used as the cells could be studied in situ, in order that the
localisation of the various proteins could be described in greater detail.
The second method of further characterising AtT-20 cells was that of RT-PCR. This
was used alongside the western blotting technique, and prior to the TX-114
fractionation, to try to detect mRNA for particular proteins. Its aim was to strengthen
the results obtained using western blotting, and in particular to confirm the presence
of syntaxin and synaptobrevin. The blots obtained for these proteins (prior to those
obtained via the TX-114 fractionation) had been poor, and further validation by this
method was sought.
A further aim was to look at the structure of actin within AtT-20 cells, and to use
9+ • •
Ba to stimulate exocytosis in the cells, to examine any consequent changes in the
9+
cytoskeletal structure. Ba triggers exocytosis in a number of cell types, and it has
been shown that this process causes true vesicular release as shown by its sensitivity
to the clostridial neurotoxins (AfMahon et al., 1992). It is thought that Ba2+
influences transmitter release at various stages, first undergoing uncontrolled influx
into the cell, which may have inhibitory effects on K+ channels. It then may exchange
9 i #
with intracellular Ca in internal stores, and react with factors other that calmodulin
to trigger transmitter release (Augustine and Eckert, 1984; Verhage et al., 1995).
9+ •
These properties make Ba a useful tool, in that it enters the cell without the need for
permeabilisation and causes rapid and massive release of secretory products.
It is proposed that in many secretory cell types, a network of actin beneath the
plasma membrane acts to prevent the docking of granules with fusion sites in resting
cells (Burgess & Kelly, 1987). In chromaffin cells re-organisation of cortical actin
occurs in parallel with catecholamine release (Cheek & Burgoyne, 1987; Cheek &
Burgoyne, 1986), and similar effects have been seen in mast cells (Koffer et al.,
1990). It is thought that such reactions may be catalysed by actin-severing proteins
(Vitale et al., 1991), and indeed agents which stabilise or de-stabilise actin filaments
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have been shown to inhibit or potentiate secretion respectively (Holm-Nielson et al.,
1989; Orci et al., 1972). Actin organisation has also been studied in exocytosis from
AtT-20 cells by Castellino et al., 1992. They concluded that the ACTH-containing
vesicles are held within an actin network, which may have to be disconnected from
the vesicles before exocytosis can occur. They found that glucocorticoids inhibited
ACTH release by stabilisation of this actin network, and they postulated that this was
its main inhibitory effect.
4.2 Indirect immunofluorescence with antibodies to exocytotic
proteins
Many of the antibodies used to detect proteins by western blotting were also used for
indirect immunofluorescence microscopy. It is important to bear in mind that
immunofluorescence is used to detect fixed, native proteins within cells, whereas
western blotting detects SDS-denatured proteins. This means that antibodies yielding
positive results in western blotting, may not do so in immunofluorescence. The
results that have been included in this chapter are those that show strong, distinct and
specific staining of the cells (e.g. punctate, plasma-membrane, cortical etc.), and are
obviously significant when compared to the normal rabbit serum (NRS) control.
Many of the antibodies used displayed a general increase in brightness of cytosolic
staining, when compared to NRS. These results have not been included as they were
not considered significant. Even with NRS immunofluoresence, the intensity of the
staining will vary, as different areas of the slide were viewed. It was therefore
difficult to select typical areas, and to accurately compare them to the staining
obtained with specific antibodies. The control used was therefore NRS, with the
same exposure and development time as the specific antibody, but little emphasis has
been put on variation in intensities, and more on variation of staining patterns. All
antisera used in this section were the same as those used for western blotting (but
were diluted 1/100), and all cells were processed as detailed in section 2.3. Any
variations in this protocol is detailed in the appropriate figure legend. The results are
shown in figures 4.2 to 4.9, along with the appropriate control.
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4.3 Discussion
Polyclonal anti-ACTH (figure 4.2)
Strong punctate staining can be seen, showing localisation of ACTH to organelles.
There is perinuclear RER staining, followed by strong Golgi staining of the
propeptide hormone as it passes through the various processing stages. Towards the
periphery of the cell the staining becomes less dense, and very small punctate bodies
can be seen. These are very probably the ACTH-containing mature secretory
vesicles, and similar ACTH staining has been shown by Wendland & Scheller, 1994.
Monoclonal anti-ACTH (figure 4.3)
A staining pattern very similar to that obtained with polyclonal anti-ACTH was seen
here, however the background was slightly lower and the staining slightly stronger. It
was therefore decided that this antibody would be used for future experiments.
Anti-aSNAP (figure 4.4)
Staining with anti-aSNAP was very punctate and strong, and unlike typical diffuse
cytosolic staining. There was little RER or Golgi staining, but much peripheral
staining, which greatly resembled that of ACTH, in quantity, position and size. This
suggests that aSNAP is pre-docked to ACTH-containing vesicles, and confirms
results obtained with subcellular fractionation and western blotting.
Anti-NSF (figure 4.5)
The staining obtained with this antiserum was weak, but unlike that obtained for
aSNAP, in that no punctate staining was seen. However plasma membrane staining
can be seen, in agreement with the results of subcellular fractionation and western
blotting. Both of these results taken together suggest that NSF is indeed bound to
membranes in non-stimulated cells, but to the plasma-membrane as opposed to
secretory vesicles.
Anti-SNAP-25 (figure 4.6)
Anti-SNAP-25 antiserum displays strong plasma membrane staining, as would be
expected from this membrane associated t-SNARE.
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Anti-Cofilin (figure 4.7)
The staining seen with anti-cofilin was very unusual in that very strong punctate
bodies were seen on the periphery of the cell. The number of these cofilin-rich bodies
(CRBs) varied from cell to cell, ranging from zero to approximately 12. Aside from
the difference in quantity, they also differed from the vesicles that stained for
aSNAP and ACTH, in that they were larger in size.
Affinity purified anti-cofilin (figure 4.8)
The anti-cofilin antiserum was affinity-purified (section 2.3.4) in an attempt to
decrease background staining. Staining similar to that obtained with unpurified
antibody was seen, however the background staining was lower. The cell shown here
has the highest level of staining found, the average being only 2-3 CRBs per cell.
Actin staining with phalloidin (figure 4.9)
The actin structure was analysed using the actin-stabilising drug phalloidin
conjugated to rhodamine. Actin was present throughout the cytosol, in a network-like
arrangement, but that the strongest staining was obtained at the plasma-membrane.
Thus it appears that most filamentous actin in AtT-20 cells is at or adjacent to the
plasma-membrane. This type of staining, with its lack of stress fibres, was also
reported by Castellino et al., 1992.
4.4 Co-localisation studies using immunofluorescence
It was decided to investigate the role of actin in exocytosis, first by looking at its
position in relation to the ACTH vesicles. In many regulated secretory cell types a
definite cortical actin ring exists, below which the majority of the vesicles appear to
lie (see review - Morgan, 1995). The CRBs were also investigated, because of the
very unusual staining pattern, and the fact that cofilin is an actin de-polymerising
protein. The double staining patterns of ACTH/actin, cofilin/actin and cofilin/ACTH
were studied using a combination of FITC- and rhodamine-conjugated antibodies




Figure 4.10 suggests that the ACTH-containing secretory vesicles are not located in a
distinct zone below the cortical actin. Instead they show that the vesicles exist within
the overall actin network, and that vesicles can be seen within actin at the very
periphery of the cells. These results agree with those of Castellino et al., 1992 who
made a similar finding using electron microscopy. As mentioned before, many
secretory cells show a more distinct pattern, in which the vesicles lie well below this
cortical actin layer, and in this aspect AtT-20 cells appear to differ.
Cofilin & actin
Figure 4.11 shows that the CRBs very definitely co-localise with the filamentous
cortical actin, suggesting that their role is connected with this actin. Further
experiments will need to be done to assess whether actin is involved in exocytosis in
AtT-20 cells and if so, whether cofilin is involved, possibly by triggering de-
polymerisation.
Cofilin & ACTH
This experiment was to assess whether the CRBs were directly linked to the ACTF1
vesicles, and the results clearly demonstrated that they were not. All photographs in
these co-localisation studies were taken on the same plane of focus, and in this
instance the CRBs were focused upon. This is why the peripheral ACTH-containing
vesicles are not well defined, and much of the staining is of the Golgi. When the
ACTH-containing peripheral vesicles were focused upon, few CRBs were seen, and
those that were did not co-localise with the ACTH vesicles.
4.6 RT-PCR as a method of characterisation of the proteins present
in AtT-20 cells
RT-PCR was used in an attempt to obtain a more convincing demonstration of the
presence of synaptobrevin and syntaxin. These proteins could not be detected in
western blots using a number of different antisera, the best results having been
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detailed in chapter 3. As they form a major part of the SNARE apparatus, more
definite proof of their presence in AtT-20 cells was needed. Synaptobrevin was
detected in AtT-20 cells by Wendland & Scheller, but it was necessary to show its
existence specifically in the cell line that was being used in the present work. The
alternative methods used were immunofluorescence microscopy, RT-PCR and TX-
114 fractionation. Synaptobrevin and syntaxin antibodies gave no significant staining
in immunofluorescence microscopy, although western blotting after TX-114
fractionation did produce positive results. However it was the last technique to be
used, and the results obtained by RT-PCR are worth mentioning.
The primers used were as detailed in the appendix to chapter 2. The initial method
used was to isolate AtT-20 cell mRNA using a Qiagen kit (section 2.9.1). RT-PCR
was then attempted using the specific primers only, to try and amplify the specific
cDNAs encoding synaptotagmin, synaptobrevin and syntaxin. Synaptotagmin was
used as a control as the primers had already been used for cloning purposes, and
synaptotagmin had been detected by western blotting. This technique met with little
success as no bands could be seen when the products were run on agarose gels. With
all RT-PCR one of the major problems is the degredation of the RNA by
contaminating RNase. Although precautions were taken, the amounts of mRNA
obtained were so small that they could not be detected on a gel or by
spectrophotometry. It was therefore decided to use a total RNA preparation a
different approach would be taken, in that a total RNA prep would be used.
Messenger RNA constitutes 1-5% of the total RNA in a cell, thus total RNA levels
should be high enough to detect.
The total RNA preparation was done as detailed in section 2.9.2 and the A260/A280
ratio was 2.1. mRNA can display secondary structures which may interfere with
specific primer binding, and this can be a reason for failure of RT-PCR. It was
decided to do the RT-PCR in two stages: the first stage involved the use of random
primers to obtain double stranded cDNA of all the cellular mRNAs. The specific
primers were then used in the second stage, to amplify the synaptotagmin,
synaptobrevin or syntaxin cDNAs (section 2.9.3). The result of the synaptotagmin
RT-PCR is shown in figure 4.13, whilst figure 4.14 shows the results obtained using
the synaptobrevin and syntaxin primers.
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Synaptotagmin gave a strong positive result, which was not seen in the negative
controls. No positive result was obtained with the synaptobrevin primers as the bands
that can be seen were also obtained with the 5' primer alone, and must therefore be
due to a non-specific reaction. 2pl of cDNA from reaction 1 was used in lOOpl the
second-stage PCR, so it is possible that random primers present has interfered and
caused non-specific amplification of some cDNA.
However a band of the correct size (864bp) was seen in the correct lane for syntaxin,
but not in the negative control lanes, showing that it is specific. As it was a fairly
faint band, a further PCR reaction was performed with the same primers. The product
was run on an agarose gel, to check that the same band was being obtained (figure
4.15), and then lOOpl of the product was run on an agorose gel with larger lanes
(figure 4.15). The band was subsequently excised using a Qiagen gel extraction kit,
and the product was sent to be sequenced by Oswel. The sequence obtained is given
in figure 4.16, and discussed in 4.7.
4.7 Discussion
The synaptotagmin primers gave a strong band of the expected size (lkb), presumed
to be the synaptotagmin cDNA. However the synaptobrevin primers gave a non¬
specific result, which was obtained with the 5' primer only. The syntaxin primers
gave a band of the expected size, which was not seen in any of the negative controls.
However when this band was sequenced, the result was not syntaxin as expected.
The homology of the sequence with that of syntaxin, and the percentage match was
very low, showing that the cDNA obtained was not syntaxin, and that it was not even
related. The failure of this technique to show the presence of the mRNA of syntaxin
or synaptobrevin could be due to many reasons. The primers were not designed using
the mouse gene as this was not available from the database (see Appendix). They
were designed against conserved regions at the ends of the gene, but it is possible
that some difference existed which prevented efficient primer binding, and
subsequent amplification. Other possibilities are that the mRNA displayed a
secondary structure which interfered with even the random primer binding, or that
RNase had destroyed these particular mRNAs.
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4.8 Ba2+ stimulation studies
On stimulation of many types of secretory cell a change in the distribution of
filamentous actin can be seen. Cheek & Burgoyne, 1986 showed disassembly of the
cortical actin 15s after stimulation with nicotine, and re-assembly at 30s, all of which
• 9 I
was independent of external Ca . Roth & Burgoyne, 1995 used the drug
cytochalasin, which prevents the assembly of actin filaments. They reported that it
had no effect on the cortical actin in resting chromaffin cells, but that acted to hinder
the re-assembly of filamentous actin, after cellular stimulation with 14-3-3 proteins
and PMA. Actin disassembly and re-assembly can be rapid and transient, and in this
study cytochalasin was used to arrest re-assembly, thus 'freezing' the disassembled
actin structure.
In the present work the distribution of ACTH, actin and cofilin in AtT-20 cells has
9+
been studied at various stages, following stimulation with Ba . The time points
shown are 15s, lmin and 5min; however 5s, 30s, 2min, 5min and up to 1 hour were
also used, but gave the same results, and the data has not been included. The cells
9+
were grown in 6-well plates on coverslips and then stimulated with Ba as detailed
• • • 94- • •
in 2.5.1.1. Following addition of the Ba , the cells were stopped by immediately
fixing with formaldehyde at the various time points. The cells were then processed
for immunofluorescence microscopy as detailed in 2.3. This was done for the results
shown in figures 4.17 & 4.18. Cytochalasin D was also used in an effort to ensure
that any transient change in actin re-organisation was not missed. In these
9 .
experiments (figure 4.19) 2.5pM cytochalasin D was included in the Ba stimulation
buffer, and the cells then processed as before. Figures 4.17-4.19 show the results
obtained. All experiments and time points used controls of Locke's buffer without
the addition of Ba2+.
4.9 Discussion
No significant changes in the distribution of actin, ACTH or cofilin were seen at any
of the time points studied. Double labelling was used to enable detection in the
relative localisation of particular proteins, but none were noticed. These results
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suggest that in AtT-20 cells stimulation of exocytosis (at least by Ba2+) does not
cause any large-scale change in the distribution of actin; nor does it cause a change in
CRBs, or indeed in vesicle distribution. This latter result suggests that AtT-20 cells
release a relatively small percentage of their granules during a single stimulatory
event, so these small changes cannot be detected by immunofluorescence microscopy
at this level. An alternative explanation may be that the process of vesicle release is a
relatively dynamic one, and released vesicles are constantly being replace by new
mature vesicles. This in turn would mean that the docked aSNAP/NSF would
recycle between the membranes of newly released vesicles and the population
replacing them. This matter has been investigated and discussed further in Chapter 5,
where radioimmunoassay was used to measure the total ACTH content in AtT-20
'y i
cells, compared with levels released during Ba stimulations.
The fact that no changes in actin or cofilin occur during stimulation of the cells does
seem to point towards their having no major regulatory role in exocytosis from AtT-
20 cells. Although such a transient event is inherently hard to detect, the inclusion of
cytochalasin D makes it less likely that it was overlooked. Furthermore, differences
in actin localisation, in relation to secretory vesicles, do not appear to appear to be as
distinct as in other cells. As with all negative results it is difficult to reach an absolute
conclusion, and this subject is further investigated in Chapter 5, in which the time
course of Ba2+-stimulation is further studied. Phalloidin and cytochalasin were also
introduced into permeabilised AtT-20 cells, in order to assess whether these agents
inhibited or potentiated secretion.
4.10 Conclusions
Immunofluorescence microscopy showed the presence of SNAP-25, cofilin, NSF,
aSNAP, ACTH (propeptides and mature forms) and showed the structure of
filamentous actin within the cell. It suggested that SNAP-25 and NSF were localised
on the plasma membrane, and aSNAP and ACTH on secretory vesicles. Cofilin
directly co-localised to cortical actin, but not to the ACTH-containing vesicles. These
vesicles were localised within the actin network, as opposed to being in an area
• 2+ • • • • 1below the actin and distinct from it. Ba stimulation studies did not reveal any
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rearrangements of cortical actin on stimulation of the AtT-20 cells, nor were any
changes in redistribution of secretory vesicles or cofilin detected using this
technique. Cytochalasin D had no effect on this process, or indeed on the cortical
actin structure itself. These results are further validated in chapter 5, where
2~F
radioimmunoassay data will be shown corresponding to the Ba stimulation study,
to prove that exocytosis was occurring in the cells studied by immunofluorescence
microscopy.
RT-PCR detected bands of the expected size, for synaptotagmin and syntaxin
mRNAs, but not for synaptobrevin, however the sequence of the latter showed it not
to be syntaxin. Although the synaptotagmin result may be a true positive, this
product would also have to be sequenced in order to confirm this.
The results obtained in the present chapter are in accord with those obtained in
chapter 3 which showed aSNAP and NSF to be membrane bound. They extend them
by suggesting that aSNAP is bound to secretory vesicles, and NSF to the plasma
membrane. They also suggest that the actin/vesicle structure differs from that seen in
many secretory cells, in that there appears to be a network as opposed to a definite
barrier. Stimulation studies failed to show any involvement of actin or cofilin in
exocytosis, and showed little changes in the detectable vesicle distribution.
The next chapter uses radioimmunoassay of ACTH and a permeabilised cell system
to look at the mechanisms of exocytosis in more detail.
131
Figure 4.1 AtT-20 cells
This is a high-powered phase contrast micrograph of AtT-20 cells, which have been
plated on coverslips, fixed and processed as they would be for immunofluorescence
microscopy. Calibration bar = 12.5pm. Photographs were taken on slightly different
planes of focus in order that the overall cell structure can be seen (a), and the nuclear
structure can be seen (b).
(a)
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4.2 Immunofluorescence microscopy using polyclonal anti-ACTH
The antibody used here was rabbit polyclonal anti-ACTH antiserum, as detailed in
figure 3.15, at a dilution of 1/100. (a) shows anti-ACTH staining, whilst (b) shows
the NRS control at the same dilution, using the same exposure/development times
respectively. The secondary antibody used was anti-rabbit conjugated to rhodamine,
at a dilution of 1/100. Calibration bar = 12.5p.M.
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4.3 Immnuofluorescence microscopy using monoclonal anti-ACTH
The monoclonal antibody obtained here was from a hybridoma cell line, and the
culture supernatant was used neat. The secondary antibody used here was therefore
anti-mouse conjugated to rhodamine, at a dilution of 1/100. Calibration bar =
12.5pM.
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4.4 Immnuofluorescence microscopy using anti- aSNAP antiserum
The antibody used was as described in figure 3.13, and was used at a dilution of 1/50.
As it was an affinity-purified antibody no NRS control has been shown, (a) shows
anti-aSNAP staining, whilst (b) shows a control of secondary antibody only. The
secondary antibody used was anti-rabbit conjugated to rhodamine, at a dilution of
1/100. Calibration = 12.5pM.
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4.5 Immnuofluorescence microscopy using anti-NSF antiserum
The antiserum used was as described in figure 3.14, and was used at a dilution of
1/100. A control of NRS has been shown, using the same dilutions, exposure and
development times, (a) shows anti-NSF staining, whilst (b) shows the control of
NRS. The secondary antibody used was anti-rabbit conjugated to rhodamine, at a
dilution of 1/100. Calibration bar = 12.5pM.
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4. 6 Immunofluorescence microscopy using anti-SNAP-25 antiserum
The antiserum used was as described in figure 3.12, and was used at a dilution of
1/100. A control of NRS is shown, using the same dilutions, exposure and
development times, (a) shows anti-SNAP-25 staining, whilst (b) shows the control of
NRS. The secondary antibody used was anti-rabbit conjugated to rhodamine, at a
dilution of 1/100. Calibration bar = 12.5pM.
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4.7 Immunofluorescence microscopy using anti-cofllin antiserum
The antiserum used was as described in figure 3.22, and was used at a dilution of
1/100. A control of NRS has been shown, using the same dilutions, exposure and
development times, (a) shows anti-cofilin staining, whilst (b) shows the control of
NRS. The secondary antibody used was anti-rabbit conjugated to rhodamine, at a
dilution of 1/100. Calibration bar = 12.5p.M.
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4.8 Immunofluorescence microscopy using affinity purified anti-
cofilin
The cofilin antibody used in figure 4.7 was affinity-purified as detailed in 2.3.4. It
was used at a dilution of 1/50, and the secondary antibody used was anti-rabbit
conjugated to rhodamine, at a 1/100 dilution.
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4.9 Actin staining with phalloidin
These cells were directly stained with the actin-stabilising drug phalloidin,
conjugated to rhodamine. It was used at a concentration of 2pg/ml.
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4.10 Colocalisation of ACTH and actin using immunofluorescence
microscopy
Cells were labelled as detailed in figures 4.3 and 4.9, except that the actin was
labelled with phalloidin conjugated to FITC. Two different areas are shown: (a)/(b)
and (c)/(d). (a) and (c) are stained for ACTH, (b) and (d) are stained for actin.
Calibration bars = 12.5pM.
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4.11 Colocalisation of cofilin and actin using immunofluorescence
micrsocopy
Cells were labelled as detailed in figures 4.8 and 4.9, except that the phalloidin used
to label the actin was conjugated to FITC. Two different areas are shown: (a)/(b) and




4.12 Colocalisation of ACTH and cofilin using immunofluorescence
microscopy
Cells were labelled as detailed in figures 4.8 and 4.3, except that the anti-rabbit
antisera used to detect cofilin, was conjugated to FITC. Two different areas are
shown: (a)/(b) and (c)/(d). (a) and (c) are stained for cofilin, (b) and (d) are stained
for ACTH. Calibration bars = 12.5pM.
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4.13 RT-PCR with synaptotagmin primers
Lanes 1 and 6 show a lkb DNA ladder (detailed on left hand side in base pairs) and
lane 2 a PCR control. Lane 3 shows the RT-PCR rection with the 5'primer only,
whilst lane 4 is the RT-PCR reaction with the 3' primer only. Lane 5 shows the band
obtained when both the 5' and the 3' primers were present. All samples were run on




4.14 RT-PCR with synaptobrevin and syntaxin primers
Lane 1 shows a lkb ladder, and the DNA fragment sizes are given on the left hand
side in base pairs. Lane 2 shows the RT-PCR product in the presence of both
synaptobrevin primers, while lanes 3 and 4 show the RT-PCR product in the
presence of the 5' synaptobrevin primer and the 3' synaptobrevin primer
respectively. Lane 5 shows the RT-PCR product in the presence of both the 5' and
the 3' syntaxin primers, while lanes 6 and 7 show the RT-PCR product in the
presence of the 5' syntaxin primer and the 3' syntaxin primer respectively. All
samples were run on agarose gels as described in section 2.7.2.2.
1 2 3 4 5 6 7
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4.15 Amplification and gel extraction of syntaxin RT-PCR product
Gel 1 shows the RT-PCR product obtained in figure 4.11, amplified up by
subsequent rounds of PCR. Lane 1 shows lkb markers, lane 2 a positive PCR control
and lane 3 the product obtained with syntaxin primers. Gel 2 shows lOOpl of this
PCR product run on an agarose gel, and the arrow indicates the band which was cut
out and purified. Gel 3 shows 10pl of the purified product, and which was then sent
for sequencing. All samples were run on agarose gels as described in section 2.7.2.2.
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4.16 RT-PCR product sequence
The sequence below represents that obtained from Oswell, for the sequencing of the








4.17 Staining for ACTH and actin after Ba2+ stimulation
AtT-20 cells were stimulated as detailed in section 2.5.1.1, and then double-labelled
for ACTH and actin, as previously described (figure4.10). (a)-(f) show Ba2+-
stimulated cells, whilst (g)-(l) show control cells, incubated in Lockes buffer, (a)-(c)
and (g)-(i) show staining for ACTH, whilst (d)-(f) and (j)-(l) show actin staining, (a)-
(c), (d)-(f), (g)-(i) and (j)-(l) represent the same time course of 15s, lmin and 5min.
Calibration bars = 12.5pM.
(g) ACTH control 15s
ACTH control lmin
(i) ACTH control 5min
(a) ACTH Ba2+ 15s
(b) ACTH Ba2+ lmin
(c) ACTH Ba2+ 5min
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(d) actin Ba2+ 15s
(e) actin Ba21 1min —
• 2~!~ •
(f) actin Ba 5mm —
(j) actin control 15s —
(k) actin control 1min —
(1) actin control 5min—
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4.18 Staining for cofilin and actin after Ba2+ stimulation
AtT-20 cells were stimulated as detailed in 2.5.1.1, and then double-labelled for
9+
cofilin and actin, as previously described, (a)-(f) show Ba -stimulated cells, whilst
(g)-(l) show control cells, incubated in Lockes buffer, (a)-(c) and (g)-(i) show
staining for cofilin, whilst (d)-(f) and (jMO show actin staining, (a)-(c), (d)-(f), (g)-
(i) and (j)-(l) represent the same time course of 15s, lmin and 5min. Calibration bars
- 12.5pM.
(a) Ba2 cofilin 15s _ (g) control cofilin 15s —
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2+ .
(d) Ba actin 15s — (j) control actin 15s
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4.19 Staining actin after Ba stimulation (in the presence of
cytochalasin)
AtT-20 cells were stimulated as detailed in section 2.5.1.1, and then labelled for actin
9+
as previously described (figure 4. 9). (a)-(c) show the Ba -stimulated cells, whilst
(d)-(f) show control cells, incubated in Lockes buffer. In each case 2.5pM
cytochalasin D, was including in within the Ba2+ stimulation or control buffer.
Calibration bars = 12.5pM.
2 j m ,
(a) Ba actin 15s — (d) control actin 15s —
2+ . . .
(c) Ba actin 5min — (f) control actin 5mm
2+ • •
(b) Ba actin lmin (e) control actin 1min
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Chapter 5
A study of Ca2+-regulated exocytosis, using permeabilised AtT-20




The aim of the work described in this chapter was to study Ca -regulated exocytosis
in permeabilised AtT-20 cells into which antibodies, proteins, toxins or drugs had
9+ •
been introduced. Buffered Ca could then be used to stimulate exocytosis, and the
secreted ACTH measured using a radioimmunoassay (RIA). This would allow
9+
detection of any changes in Ca -regulated exocytosis, as a result of the various
factors which had entered the cells.
The radioimmunoassay was set up with reagents obtained from NIDDK (National
Institute of Diabetes and Digestive and Kidney Diseases). It was then used to check
that the cells were secreting in a normal, regulated way as reported by Sabol, 1980,
Hook et al., 1982; Phillips & Tashjian, 1982; Loechner et al., 1996. For these studies
non-permeabilised AtT-20 cells were used with K+, K-bromo-cAMP, CRH and Ba2+
to stimulate secretion, whilst dexamethasone was used as an inhibitor of secretion.
The digitonin permeabilisation conditions were optimised, ensuring that excessive
levels of ACTH were not being lost, but that the incubation times allowed the entry
of a number of different factors.
Having developed a permeabilised cell assay, a number of different approaches were
used. Antibodies directed against proteins involved in secretion, purified
recombinant proteins (normally involved in secretion), actin stabilising or
destabilising drugs and recombinant clostridial neurotoxin light chains were all
added to the permeabilised AtT-20 cells, and their effects on secretion measured
using the ACTH RIA.
5.2 ACTH radioimmunoassay
ACTH and anti-ACTH were obtained from NIDDK, and iodination of the ACTH
was done as detailed in section 2.4.1. The protocol for the ACTH RIA was obtained
from Dr. John Bennie (Royal Edinburgh Hospital, Edinburgh), however the anti-
ACTH antiserum was from a different source, and it was necessary to re-optimise the
assay using this new antiserum. The assay was performed as detailed in section 2.4.2.
The anti-ACTH antiserum dilutions used in this experiment were 1/20000, 1/30000,
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1/40000, 1/50000 and 1/60000 with standards ranging from 0-80ng/ml ACTH. All
data were fitted using a third order polynomial curve to the order of three. The aim
was to obtain an anti-ACTH concentration that gave a well-fitted curve, with a
Bo/TC value of around 20-25%, as this part of the curve allows for the most accurate
calculations of ACTH concentrations. The B0 value is the count obtained in the
presence of approximately 10,000cpm iodinated ACTH, but no standard ('cold')
ACTH. The TC (total counts) value is the cpm in 50pl (i.e. a normal sample) of
iodinated ACTH, with no subsequent treatment, and this is approximately
10,000cpm. Bo/TC is simply used to optimise the assay within the correct area of the
curve. As the total counts were around lOOOOcpm, and the Bo values were around
2500-3000cpm, samples were read on the gamma counter for 3min in order to give
sufficient accuracy. Doubling dilutions were not used to produce the standards for
the standard curve, as this can lead to inaccuracies, and all standards were diluted
separately from a stock solution. Figure 5.1 shows the standard curves and Bo/TC
values obtained for each concentration of antiserum. Normal samples and standards
are plotted as shown on this curve, as %B/Bo, that is percentage bound iodinated
ACTH (in the presence of sample or standard 'cold' ACTH) over bound iodinated
ACTH (in the absence of any standard or sample 'cold' ACTH).
5.3 Discussion
It was decided to use an antiserum concentration of 1/60000, as this gave a very
reproducible curve with a Bo/TC value of 23%. All standards were assayed in
triplicate, whilst actual samples were assayed in duplicate. ACTH standards were
obtained from the Royal Edinburgh Hospital, and assayed using this system. In this
work they all gave values within 2-3 times the values obtained using the Royal
Edinburgh assay.
The calculation of the ACTH concentration of unknown samples was done using the
polynomial equation obtained for each assay. The equation was used to produce an
iterative formula which allowed the calculation of unkown values. A standard curve
and formula was calculated for each single radioimmunoassay, however these are not
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all given in the results chapters. Figure 5.2 shows a representative standard curve and
the formula used to calculate values from it. Having obtained an accurate and
reproducible method of measuring ACTH secretion, the next stage was to assess
whether the AtT-20 cells used were secreting ACTH normally fashion, and whether
the levels were measurable by RIA.
In all subsequent experiments where ACTH concentration has been measured
standard error bars have been shown, and unless otherwise stated n=4. In this case
'n' refers to the number of wells assayed, however to further increase accuracy these
samples were all assayed twice and the mean values used for further calculation, and
calculation of standard errors. Each set of results reported in this chapter was
obtained within the same radioimmunoassay to avoid the problem of variations in
standard curves giving rise to differences in results, between assays. Each assay was
done using cells grown to 70-80% confluency in 24-well plates, and the volumes
used were always 1ml per well. The results are reported as ACTH concentration in
ng/ml, rather than per number of cells, as this varied slightly between assays. As a
rough guide, one well of a 24-well plate contained 10,000 - 20,000 cells, therefore
the ACTH release could be calculated as ng/10,000-20,000 cells.
5.4 Secretion of ACTH by non-permeabilised AtT-20 cells, in
response to various secretagogues.
A time course was obtained for release stimulated by CRE, KC1 and Ba2+, to assess
the optimum time for measuring ACTH secretion, all stimulations being done as
detailed in section 2.5.1. Two time courses were obtained for the Ba2, stimulations,
in order that these could be compared to the experiments detailed in figures 4.17-
4.19. A dose-response curve was also obtained for CRF, and the various
secretagogues were then used at their optimal concentrations to stimulate the AtT-20
cells. The inhibitory effect of dexamethasone on CRF-, K+- and 8 -bromo-cAMP-
mediated exocytosis was examined in parallel. Figures 5.3-5.7 detail the results
obtained in these experiments.
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5.5 Discussion
The time course of CRF-stimulated ACTH secretion (figure 5.3a) showed that
maximal release was obtained at 30-40min, in that the largest difference was seen
between basal and CRF-stimulated samples, as well as the smallest standard errors.
The dose response (figure 5.3b) confirmed that lOOnM CRF was optimal, as lower
CRF concentrations lead to increased standard errors. Thus in subsequent CRF-
stimulation experiments 30 minute incubations with lOOnM CRF were used, at 37°C.
Although the differences between basal levels of secretion and CRF-stimulated
levels of secretion were not large, they are similar to those previously found. Reports
on the extent of stimulation range from 2 to 5 times the basal level of stimulation
(Reisine et al., 1985; Hook et al., 1982). In the system used here CRF stimulation
produced 1.5-2 times the levels of basal secretion, and although this is fairly low the
results were consistent and reproducible. However it is important to note such
variations as they may be due to differentiation of the cells, or the use of slightly
different methods of culture.
The time course of K+-stimulated ACTH secretion (figure 5.4) also showed the
optimum time of assay to be around 30min, and to produce approximately twice the
basal levels ofACTH secretion.
Figure 5.5 shows the results obtained when the effect of dexamethasone on ACTH
secretion was measured, after stimulating the cells with lOOnM CRF or 50mM K+.
The results showed that both CRF and K+ stimulated the cells to secrete around 2
times the basal level of ACTH. Dexamethasone reduced CRF-stimulated and K+-
stimulated ACTH secretion by approximately 65% in both cases, and almost returned
them to basal levels. The basal level itself was also reduced by 55%. Again reports
vary with respect to the effect of dexamethasone on ACTH secretion, with many
suggesting that it inhibits CRF-, but not K+- stimulated secretion (Phillips &
Tashjian, 1982). However Sabol, 1980 showed that K+-stimulated endorphin
secretion was significantly decreased with dexamethasone. These differences suggest
that cell lines may differentiate and behave slightly differently. Dexamethasone was
stored in a stock solution at a concentration of lOmM in DMSO, and the experiment
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was repeated using controls with the same levels of DMSO only. The same results,
were seen thus any inhibitory effect was due a specific effect of the dexamethasone.
The effects of 8-bromo-cAMP on AtT-20 cells were also investigated, and are
detailed in figure 5.6. A time course has not been included in this experiment as
preliminary work identified optimal incubation times of 30min. The basal level of
ACTH secretion was 6.3ng/ml, and 5mM 8-bromo-cAMP increased this to
13.2ng/ml. Dexamethasone inhibited both basal and stimulated levels of ACTH
secretion, bringing them down to 5.3ng/ml and 6.5ng/ml respectively, an effect
commonly reported in AtT-20 cells (Phillips & Tashijan, 1982).
• **» |
The time course of Ba -stimulated release (figure 5.7) was determined in order to
further analyse the immunfluorescence results obtained in figures 4.17-4.19. These
results did not show any change in actin or cofilin distribution, over a time course of
Ba2+-stimulation (15s, lmin and 5min). The time course of Ba2+-stimulation
measured by RIA was done in two parts to increase the accuracy of the times at
which the samples were taken: (a) shows 5min-60min and (b) shows 15s-5min.
'j i
There is little Ba -stimulation between 15s and 2min, after which there is a large
increase to 3-4.5 times that of the basal levels. Graph (a) shows a maximal stimulated
level of 3.4ng/ml ACTH, whilst graph (b) shows a maximal stimulated level of
8.7ng/ml. As the ACTH concentration was assessed on separate occasions using
different RIAs the discrepancy could simply be due to variation between the assays.
However it is also possible that 5 min represents the point where ACTH secretion
has only just begun, in which case any variation in taking samples would have a
large effect. It was therefore decided that in subsequent Ba2+-stimulation experiments
10 minute incubation times would be used.
These results are important in that they show that the immunofluorescence studies
were performed within the correct time scale. At 15s and lmin, there is little ACTH
secretion, however at 5min ACTH secretion has just begun. No changes in actin or
cofilin distribution could be seen at any of these time points, and even the addition of
cytochalasin D failed to slow any re-polymerisation and reveal any changes.
Immunofluorescence microscopy was performed at various time points between 10-
60mins, however these results were not been included as they were the same as at the
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time points shown. Again there was no evidence for the involvement of actin or
cofilin in Ca2+-regulated exocytosis in AtT-20 cells, unless the changes were so small
that the techniques used were not sensitive enough to detect them.
These experiments have shown that the AtT-20 cell line used in these studies secretes
I 2~F
ACTH in a regulated manner, in response to CRF, K , Ba and 5"-bromo-cAMP.
Dexamethasone inhibits release stimulated by CRF, K+ and 5'-bromo-cAMP, in
disagreement with many reports but agreement with others, suggesting variations
between cell lines or culture techniques. The different methods of action of these
various secretagogues can also be seen in that CRF, K+ and 5"-bromo-cAMP all gave
maximal levels of secretion at around 30 min, whereas Ba2+ acts at the much faster
time of 5min.
5.6 Permeabilisation of AtT-20 cells and subsequent stimulation of
ACTH secretion by Ca2+
5.6.1 Optimisation of digitonin permeabilisation
Streptolysin-0 was initially used for cell permeabilisation, however trypan blue
staining showed little permeabilisation to be occurring, and when chicken red blood
cells were used as a control, similar results were seen. When digitonin was used the
results were much more reproducible and trypan blue showed permeabilisation of a
high percentage of the AtT-20 cells. Various intracellular buffers were also tested,
for preventing loss of AtT-20 cells from the wells, and the best was found to be the
K+-glutamate/PIPES buffer detailed in section 2.5.2. The assay involved the cells
being washed in 1ml intracellular buffer, followed by permeabilisation in the
intracellular buffer containing digitonin. This was then removed and 0.5ml of
intracellular buffer was added including any factors that were required to enter the
cells. Ca2+-stimulated ACTH secretion was evoked by adding an additional 0.5ml
intracellular buffer, containing the appropriate concentration of Ca2+. Initial
experiments showed that significant cell loss was occurring on removal of the
digitonin permeabilisation buffer, however when the cells were plated on to poly-L-
lysine coated 24-well plates (section 2.5.2), this problem was eliminated. Varying
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digitonin concentrations were used (5-50pg/ml), and trypan blue was used to stain
permeabilised cells and assess the percentage cell permeabilisation. It was found that
below 10pg/ml digitonin, only approximately 50% of AtT-20 cells were
permeabilised, however at 10 and 20pg/ml digitonin (for 5-10min), greater than 80%
of cells were permeabilised. In subsequent experiments, 20pg/ml digitonin (for
lOmin) was found to produce the most reliable results and to cause greater than 90%
of cells to be permeabilised. The ACTH RIA was then used to assess the amount of
ACTH that was leaking into the digitonin buffer during permeabilisation. This latter
value should be as low as possible, as it is in effect a measure of intracellular
membrane damage. The amount of Ca2+-stimulated secretion that occurred in these
permeabilised cells was also measured, as well as ACTH release on total lysis
(section 2.5.4), in cells prior to digitonin permeabilisation and after digitonin
permeabilisation. The ACTH levels that were found are shown in figure 5.8.
At this stage it is necessary to introduce some terminology to clarify the descriptions
of any variations in the process. The buffer used for washing, digitonin incubation
2+
(lOmin), incubation with proteins and drugs (15min) and subsequent Ca
stimulation (lOmin) was based on the PIPES/K+ glutamate buffer previously
• • 2"b •
described. In the presence of digtonin, proteins or drugs, and stimulatory Ca it will
be respectively referred to as permeabilisation buffer, pre-Ca2+ incubation buffer and
Ca2+-stimulation buffer. The assay stages i.e. digitonin permeabilisation of the cells,
incubation of the cells with proteins or drugs and stimulation of the cells with 10pM
Ca2+ will be respectively detailed as permeabilisation stage, pre-Ca2+ incubation
2"b • • *1
stage and Ca -stimulation stage. All experiments were done using the above
protocol and incubation times, unless otherwise stated. All experiments used AtT-20
cells, grown to 70-80% confluency in 24-well plates, the incubation stages using lml
buffer, and the ACTH being assayed in lml buffer.
5.6.2 Optimisation of Ca2+-stimulated ACTH secretion in AtT-20 cells
Up until this point, lOpM free Ca2+ was used to stimulate ACTH secretion in AtT-20
cells, as this was the level used in most of the work here. However as every
2+ .
experimental system varies, it was necessary to assess the optimal Ca concentration
which should be used to stimulate secretion, as well as the optimal time at which to
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9+
measure release. The dose-response curve for Ca -stimulation, and the time course
2+ #of release are shown in figure 5.9. The effect of temperature on Ca -mediated
ACTH secretion was measured and is displayed in figure 5.10.
5.6.3 Evaluation of the viability of the permeabilised cell system
Having optimised the permeabilisation system, it was necessary to prove that
proteins and drugs could actually enter the permeabilised AtT-20 cells. To assess
this, a number of agents were incubated with the permeabilised AtT-20 cells for
15min, and the results were assessed by immunofluorescence microscopy. This was
done by fixing the cells (as detailed in 2.5.2), immediately on removal of the pre-
9+ « •
Ca incubation buffer (including the proteins or drugs), and following the
immunofluorescence protocol from this point on. The following were used in this
experiment: phalloidin-conjugated rhodamine (to label actin), affinity-purified anti-
cofilin antiserum and a plant-actin binding protein (ZMAPB3) conjugated to GFP.
The molecular weights of these were 0.5kDa, 150kDa and 50kDa respectively, and
figure 5.11 shows the results.
5.7 Discussion
Trypan blue staining of permeabilised cells indicated that 20pg/ml digitonin was
necessary to obtain reproducible permeabilisation of greater than 90% of AtT-20
cells. Although the leakage of ACTH into the digitonin buffer (indicating
intracellular membrane damage) was increased at this digitonin concentration, it was
decided that reproducible and efficient permeabilisation was essential. Total lysis
values showed that AtT-20 cells in one well of a 24 well plate contained 9.7ng/ml
ACTH, which decreased to 6.2ng/ml ACTH following digitonin permeabilisation.
The 1,6ng/ml lost during permeabilisation corresponds fairly well with these figures,
and represents 13% of the total ACTH content (taking into account basal levels of
9-i t
leakage). Although this is significant, later Ca -stimulation results showed that the
cells still secreted in a regulated manner, and it was considered a tolerable loss.
The corresponding Ba2+-stimulation results (obtained using the same RIA) showed
that during a lOmin stimulation the cells released 71% of their total ACTH content.
164
Considering the immunofluorescence results, in which the ACTH staining was
examined following a Ba2+-stimulation, it it is surprising that no change in granule
distribution was seen. One explanation for this is that the cells might produce and
replace ACTH in a very efficient manner, ready for the next stimulatory event.
Another might be that the lysis buffer gave inaccurate readings using the RIA, and
indeed the Bo values did vary, however these were taken into account in calculations
of the ACTH concentration. It may be that a combination of the buffer and lysis
process caused general degradation of the ACTH.
■y i t #
The Ca -mediated release of ACTH from these permeabilised cells was 2.5ng/ml (3
times that of basal levels), thus the cells were releasing 40% of their total ACTH
content after permeabilisation. Although these levels were lower than those produced
•y |
by Ba -stimulation, the standard errors were small and the results very reproducible.
9+ 2"bThis indicates differences in the mechanisms of Ca - and Ba -stimulated ACTH
release, and should be considered when interpreting results obtained using this
• 9+
method of stimulation. The actin distribution was also examined following Ba -
stimulation, and as this is not a physiological stimulatory event, it will be important
9+
in the following section to look at the role of actin during Ca -stimulated ACTH
release.
2_|_The time-course and dose-response curves of Ca -stimulated ACTH release were
• • 9+ •
typical, in that the optimal Ca concentration was lOpM and the optimal time of
sampling was around lOmin. These conditions were used in all subsequent
experiments.
The effect of temperature was examined to assess whether it was possible obtain
secretion at room temperature, as opposed to the more physiological 37°C. ACTH
secretion at room temperature was 2.9 times the basal level, and at 37°C was 3.2
times the basal level. As the difference was not significant it was decided that it
would be possible to incubate all samples at room temperature, as this allowed for
greater accuracy, particularly with respect to the time at which the samples were
taken.
Immunofluorescence microscopy proved that factors of varying molecular weight
could efficiently enter the permeabilised AtT-20 cells and bind, in the 15min pre-
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incubation stage before the addition of the Ca . A 15min incubation was used during
subsequent experiments, unless otherwise stated. The real value of such a result was
that it added validity to any negative results obtained with recombinant proteins,
antibodies or drugs such as phalloidin.
Having fully optimised and validated the permeabilised cell assay, the next stage was
to examine the effects of possible interfering factors, on Ca2+-stimulated ACTH
secretion in AtT-20 cells.
5.8 Introduction of antibodies and recombinant proteins into
permeabilised AtT-20 cells
5.8.1 Introduction of antibodies to permeabilised AtT-20 cells
AtT-20 cells were permeabilised as detailed in 2.5.2, and diluted antiserum was
9+
included in the pre-Ca incubation buffer. All subsequent experiments used this
same protocol unless otherwise stated. Antisera to cofilin, syntaxin and
synaptotagmin were used to assess the involvement of these proteins in exocytosis.
All antisera were used at a dilution of 1/100 and results are shown in figure 5.12.
NRS was used as a control, and basal levels of secretion without any additions were
also measured.
5.8.2 Introduction of recombinant proteins into permeabilised AtT-20 cells
Recombinant cofilin and synaptotagmin were introduced into AtT-20 cells in the pre-
2+ •Ca incubation buffer. BSA at similar concentrations was used as a control, and
basal levels with no additions were also measured. Figures 5.13 & 5.14 show the
results obtained for cofilin and synaptotagmin.
Another approach was to assess the effect of adding recombinant cofilin on the
• • 9+
kinetics ofACTH secretion. Following a pre-Ca incubation stage with cofilin, AtT-
• • 2"F •20 cells were stimulated with lOpM Ca for 2, 5 and lOmin, and then samples
removed and ACTH levels measured. The control was BSA, as this was shown in




The introduction of antibodies to synaptotagmin, syntaxin and cofilin into
permeabilised AtT-20 cells had negligible effects on Ca2+-stimulated ACTH
• • 2~b •
secretion. Although anti-cofilin caused a small decrease in Ca - stimulated ACTH
secretion, NRS had the same effect, suggesting that the effect was non-specific. Anti-
synaptotagmin and anti-syntaxin had no significant effect on either Ca2+-stimulated
or basal levels of secretion, when compared to ACTH secretion in cells incubated
with intracellular buffer containing no antibodies. Whilst these results could suggest
that cofilin, synaptotagmin and syntaxin have no role in ACTH secretion, results of
similar experiments in chromaffin cells, in which such proteins are known to have a
role, were also negative (Vitale et al., 1995). However there are other experimental
systems in which the introduction of antibodies into permeabilised chromaffin cells,
has pronounced effects (Ohara-Imaizumi et al., 1997). The other explanation for the
lack of effect of anti-synaptotagmin and anti-syntaxin is that vesicles are already
docked at the plasma membrane, and the antibodies are either unable to bind, or do
not affect a rate-limiting step, although this would rule out a role for synaptotagmin
as a Ca2+-sensor.
Similar results were obtained on the introduction of recombinant cofilin and
synaptotagmin, in that they had no significant effect on ACTH secretion. Both cofilin
and synaptotagmin caused a slight increase in ACTH secretion, but this was
mimicked by the BSA control and therefore was deemed non-specific. The
explanation for this lack of effect is similar to those offered on introduction of the
antibodies; that these proteins do not have a major role in this particular stage of
exocytosis. It seems likely that adding an excess of functional recombinant cofilin
had no effect as there was already a plentiful reservoir of cytosolic protein. The
explanation for synaptotagmin is not as simple, since it is an integral membrane
protein, and only the recombinant cytosolic domain was being introduced to the
cells. The presumption was that this recombinant protein would act as a dominant
negative effector of the exocytotic machinery, for example by competing with native
synaptotagmin for interactions with other proteins. As no effect was seen, this
protein may not have a rate-determining role in Ca2+-regulated exocytosis in AtT-20
cells. A similar result was reported by Wendland & Scheller, 1994, who used AtT-20
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cells that were stably transfected with the gene for the cytoplasmic domain of
synaptotagmin, and found no effect on Ca2+-regulated exocytosis. Another possibility
is that there is an alternative pathway which can be utilised when the synaptotagmin
pathway is blocked. These explanations imply that synaptotagmin may be a Ca2+-
sensor, but if its main role were as a v-SNARE, the lack of effect of the cytoplasmic
domain may simply be due to the fact that the vesicles are already docked at the
plasma-membrane. This idea has already been proposed by Schiavo et al., 1997 to
explain the fact that vesicles remain docked at the plasma membrane after treatment
with botulinum toxins A and E, which proteolytically digest SNAP-25. The time
course of ACTH secretion in the presence of cofilin showed no effect on the kinetics
of ACTH secretion. If actin has a rate-determining role in Ca2+-stimulated ACTH
secretion, the introduced cofilin might stimulate ACTH secretion, by increasing actin
de-polymerisation. Since no change in the kinetics was seen an adequate pool of
functional protein may already have been present in the cells.
5.10 Further investigation of the role of actin in Ca2+-stimulated
ACTH secretion in AtT-20 cells
2+Phalloidin and cytochalasin D were also used to study the role of actin in Ca -
regulated exocytosis in AtT-20 cells. Figure 5.16 shows the results obtained when
0_1_
phalloidin was incubated with AtT-20 cells prior to Ca -stimulation, and samples
were taken at varying times (2, 5 and lOmin), to assess whether the actin-stabilising
drug had any effect on the kinetics. Finally cytochalasin D (an actin de-stabilising
drug) was used to assess whether destabilisation of the actin had any effect on ACTH
secretion, and these results are shown in figure 5.17.
5.11 Discussion
Neither phalloidin nor cytochalasin D appeared to have any effect on Ca2+-stimulated
or basal ACTH secretion in permeabilised AtT-20 cells (figures 5.16-5.17).
Immunofluorescence studies showed that phalloidin binds to the actin in such cells
(figure 5.11), so the lack of effect cannot be explained by its failure to enter and bind.
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Figures 4.17-4.18 showed that no changes could be seen in actin distribution,
following Ba2+-stimulation of ACTH secretion. The inclusion of cytochalasin D, to
slow down the re-polymerisation of the actin (figure 4.19) was also investigated in
these experiments. A slight change in the actin distribution could be seen, in that it
2+
appeared more 'patchy', however this effect occurred in both control and Ba -
stimulated cells and thus was not a consequence of ACTH secretion. Cytochalasin D
had no effect, producing no significant change in ACTH secretion (figure 5.17). One
could say that the Ba2+-stimulation experiments may not be physiologically relevant,
however the same explanation cannot be offered for experiments in which ACTH
2+secretion was stimulated with Ca . Furthermore, measurements ofACTH release do
not rely on qualitative judgement, but on statistically-analysed data. These findings
(as well as those reported in chapter 4) do not prove any role for actin in Ca2+-
stimulated ACTH secretion in AtT-20 cells. Many similar studies of different cell
types produced different results. For example Lelkes et al., 1986 reported that 5pM
• • 94-
cytochalasin D caused a large increase in Ca -stimulated catecholamine release from
chromaffin cells, while phalloidin had the opposite effect in the same system.
5.12 Investigation of cytosolic rundown and the introduction of
recombinant aSNAP into permeabilised AtT-20 cells
94- •
Much work has been done on the role of aSNAP in Ca -regulated exocytosis,
particularly in chromaffin cells, and in relation to the cytosolic rundown seen in
permeabilised cells. The leakage of soluble proteins from permeabilised cells has
2"Fbeen used as a means to identify cytosolic proteins involved in Ca -regulated
exocytosis. Introduction of cytosol to rundown cells can reconstitute efficient
• • 94- • • •
secretion in response to Ca , as can the introduction of various proteins involved in
exocytosis, and one of these proteins is aSNAP. This section repeats studies of the
extent to which cytosolic rundown occurs in AtT-20 cells, as assesssed by the
94-
rundown of the exocytotic response to Ca , and the leakage of the cytosolic enzyme
LDH. Further experiments tested whether this rundown could be reversed by the
addition of rat brain cytosol or aSNAP. Rat brain cytosol was obtained from Dr.
Leonora Ciufo (University of Edinburgh), and was a by-product of the preparation of
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rat brain synaptosomes, whilst recombinant aSNAP was obtained from Professor
Burgoyne (University of Liverpool) and was prepared as detailed in Morgan &
Burgoyne, 1995.
Figure 5.18 shows exocytotic rundown in permeabilised AtT-20 cells. This rundown
was produced by permeabilising AtT-20 cells in the normal way (i.e. 20pg/ml
digitonin for lOmin), and then varying the time of the pre-Ca2+ incubation stage (15,
30, 60, 90 min), before stimulation of secretion with lOpM Ca2+ for lOmin. This was
repeated and expanded in figure 5.19, with the introduction of rat brain cytosol to
assess whether any increase in secretion was seen. AtT-20 cells were also
permeabilised for increasing lengths of time, followed by incubation with or without
rat brain cytosol before Ca2+-stimulation. Figure 5.20 shows cytosolic leakage
manifested as leakage of LDH under varying conditions (section 2.5.5). Figure 5.21
shows the results obtained when aSNAP was introduced to cells with varying
• • 2~Pincubation times prior to Ca -stimulation. Figure 5.22 shows the effect of
introducing aSNAP into cells permeabilised for extended periods of time, followed
by the usual 15min pre-Ca2+ incubation period, prior to Ca2+-stimulation. Rat brain
cytosol was present at a concentration of 3mg/ml in a buffer containing 25mM
Hepes-KOH and 0.32M sucrose. This was diluted in intracellular buffer to 1.5mg/ml,
however the intracellular buffer was modified so that it would be iso-osmotic with
the AtT-20 cells, lowering the potassium glutamate concentration from 150mM to
70mM. Control experiments without added cytosol used this intracellular buffer
diluted with the Hepes/sucrose buffer only. aSNAP was equilibrated with the
required intracellular buffer by passage through Biogel P-6 DG. A 15% loss occured
during this process, as judged by A280 measurements and the final concentration of
aSNAP was 53pg/ml. Figure 5.21 shows a polyacrylamide gel of aSNAP.
5.13 Discussion
Figure 5.18 shows the effects of increasing the pre-Ca2+ incubation time, prior to
Ca -stimulation. It has already been demonstrated that factors can enter and bind in
AtT-20 cells (figure 5.11), and one would expect that if unbound cytosolic factors
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were important in ACTH secretion in AtT-20 cells there would be a decrease in
• 9 |
ACTH secretion with increasing pre-Ca incubation times. In fact, little decrease
was seen from 15min to 60min, after which point there was a small drop. This drop
at 90 min may have been due to reduced cell viability as opposed to true exocytotic
rundown. Figure 5.19 expands on this and shows the effects of adding cytosol, with
an attempt to increase the exocytotic rundown by using increased permeabilisation
times. These results show that there is a decrease in ACTH secretion when the pre-
2~b * * • • 71Ca incubation times, prior to Ca -stimulation is increased from Omin to 15min. Rat
9+
brain cytosol had no effect on the Ca -stimulated zero-time sample, but it caused a
37% increase in the basal sample. Cytosol also had no effect on the Ca2+-stimulated
15min sample, but it caused a 33% increase in the basal 15min sample. These results
suggest that the 'rundown' seen between 0 and 15min is cellular damage rather than
cytosolic or exocytotic rundown. The increase in basal levels of secretion is probably
9+
due to the an effect on the levels of free Ca , and some factor may be present which
slightly elevates these levels, so that the control cells show a degree of Ca2+-
• ... 9+
stimulated ACTH secretion. Addition of cytosol does have an effect on the Ca -
stimulated sample at 90min causing a 21% increase and restoring the level of
secretion to that seen at 15min. It continues to have an effect on the basal level,
which displays a 12% increase. Thus it appears that true exocytotic rundown only
begins much later, at around 90min. The permeabilisation time was increased to
45min to try to accelerate rundown, and indeed the ACTH secretion dropped to basal
levels. On the introduction of cytosol for 15min prior to Ca2+-stimulation, ACTH
secretion was increased 62%, whilst basal levels were only increased by 25%. Thus
cytosolic rundown also appears to occur with a 45min permeabilisation, and the
effect can be reversed to some extent by the addition of cytosol. This protocol
provided a quicker method of assaying cytosolic rundown, produced lower standard
errors than the in 90min rundown experiment and proved more reproducible.
Figure 5.20 shows true cytosolic rundown, as opposed to a decrease in Ca2+-
stimulated ACTH secretion, measured as LDH leakage from AtT-20 cells. After
lOmin the permeabilisation buffer contained 145U/ml LDH, and after 45min
446IU/ml, showing that cytosolic components leak out of the cells during
permeabilisation, and increasing the permeabilisation time increases this effect. It
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2+ • • •also shows that leakage occurs during the pre-Ca incubation stage (using a lOmin
94-
permeabilisation), the pre-Ca incubation buffer containing 48IU/ml LDH. When
2+ •this pre-Ca incubation was increased to 30 and 60min the buffer contained
119U/ml and 123U/ml LDH respectively. In cells permeabilised for 45min, followed
by the normal 15min pre-Ca2+ incubation, the pre-Ca2+ incubation buffer contained
no significant levels of LDH, suggesting that all the LDH had leaked out during the
45min permeabilisation period. These results confirm that cytosolic leakage occurs in
these cells, but at a much faster rate than the exocytotic rundown. Leakage of LDH is
significant at 15min and plateaus at 30min, unlike the exocytotic rundown which is
not significant at 15min, but significant at 90min. This again suggests that that the
exocytotic machinery is docked and in place.
• 9 I
The inclusion of aSNAP during the pre-Ca incubation for 15, 30 or 60min had no
2"beffect on Ca -stimulated ACTH secretion (figure 5.21). This is consistent with the
demonstration that no significant exocytotic rundown occurs over this period of time
(figure 5.18), however numerous other studies have shown aSNAP to have the
9_i
ability to increase Ca -stimulated exocytosis. Morgan & Burgoyne, 1995 showed an
increase from 25% total catecholamine release to 31% total catecholamine release in
chromaffin cells. As shown in figure 5.22, aSNAP (unlike whole brain cytosol), had
no effect when the cells were permeabilised for 45 min, in that it could not re-
9_l_ t %
constitute Ca -stimulated secretion. Morgan & Burgoyne, 1995 showed aSNAP to
• • 2"bhave this ability in chromaffin cells, when they showed aSNAP to increase in Ca -
stimulated catecholamine secretion in chromaffin cells under similar conditions.
In summary these results suggest that exocytotic rundown does occur in
permeabilised AtT-20 cells, but only after a fairly long period of time, whereas
leakage of cytosolic proteins occurs over a shorter period of time. Rat brain cytosol
can reverse this exocytotic rundown, whereas recombinant aSNAP does not appear
to have any effect.
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5.14 Introduction of Botulinum and Tetanus toxins into
permeabilised AtT-20 cells
One of the most effective ways of studying Ca2+-regulated exocytosis is by using
Clostridial neurotoxins. Many studies have shown these toxins to greatly inhibit
2"h • •Ca -regulated exocytosis in both neuronal and chromaffin cells and the inhibition
has been related to the specific proteolytic degradation of synaptobrevin, syntaxin or
SNAP-25 by particular toxins (Hayashi et al., 1994; Niemann et al., 1994).
2~bLittle effect on Ca -regulated exocytosis was found, on the introduction of
antibodies, recombinant proteins, actin-stabilising drugs or actin de-stabilising drugs
into AtT-20 cells. The recombinant protein and antibody results were attributed to
the fact that in AtT-20 cells secretory vesicles are already docked at the plasma
membrane, thus preventing these factors from interfering. The use of toxins should
allow proteolysis of t-SNAREs or v-SNAREs, even in docked vesicles, and thus
inhibit exocytosis. Toxin-mediated inhibition of Ca2+-regulated exocytosis in AtT-20
cells would also prove that the susceptible protein had a definite role in ACTH
secretion. It was decided initially to use recombinant light chains of Botulinum
neurotoxin D (BoNTD-LC), Tetanus toxin (TeTX) and Botulinum neurotoxin C
(BoNTC-LC), the former two being specific for synaptobrevin, and the latter for
syntaxin, as these proteins are the main SNARE proteins. However preliminary
experiments failed to detect expression of the BoNTC-LC by transfected NM522
cells, and due to time constraints efforts were concentrated on BoNTD-LC and
TeTX-LC expression, as preliminary work showed expression of these recombinant
proteins.
5.14.1 Preparation of recombinant light chains of tetanus toxin (TeTX-LC) and
Botulinum toxin D (BoNTD-LC)
The optimised protocols for the production and purification of TeTX-LC and
BoNTD-LC are detailed in 2.6; in this section some of the preliminary work on toxin
production production is described. The purification conditions were initially varied
in order to optimise yield and purity, mainly by varying the number of washes and
wash buffer concentration and composition. Ni-agarose was used throughout the
procedure, in conical glass tubes. Washing and sample collection stages were done
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by re-suspension of the Ni-agarose and centrifugation to collect the supernatant. It
was found that TeTX-LC was best eluted using a pH change and a number of
washing stages, while BoNTD-LC was best eluted using an imidazole gradient. Ni-
agarose bound TeTX was washed with SE buffer (pH8.0), followed by SE buffer
(pH6.5), and then a number of washes with SE buffer (pH5.0). The most
concentrated and purest fraction was wash 10 of the SE buffer (pH5.0), and this was
used in subsequent experiments. Figure 5.23 shows the various TeTX fractions
obtained during the washing stages, and run on an acrylamide gel. BoNTD was
initially eluted using a stepwise imidazole gradient, however BoNTD-LC could be
seen in any of the fractions following the 30mM wash, none of which were
particularly pure (figure 5.24 shows a gel of the fractions). It was therefore decided
to extend the number and the volume of the lOmM and 30mM imidazole washes, to
remove contaminating bacterial proteins, without losing any of the BoNTD-LC. At
this point it was also concluded that the use of non-transfected bacterial NM522
cells, grown in non-selective media, and then treated in exactly the same way as the
transfected bacterial cells, was necessary to show this 50kDa band to be specific.
Figure 5.25 shows a gel of the fractions from the purification of BoNTD-LC (using
the lOmM and 30mM imidazole washes), and also the fractions obtained with the
non-transfected bacterial cells. Passage through Biogel P-6DG was used to change
the buffer of the BoNTD-LC and BoNTD-LC control to that of the intracellular
buffer used in permeabilisation experiments. The same control (i.e. non-transformed
bacterial cells fractionated in the same way as the TeTX-LC transfected cells) was
used for TeTX-LC, and figure 5.26 shows a gel of the fractions obtained for both of
these.
5.14.2 Introduction of TeTX-LC and BoNTD-LC into permeabilised AtT-20
cells
Optimisation of the purification of BoNTD-LC and TeTX-LC, was based on the
acrylamide gels that were run of the various fractions. BoNTD-LC and TeTX-LC
were identified by the presence of a 50kDa band that was absent, or greatly reduced,
in the control cell fractions. A preliminary experiment was performed as follows:
toxin purification was as detailed in 2.6, and two 0.5ml fractions were obtained for
each toxin, which were equilibrated with intracellular buffer. 0.4ml of the BoNTD-
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LC fraction was then added to 4.5ml intracellular buffer, and 0.5ml of the resulting
2~b • • 2~bmixture was used per sample in a 20min pre-Ca incubation stage (prior to Ca -
stimulation of the cells). The control was BSA (2.5pg/ml), which was around the
concentration expected for the BoNTD-LC. In this preliminary experiment exact
estimates were not made of the BoNTD-LC concentration, but rough estimates could
be made from the acrylamide gels (figure 5.25). The results of the Ca2+-stimulation
and ACTH RIA for this experiment have been displayed in figure 5.27. The
introduction of TeTX-LC (figure 5.28) was done at a slightly later stage in the
project, and used a control of non-transformed bacteria fractionated in the same way,
as opposed to BSA. In this experiment 200pl or 20pl of the 0.5ml fraction after
passage through BioGel, was added to 4.3ml or 4.48ml respectively of intracellular
buffer, and 0.5ml of the resulting mixture was used per sample in the 20min
incubation preceding the Ca2+-stimulation stage. The concentration of the toxin was
not accurately assayed at this stage, and again could be roughly estimated using
fractions run on acrylamide gels (figure 5.26). An additional control was used that
contained no bacterial fraction, in order to assess basal ACTH secretion. The results
of this experiment are shown in figure 5.28.
Having confirmed the activity of the BoNTD-LC and TeTX-LC fractions being used,
it was decided to repeat the experiment using properly quantitated toxin samples,
varying toxin concentrations and all the necessary controls. To quantify the toxins a
combination of Peterson's assay (detailed in 2.5.1.1) and densitometry were used.
The Peterson assay allowed the total protein concentration to be calculated, whilst
the densitometry allowed other protein bands to be taken into account, as the samples
were not totally pure. The percentage of 50kDa protein compared to total protein was
obtained by densitometry and then this percentage was used to calculate the
concentration of protein that was toxin. Figure 5.29 shows the acrylamide gel of the
samples used for densitometry, and shows how the toxin concentrations were
calculated.
These toxins were then introduced into permeabilised AtT-20 cells, as in the previous




The protocol for purification ofTeTX-LC (see 2.6), was chosen as there was a strong
50kDa band seen in fraction 18 (diagram 5.23) which was relatively pure. Further
experiments on a non-transformed bacterial control showed the absence of this
50kDa band (figure 5.26). The initial protocol using stepwise increases in imidazole
concentrations to purify BoNTD-LC resulted in elution of BoNTD-LC after 30mM
imidazole (figure 5.24). It was therefore decided to increase the washing stages up to
this point and then elute the BoNTD-LC immediately with lOOmM imidazole, and
this proved to be more successful (figure 5.25).
The introduction of BoNTD-LC into permeabilised AtT-20 cells, followed by
stimulation with Ca2+, produced a reduction in ACTH secretion, although the basal
(Ca2+-independent) ACTH secretion was unaltered (figure 5.27). The highest TeTX-
LC concentration reduced ACTH secretion to 65% of the control, and there was no
effect on basal ACTH secretion.
The concentrations of the toxins were quantified using a combination of Peterson's
assays and densitometry. After buffer equilibration the concentrations of BoNTD-LC
and TeTX-LC were 48pg/ml and 38pg/ml respectively (the recovery after Biogel
treatment being about 70%). The toxins comprised approximately 25% of the total
protein present in the active fractions.
These toxin preparations were introduced into permeabilised AtT-20 cells, prior to
9+
Ca -stimulation. One of the main problems of these experiments was that the toxins
could not be frozen, even in the presence of glycerol, without extensive loss of
activity. The low yield of from each preparation also caused problems, as the dose
used had to be kept to a minimum, in order that sufficient numbers of samples could
be tested to ensure that the results were statistically significant and accurate. The
introduction of 38nM TeTX-LC caused a drop in ACTH secretion to 78% of the
control level, whilst 17nM TeTX-LC caused no detectable reduction. The
introduction of 30nM BoNTD-LC caused a drop in ACTH secretion to 77% of the
control level, whilst 15nM BoNTD-LC caused a similar drop to 74% of its control
level. It is interesting to note that in the BoNTD-LC control ACTH secretion is
reduced to 85% of the normal levels obtained in the absence of any bacterial
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proteins, suggesting that even 15nM BoNTD-LC produces maximal effects. Other
experiments tested the buffer only, by passing it through BioGel P-6DG, and found it
to have no effect on ACTH secretion. Thus it appears that this drop is not due to
incomplete buffer equilibration (and subsequent effects on free Ca2+ concentrations),
but to proteins present in the non-transformed bacterial cells that interfere with
ACTH secretion. In this second experiment slightly lower inhibition of secretion was
seen, however this is most likely due to differences in the toxin concentrations being
used. The results are statistically significant, reproducible, and exhibit a dose
response, thus suggesting a definite role for synaptobrevin in Ca2+-stimulated ACTH
secretion in AtT-20 cells. Another important finding is the lack of effect of either of
these toxins on the basal levels of secretion in AtT-20 cells. Much of the literature
suggests that basal secretion in AtT-20 cells is not simply constitutive secretion, but
due to the regulated pathway (Matsuuchi & Kelly, 1991). These results would
suggest this not to be true and show that vesicles are being released via a completely
different, synaptobrevin-independent pathway.
5.16 Introduction of a-Iatrotoxin to non-permeabilised AtT-20 cells
a-Latrotoxin (the neurotoxin in black widow spider venom) is a potent stimulator of
neurosecretion, through its binding to high-affinity pre-synaptic receptors. It can
stimulate massive vesicle release in the presence or absence of Ca2+, in both neuronal
and PC 12 cells, and this may be due to the presence of two distinct receptors
(.Davletov et al., 1996; Krasnoperov et al., 1997). The effects of a-latrotoxin were
investigated in intact AtT-20 cells, using Locke's buffer as the extracellular buffer,
with EGTA used to remove extracellular Ca in some experiments. The cells were
washed with Locke's buffer, after which they were incubated with 5nM a-latrotoxin,
with Ca or EGTA for 10 or 40min, at room temperature. Supernatants were then
removed and assayed for ACTH, the results for which are seen in figure 5.32.
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5.17 Discussion
There was no increase in secreted ACTH in the presence of a-latrotoxin, but rather a
slight decrease, compared to the control samples. The samples containing the a-
• • 7 I
latrotoxin in the absence of Ca showed an even larger decrease, and increasing the
time of incubations (in either the absence or the presence of calcium) had little effect
on either. Exactly what caused this decrease is open to discussion, and may be some
other factor within the a-latrotoxin preparation. Certainly the results are statistically
significant, however further work is required to elucidate mechanisms involved.
The a-latrotoxin sample that was used in this set of experiments was kindly donated
by Dr. Robert Chow (Dept. of Physiology, University of Edinburgh), who had also
tested it on chromaffin cells. In his experiments massive secretion was seen both in
the presence and in the absence of calcium, confirming that the toxin preparation was
active. However the experiments on AtT-20 cells show that a-latrotoxin has no
effect on ACTH secretion, and if anything actually reduces basal secretion slightly.
This indicates a lack of a-latrotoxin receptors, indicating a significant difference
between the AtT-20 cell line and chromaffin or neuronal cells.
5.18 Conclusions
The results presented in this chapter confirm that the AtT-20 cells were behaving
appropriately in response to various secretagogues, and that the radioimmunassay
was sensitive enough to yield reproducible and accurate measurements of these
levels ofACTH secretion.
The cells could be permeabilised with digitonin, and subsequently stimulated with
9+
10pM Ca to secrete around 26% of the total ACTH content (3 times the basal
levels of secretion). Immunofluorescence microscopy was used to prove that under
• 9+
these conditions, with a 15min incubation prior to Ca -stimulation, various proteins
or drugs could enter the cells and bind to intracellular components.
In this permeabilised cell system, antibodies to synaptotagmin, cofilin and syntaxin
had no effect on basal or Ca2+-stimulated levels of ACTH secretion. Recombinant
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9+ •
cofilin, synaptotagmin or aSNAP also had no effect on basal or Ca -stimulated
ACTH secretion. The introduction of actin-stabilising or -destabilising drugs
• i 2+ • ....
produced no change in basal or Ca -stimulated ACTH secretion, nor in the kinetics
ofACTH secretion.
These results suggest that neither actin nor cofilin has a major rate-determining role
in ACTH secretion from AtT-20 cell. Antibodies and non-functional recombinant
proteins also showed no effect on ACTH secretion, suggesting a lack of involvement
of synaptotagmin, syntaxin, aSNAP or synaptotagmin in rate-determining steps, or
an inability to interfere with the process. The latter is more likely, particularly in
view of the immunofluorescent staining patterns, which suggest that vesicles are
docked and soluble factors such as aSNAP have already bound.
Cytosolic rundown (the loss of cytosolic proteins from permeabilised cells) and
exocytotic rundown (the loss of Ca2+-stimulated ACTH secretion from permeabilised
cells) were also investigated. True exocytotic rundown was only seen at around
90min after permeabilisation, and this could be inhibited by the addition of cytosol.
This rundown was also seen by increasing the permeabilisation time to 45min, and
again cytosol inhibited this. LDH leakage was assayed as a measure of cytosolic
leakage and indicated that cytosolic leakage was much faster and more complete than
exocytotic rundown. aSNAP had no effect on exocytotic rundown in that it failed to
increase ACTH secretion in cells permeabilised for 45min.
These results are consistent with the idea that secretory vesicles are pre-docked, and
aSNAP is pre-bound. Exogenous aSNAP caused no inhibition of exocytotic
rundown, suggesting that the drop in secretion is not due to the leakage of aSNAP.
The effect of cytosol by no means proves that the drop in secretion seen at 90min is
even due to loss of proteins specific to exocytosis. The drop may simply be due to a
loss of cell viability over this period of time, which cytosol may protect against in a
manner unrelated to effects on exocytosis.
The introduction of Tetanus toxin and Botulinum neurotoxin D light chains into
permeabilised AtT-20 cells caused a significant drop in secretion, indicating an
• . 9+
important role for synaptobrevin in Ca -regulated exocytosis in AtT-20 cells. In
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contrast a-latrotoxin, when introduced into intact AtT-20 cells did not cause
exocytosis, but slightly reduced basal levels ofACTH secretion.
9+
These results suggest that the cellular machinery involved in Ca -regulated
exocytosis in AtT-20 cells has similarities to that used by neuronal and chromaffin
cells, but that the mechanism of vesicle release may vary in some respects.
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Figure 5.1 Optimisation of radioimmunoassay for ACTH
(a) standard curves obtained using different anti-ACTH concentrations. These were
plotted as % bound/bound zero (% B/BO) against log ACTH (ng/ml). 'Bound' is the
measurement of iodinated ACTH (in cpm) present in the pellet of samples containing
'cold' non-iodinated ACTH. 'Bound zero' is the measured iodinated ACTH (in cpm)
in the pellet of samples containing no 'cold' non-iodinated ACTH. The data were all
fitted with a third order polynomial curve, (b) shows the Bo over total counts (TC)
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Figure 5.2 Standard curve and formula used to calculate unknown
ACTH concentrations of samples.
(a) mean standard curve obtained in an ACTH radioimmunoassay. The values were
always plotted %B/Bo against log ACTH. The equation obtained was as shown and
the R value is given below, (b) shows the derivation of the formula of this equation





y = 4.3666X3 - 0.4099X2 - 34.752x + 43.475











f(x) = 4.3666x3 - 0.4099X2 - 34.752x + 43.475 = f(x)
differentiating with respect to x: f' (x) = 13.0998x2 - 0.8198x - 34.752
The value of x cannot be directly found from this equation, however the following
expansion of the equation allows substitution of "guess values" into the expanded
equation, and x is then determined by an iterative procedure.
The following formula was used:
log ACTH (ng/ml) = x + (y - f (x)) / f' (x)
Thus the 'guess value' of x can be 0. This gives a value of 0.249626. This new value
of x is then substituted back into the formula, and another value obtained. Eventually
the same value is consistently obtained and this is transformed from log ACTH to
ACTH concentration (ng/ml). The table below shows an example from the
spreadsheets used for all these assays, and shows the calculation for a B/B0 value of
34.8%, using the previous standard curve and equation. The ACTH concentration
obtained was 1.782ng/ml (1.8ng/ml).
y X f(x) f(x) log ans ans
34.8 0 43.475 -34.752 0.249626 1.776748
34.8 0.249626 34.84238 -34.1404 0.250067 1.781834
34.8 0.250867 34.80001 -34.1332 0.250867 1.781835
34.8 0.250867 34.80001 -34.1332 0.250867 1.781835
[where log ans = x + (y-f(x))/f'(x)]
N.B Please note that all subsequent graphs of results within this chapter are based on
single experiments however duplicate or triplicate experiments were carried out and
gave similar results.
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Figure 5.3 Time-course and dose-response of CRF-stimulated
exocytosis
(a) time course of ACTH secretion, stimulated with lOOnM CRF. (b) dose response
curve obtained with increasing concentrations of CRF, all samples having been taken






Figure 5.4 Time-course ofK+-stimulated exocytosis
Time course obtained when ACTH secretion was stimulated by depolarisation of
AtT-20 cells with 50mM K+.
time (mins)
- - ♦ - -KCI
hacal
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Figure 5.5 Effects of dexamethasone on ACTH secretion stimulated
with CRF or K+
The bar chart shows ACTH secretion in response to lOOnM CRF (CRF) or 50mM K+
(KC1), all over 30min and at 37°C. To assess the effects of the glucocorticoid
analogue dexamethasone, the cells were pre-incubated with lOOnM for 60min, after
which the appropriate secretagogue was used.
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Figure 5.6 Effects of dexamethasone on ACTH secretion stimulated
with 8-bromo-cAMP
The bar chart shows the levels ofACTH secretion obtained on stimulation ofAtT-20
cells with 5mM 8-bromo-cAMP (lhour incubation at 37°C). Basal levels represent






Figure 5.7 Time course of Ba2+-stimulated ACTH secretion
2~b
(a) time course of Ba -stimulated ACTH secretion up to 5min. (b) a similar time
9+
course up to 60 min. All incubations were at room temperature. Ba stimulation is
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Figure 5.8 Effects of digitonin permeabilisation on AtT-20 cells
(a) concentration of ACTH measured in the permeabilisation buffer after removal
from the cells. Cells were permeabilised for 5 or lOmin, with the concentrations of
digitonin shown, (b) total lysis values for AtT-20 cells before digitonin
permeabilisation (TL (pre-dig)) and after digitonin permeabilisation (TL (post-dig)),
compared to typical values released by Ba2+-stimulation (Ba stim) and Ca2+-
stimulation (Ca stim). Two basal levels of ACTH secretion are shown (Ba Ctrl and ca
• r* 2"b • •
Ctrl) as the buffers vary in these two types of stimulation. The Ca -stimulation used





Figure 5.9 Dose-response curve and time-course of Ca -stimulated
ACTH secretion
(a) ACTH secretion obtained using varying Ca2+ concentrations. All samples were
taken at lOmin. (b) Time course of ACTH secretion after stimulation with lOpM











Figure 5.10 Effect of temperature on Ca2+-stimulated ACTH
secretion
The bar chart shows the effect of temperature variation on the levels of ACTH
9+
secretion obtained using 10pM Ca for lOmin. Cells were permeabilised at room
temperature as usual, after which they were incubated at room temperature or 37°C
2+for 15min, followed by a lOmin stimulation with lOpM Ca at room temperature or
37°C. Basal levels are represented by -Ca, stimulated cells are shown by +Ca; at
room temperature (RT), or 37°C (37).
4.5
Kl+Ca Kl-Ca 37+Cb 37-03
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Figure 5.11 Immunofluorescence microscopy as a method to test the
entry of various factors into permeabilised AtT-20 cells
The figures below show the staining patterns obtained with digitonin-permeabilised
AtT-20 cells labelled with with various immunofluorescent probes, (a) staining with
a plant actin-binding protein ZMAP-B3 conjugated to GFP, (b) phalloidin conjugated
to FITC and (c) anti-cofilin rabbit antiserum followed by goat anti-rabbit serum
conjugated to rhodamine. All concentrations and dilution were as detailed in Chapter
4, and ZMAP-B3 was used at a concentration of 100p.g/ml.
(a) (b)
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Figure 5.12 Effect of antibodies on ACTH secretion from
permeabilised AtT-20 cells
The bar chart below shows ACTH secretion obtained from permeabilised AtT-20
cells which had been incubated with various antisera, prior to stimulation with 1 OpM
9-4- .
Ca . Anti-cofilin, anti-synaptotagmin, anti-syntaxin and NRS antisera were as
previously described in figures 3.22, 3.10, 3.11 and 3.17 respectively, and anti-
cofilin was used without affinity purification. All antisera were diluted 1/100 in the
pre-incubation buffer. Ca2+-stimulation is represented by (+), and the control by (-),
normal rabbit serum (nrs), anti-cofilin (C), anti-synaptotagmin (p65),anti-syntaxin
(S) and no antiserum (N).
2.5
nrs (+) nrs(-) p65 (+) p65 (-) C(+) C(-) S(+) S(-) N(+) N (-)
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Figure 5.13 Effects of recombinant cofilin on ACTH secretion from
permeabilised AtT-20 cells
(a) secretion obtained from cells incubated with lOOpg/ml recombinant cofilin for
94-
15min prior to the addition of the Ca -stimulation buffer. Recombinant human
cofilin (21kDa) was obtained from Dr. Sutherland Maciver. (b) Gel of a sample of
cofilin (20pg); molecular weight markers are shown in kDa at the side. Cofilin was
stored as a stock solution in lOmMTris-HCl buffer containing DTT and NaN3, at a
concentration of lOOmg/ml. This was diluted in the pre-incubation buffer, to a
concentration of lOOpg/ml. A control of lOOpg/ml BSA was used, as well as a
control with no protein additions, however both these controls contained the
• • 9+ •
equivalent amounts of Tris buffer, without cofilin. The presence of lOpM Ca is
shown by (+), and its absence as (-), whilst BSA is the BSA control, N the control
with no protein additions, and cof is recombinant cofilin.
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Figure 5.14 Effects of recombinant synaptotagmin on ACTH
secretion from permeabiiised AtT-20 cells
(a) secretion obtained from cells incubated with 1OOpg/ml recombinant
synaptotagmin (cytoplasmic domain) in the 15min incubation stage prior to the
2_j_addition of the Ca -stimulation buffer. Recombinant bovine synaptotagmin I
cytoplasmic domain was obtained from Leonora Ciufo (Biochemistry Department,
University of Edinburgh), (b) gel of synaptotagmin; molecular weight markers are
shown in kDa at the side. Passage through BioGel P-6DG was used to transfer
synaptotagmin into the correct intracellular buffer. Lanes 1 and 2 respectively show
20pg synaptotagmin before and after equilibration with BioGel. A control of
100pg/ml BSA was used, as well as a control with no protein additions, and both
contained the equivalent amounts of intracellular buffer and were also equilibrated
9+
with BioGel. The presence of 10pM Ca is shown as (+), and its absence as (-),
whilst BSA represents the BSA control, N the control with no protein additions, and
p65 the presence of recombinant synaptotagmin.
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Figure 5.15 Time course of ACTH release from permeabilised AtT-
20 cells, incubated with recombinant cofilin
The details of this experiment were exactly as in figure 5.12, except that following
addition of the Ca -stimulation buffer, samples were taken at 2, 5 and lOmin. The
control for this experiment was intracellular buffer containing 100p.g/ml BSA.
Samples taken from cells incubated with cofilin are labelled as cof with (+) or (-)
2~b
showing the presence or absence of lOpM Ca respectively. Samples taken from
cells incubated with BSA are labelled as BSA with (+) or (-) showing the presence or


















Figure 5.16 Effect of phalloidin on ACTH secretion from
permeabilised AtT-20 cells
94-
Permeabilised AtT-20 cells were incubated with phalloidin (27pg/ml), prior to Ca -
stimulation. As the stock was stored in ethanol, the control was the intracellular
• • 9+
buffer containing the appropriate volume of ethanol. Following Ca -stimulation
2"b
samples were taken at 2, 5 and 10 min. The presence of lOpM Ca is shown as (+),
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Figure 5.17 Effect of cytochalasin on ACTH secretion from
permeabilised AtT-20 cells
Permeabilised AtT-20 cells were incubated with Cytochalasin D (lOpM) prior to
stimulation with 10p.M Ca . Cytochalasin was stored as a stock solution in DMSO,
so the control contained the appropriate concentration of DMSO. The presence or
9+
absence of Ca is indicated as (+) or (-) respectively, whilst cytochalasin samples
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Figure 5.18 Exocytotic rundown in permeabilised AtT-20 cells
The graph below represents the effect on ACTH release of increased incubation
times, prior to Ca2+-stimulation of ACTH secretion. The presence of Ca2+ is shown
as CALCIUM, while its absence is shown as BASAL.
15 30 60
time (mins)




Figure 5.19 Exocytotic rundown in permeabilised AtT-20 cells and
introduction of rat brain cytosol
The barchart below shows the effect of increasing both the pre-Ca2+ incubation times
prior to Ca2+-stimulation, the permeabilsation time itself, and the effects of the
introduction of cytosol. Rat brain cytosol was used at a concentration of 1.5mg/ml
protein and is shown as CYT, and the presence and absence of Ca2 is shown as (+)
or (-) respectively. The various incubation times prior to Ca2 -stimulation were 0, 15
and 90min respectively, and are shown as the first three groups of columns. The
increased permeabilisation time was 45min, and is displayed in the last group of
columns.
Orrin 15rrin 90rrin 45rrin
□ (+) □ (-)□ (+)CYT! (-)CYT
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Figure 5.20 Cytosolic rundown in permeabilised AtT-20 cells
The bar chart below shows the leakage of LDH (measured in arbitory units) from
permeabilised AtT-20 cells. AtT-20 cells were permeabilised in 24 well plates with
2+
20pg/ml digitonin for lOmin as usual, and then incubated in the usual pre-Ca
incubation buffer for 15, 30 and 60min. An additional permeabilisation time of
2+45min was also used, following which the cells were incubated with pre-Ca
incubation buffer for 15min (shown as 45min/15min). LDH activity was estimated in
• • 2"bthe digitonin-containing permeabilisation buffer (PB) and in the pre-Ca incubation
buffer (intracellular buffer; IC). Controls were these buffers without the presence of
digitonin (-D), permeabilised samples being shown as (+D).
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Figure 5.21 Effect of introduction of recombinant aSNAP on
secretion from permeabilised AtT-20 cells
9+ •
(a) the effect of recombinant aSNAP, on Ca -stimulated ACTH secretion in
permeabilised AtT-20 cells. The cells were permeabilised with 20pg/ml digitonin for
9+
lOmin, and then incubated with pre-Ca incubation buffer containing 53pg/ml
aSNAP or BSA, for 15, 30 or 60min, before stimulation with Ca2+. The presence or
9+ • •
absence of 10pM Ca is indicated by (+) or (-) respectively, (b) gel of recombinant
aSNAP (20|ig); molecular weight markers are shown on the left hand side in kDa,
and 36kDa recombinant aSNAP is also labelled. * is some spill-over from an
adjacent lane in the gel, and not contamination the recombinant aSNAP sample.
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Figure 5.22 Introduction of aSNAP into extensively permeabilised
AtT-20 cells
The bar chart below displays the results obtained on the introduction of recombinant
aSNAP into AtT-20 cells that had been permeabilised with 20pg/ml digitonin for
45min. 53pg/ml aSNAP or BSA included in the pre-Ca2+ incubation buffer before
0-|- • • •
stimulation with lOpM Ca . The presence or absence ofCa is indicated by (+) or (-).
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Figure 5.23 Optimisation of TeTX-LC purification
Following overnight incubation with 9ml lysate, the Ni-agarose was washed 5X with
4ml SE buffer (pH8.0), 10X with 4ml SE buffer (pH6.5) and 14X with 0.5ml SE
buffer (pH5.0). 20pl samples of each fraction were loaded on an polyacrylamide gel
in the following order: Lane 1 - molecular weight markers (kDa); lane 2 -
supernatant of sonicated NM522 cells (before binding to Ni-agarose); lane 3 -
supernatant of sonicated NM522 cells (after binding to Ni-agarose); lane 4 - first
wash with SE buffer (pH8.0); lane 5 - last wash with SE buffer (pH8.0); lane 6 -
first wash with SE buffer (pH6.5); lane 7 - last wash with SE buffer (pH6.5); lanes
8-10 - washes 1-3 with SE buffer (pH5.0); lane 11 - molecular weight markers;
lanes 12-22 - washes 4-14 with SE buffer (pH5.0). Lanes 2 and 3 were heavily over¬
loaded but serve to show the small percentage of bacterial protein which bound to the
Ni-agarose. The fraction which was tested on permeabilised cells has been marked
with an arrow.
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Figure 5.24 Development of purification protocol for Botulinum
neurotoxin D light chain
Following overnight incubation with 9ml lysate, Ni-agarose was washed 5X with
lml SE buffer (pH8.0) and once with 0.5ml SE buffer containing 10, 20, 30, 40, 50,
60, 70, 80 or 90mM imidazole (9 washes in total). This was then followed by three
washes with 0.5ml SE buffer containing lOOmM imidazole. All buffers were pH8.0.
2Opl samples of each fraction were loaded on a polyacrylamide in the following
order: Lane 1 - molecular weight markers (kDa); lane 2 - last wash with SE buffer
(pE18.0); lanes 3-11 - washes with SE buffer containing increasing imidazole
concentrations of 10,20,30,40,50,60,70,80 and 90mM respectively; lanes 12-14 -
washes 1-3 with SE buffer containing lOOmM imidazole; lane 15 - first wash with
SE buffer (pH8.0); the first wash with SE buffer (pH8.0) was loaded out of order,
and this wash was in fact the first to be done.
1 2 3 4 5 6 7 8 9 10 11 12 13 14
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Figure 5.25 Purification of BoNTD-LC
The protocol used in figure 5.23 was modified, in that washing was restricted to an
imidazole concentration of 30mM, and elution with lOOmM imidazole. The Ni-
agarose was washed 10X with 4ml SE buffer (pH8.0), 10X with 4ml SE buffer
containing lOmM imidazole, 10X with 4ml SE buffer containing 30mM imidazole,
and 5X with 0.5ml SE buffer containing lOOmM imidazole; all buffers were pH8.0.
20pl samples of fractions were run on polyacrylamide gels and were loaded as
follows: lane 1 - molecular weight markers (kDa); lane 2 - supernatant of sonicated
NM522 cells before binding to Ni-agarose; lane 3 - supernatant of sonicated NM522
cells after binding to Ni-agarose; lane 4 - first wash with SE buffer (pH8.0), lane 5 -
last wash with SE buffer (pH8.0); lane 6 - first wash with SE buffer containing
lOmM imidazole; lane 7 - last wash with SE buffer containing lOmM imidazole;
lane 8 - first wash with SE buffer containing 30mM imidazole; lane 9 - last wash
with SE buffer containing 30mM imidazole; lane 10 - first wash with SE buffer
containing lOOmM imidazole (pre-BioGel treatment); lane 11 - as for 10 but after
BioGel equilibration; lanes 12-15 - washes 2-5 with SE buffer containing lOOmM
imidazole. Gel 1 shows an experiment with BoNTD-LC transformed cells, and gel 2
shows the same for control (non-transformed) cells.
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Figure 5.26 Purification of TeTX-LC
This purification was carried out as detailed in 2.6, but non-transformed NM522 cells
were used as a control, and were treated in the same way. 20pl samples of fractions
were run on polyacrylamide gels. The gels were loaded as follows: lanes 1 & 16 -
molecular weight markers (kDa); lane 2 - supernatant of sonicated cell extract prior
to Ni-agarose binding; lane 3 - supernatant of sonicated cell extract after Ni-agarose
binding; lane 4 - first wash with SE buffer (pH8.0); lane 5 - last wash with SE buffer
(pH8.0); lane 6 - first wash with SE buffer (pH6.5); lane 7 - last wash with SE
buffer (pH6.5); lanes 8-15 - washes 1-9 with SE buffer (pH5.0); lanes 17-22 - as for
lanes 2-7 above, but with control cells; lanes 23-25 - first, third and ninth wash with
SE buffer (pH 5.0); lane 26 - control cells tenth wash with SE buffer (pH5.0) pre-
BioGel equilibration; lane 27 - as for lane 26 but after BioGel equilibration; lanes 28








Figure 5.27 Introduction of BoNTD-LC into permeabilised AtT-20
cells, followed by Ca2+-stimulation of ACTH secretion
The barchart shows secretion from permeabilised cells after introduction of the
recombinant BoNTD-LC (prepared as in 2.6). The cells were incubated with the
• • • • *71
toxin for 20min and then stimulated with 10pM Ca . BoNTD shows samples taken
from cells incubated with BoNTD-LC, and then incubated with (+) or without 1OpM
9+
Ca (-). The control samples are shown as BSA (lOOpg/ml), and were again
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Figure 5.28 Introduction of TeTX-LC into permeabilised AtT-20
cells, followed by Ca2+-stimulation ofACTH secretion
The bar chart below shows the results obtained on incubation of permeabilised AtT-
20 cells with TeTX-LC for 20min, followed by stimulation of the cells with 10pM
Ca2+. In all cases (+) shows the presence of Ca2+, whereas (-) shows the absence of
Ca (i.e. basal levels of secretion), and Ctrl shows normal secretion levels. The
presence of TeTX-LC is shown as TeTX whilst the control of non-transformed
bacterial cells is shown as TeTXctrl. Two different concentrations of TeTX/TeTXctrl
were used: 200 indicates the addition of 200pl TeTX/TeTXctrl to 4.8ml intracellular
buffer, and 0.5ml of this was used per well; 20 indicates the addition of 20pl
TeTX/TeTXctrl to 4.98ml intracellular buffer, and 0.5ml of this was used per well,
'buff was a control in which the SE buffer (pH5.0) was passed through BioGel P-
94-
6DG and then added to the pre-Ca incubation buffer at the aforementioned
concentrations. This was to check that it was having no effect on normal AtT-20 cell
secretion and that buffer exchange was occurring efficiently, thus causing no change
94-
in free Ca concentrations.
2.5
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Figure 5.29 Quantitation of BoNTD-LC and TeTX-LC
(a) 20(il samples of toxin fractions were run on a 10% acrylamide gel in the
following order: lane 1 - molecular weight markers (kDa); lane 2 - TeTX-LC before
BioGel; lane 3 TeTX-LC after BioGel; lane 4 TeTX-LC control before BioGel; lane
5 TeTX-LC control after BioGel; lane 6 - BoNTD-LC control before BioGel; lane 7
- BoNTD-LC control after BioGel; lane 8 - BoNTD-LC before BioGel; lane 9 -
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(b)
Total protein concentration (lane 3) = 140fig/ml
% TeTX-LC of total protein = 27%
TeTX-LC concentration = 37.8pg/ml (following a 20% loss due to BioGel treatment)
Total protein concentration (lane 8) = 209mg/ml
% BoNTD-LC of total protein = 23%
BoNTD-LC concentration = 48.07pg/ml (following a 37% loss due to BioGel treatment
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Figure 5.30 Introduction of quantitated TeTX-LC into
permeabilised AtT-20 cells
The effect of quantitated TeTX-LC on Ca2+-stimulated ACTH secretion from AtT-20
cells. Stimulation with lOpM Ca2+ is shown as (+), whilst basal secretion (no Ca2+
present) is shown as (-). Normal stimulation is displayed as normal, the presence of
TeTX-LC as TeTX, and the presence of TeTX-LC control as TeTXctrl. Toxin
concentrations are shown in nM. Control samples are also shown as nM, and this
relates to the volume of control preparation added to the pre-Ca2+ stimulation buffer,
i.e. the same as for the toxin preparation.
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Figure 5.31 Introduction of quantified BoNTD-LC into
permeabilised AtT-20 cells
The effect of quantitated BoNTD-LC on Ca2+-stimulated ACTH secretion from AtT-
20 cells. Stimulation with lOpM Ca2+ is shown as (+), whilst basal secretion (no Ca2+
present) is shown as (-). Normal stimulation is displayed as normal, the presence of
BoNTD-LC as BoNTD, and the presence of BoNTD-LC control as BoNTDctrl.
Concentrations used are shown in nM. Control samples are also shown as nM, and
2"hthis relates to the volume of control preparation added to the pre-Ca stimulation
buffer, i.e. the same as for the toxin preparation.
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Figure 5.32 Treatment of intact AtT-20 cells with oc-latrotoxin
AtT-20 cells were washed with Locke's buffer (see 2.5.1.1), and then incubated with
the same buffer for 10 or 40min, in the presence or absence of 5nM a-latrotoxin. The
bar chart below shows the resulting ACTH secretion, the time points being shown as
10 or 40, and the presence or absence of a-latrotoxin as Tatro' or 'ctrl' respectively.
Two types of Lockes buffer were used: calcium free (-), containing 10mM EGTA, or
standard Locke's buffer containing calcium (+). The a-latrotoxin was prepared from






Iatro10(+) Iatro40(+) latrol O(-) Iatro40(-) ctrl10(+) ctrl40(+) ctrMO(-) ctrl40(-)
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Chapter 6
Investigation of alternative methods of measuring ACTH secretion
in AtT-20 cells and further molecular work
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6.1 Introduction
This chapter is divided into two main sections. Section I describes results obtained
when molecular biological techniques were used to try and produce an alternative
• 2"b
system of measuring Ca -regulated exocytosis in AtT-20 cells. Section II describes
the results obtained when molecular biological techniques were used to try and
produce an alternative way of studying the mechanism of Ca2+-regulated ACTH
secretion in AtT-20 cells.
Section I
One of the major difficulties encountered in this project was the need to use a
radioimmunoassay (RIA) to measure ACTH secretion from AtT-20 cells. This assay
was very time-consuming, taking two full days to obtain results. The iodinated
ACTH was also very unstable and was only usable for 3-4 weeks after iodination,
and the centrifugation step limited the number of samples that could be handled in
one RIA. It was decided to try to produce an alternative method of assaying regulated
secretion in AtT-20 cells, by transfecting the cells with the gene for an easily-
measured secretory protein. The reporter gene used was secreted alkaline
phosphatase (SEAP), a human placental enzyme, with the unusual and useful
properties of high temperature stability and highly restricted species and tissue
expression. All samples can therefore be heated to 65°C before assaying, thus
removing any non-SEAP alkaline phosphatase and providing a very specific assay.
Two plasmid types were used in this section, the maps for which are in the appendix
section (C). The first plasmid (SEAP-ctrl) produced constitutive secretion of alkaline
phosphatase when transfected into cells, and contained no G418 resistance gene. The
second plasmid (HGH-SEAP) was constructed by excision of the SEAP gene from
SEAP-ctrl and construction of a fusion protein by joining it to human growth
hormone (HGH) gene. This fusion product would enter the regulatory secretory
9+
pathway of AtT-20 cells and be secreted in a Ca -regulated manner. All cDNA
manipulation and plasmid construction was performed by Dr. Allan Colley (Dept. of
Biochemistry, University of Edinburgh). Transfections have previously been
performed on AtT-20 cells, to examine pro-hormone targeting and processing.
Several studies have shown that exogenous hormones can be transfected into these
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cells and are correctly processed and released in a regulated manner {Jung et al.,
1993; Chavez & Moore, 1997). A plasmid called pPHCAGGS-BstXI-LacZ (see
appendix E), was used as a control for optimisation of the lipofectamine transfection.
This was a high-expression plasmid which on transfection of mammalian cells
expressed the enzyme P-galactosidase, which could then be detected using the
protocol detailed in 2.7.1, that resulted in transfected cells being stained blue.
Section II
The second technique used was an extension of the work described in Chapter 4, in
which the mechanisms of exocytosis in AtT-20 cells were investigated. A major
problem in this work was that the introduction of several recombinant proteins
• • 9+
thought to be important in exocytosis had little effect on Ca -regulated exocytosis.
The best explanation is that the secretory vesicles are docked and ready to be
released on Ca2+-stimulation, thus introduction of proteins would have no effect on
measured secretion. The transfection of cells with plasmids encoding mutant forms
of proteins involved in exocytosis might be a way to overcome this problem. NSF
• 9+ . .
has long been known to be involved in Ca -regulated exocytosis in many cell types,
through experiments similar to those done with aSNAP (Banarjee et al., 1996). NSF
exists within the cell as a homotrimer of 76kDa units and has ATPase activity
9+
reported to be involved in Ca -regulated exocytosis (Morgan & Burgoyne, 1995).
Carol Harley, 1994 reported a point mutation (obtained using mutagenic polymerase
chain reaction; Muhlrad et al., 1992) of Thr394 to Prc>394 in SEC18 (the yeast NSF
homologue). This mutant form of the SEC 18 protein interacts with wild type SEC 18
monomers to produce trimers, and acts in a dominant negative fashion. The mutation
was not within the region of NSF containing ATPase activity, nor did it have any
effect on secondary structure of the protein. When the mutant SEC 18 was expressed
in yeast, it caused a decrease in the growth rate of the yeast culture and an internal
accumulation of secretory proteins. It was decided to try to make the same point
mutation in mammalian NSF cDNA (obtained from Chinese hamster ovary cell line),
and then to clone this into the mammalian expression vector pRC/CMV2 (see
appendix C) and transfect AtT-20 cells. The template used for the mutation was a
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generous gift from Professor R. Burgoyne, University of Liverpool, and is shown in
appendix (A).
Section I Investigation of alternative methods of measuring Ca -
regulated secretion in AtT-20 cells
6.2 Optimisation of lipofectamine transfection conditions using lacZ
expression vector
AtT-20 cells were plated in 6-well plates and grown until they were approximately
60% confluent, at which point they were used for transfection. The method of
transfection was as detailed in 2.7.1 and the ratios ofDNA (pg) to lipofectamine (pi)
used were 0:2, 1:4, 1:6, 1:8, 1:10, 1:12. The cells were then tested for p-galactosidase
activity as detailed in 2.7.1.1, and transfected cells stained blue. The plates were then
photographed, the results ofwhich are shown in figure 6.1.
6.3 Discussion
The results show well 5 to have the greatest percentage of transfected cells, and this
was obtained at a ratio of 1: 10 DNA (pg):lipofectamine (pi). Control cells (well 1)
showed no staining. Although this result was specific to a particular vector, it
provided a starting point for the transfections. It also was a useful and quick method
of assessing that this particular method of transfection was working efficiently,
allowing the identification of any future problems as plasmid-specific.
6.4 Investigation of transient transfections with SEAP-ctrl and
HGH-SEAP vectors
Before attempting to study AtT-20 cells stably transfected with HGH-SEAP it was
necessary to show that the cells could be transiently transfected with SEAP-ctrl and
HGH-SEAP vectors, and that SEAP activity could be seen. AtT-20 cells were first
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transfected with SEAP-ctrl and SEAP-HGH vectors, and transiently transfected cells
assayed for SEAP using cytochemistry, chemiluminescence and spectophotometric
assays. The standard ACTH RIA was also used to ensure that these cells were
secreting in the normal way. The cytochemistry experiments were done using cells
grown to 70% confluency in on glass coverslips in 6-well plates, containing 2ml
medium. The chemiluminescence experiments used medium from cells grown in 6
well plates to 70% confluency, in 2ml medium. The spectrophotometric assays were
all done using cells grown in 24-well plates to 70% confluency in 1ml medium, or
9+
the equivalent volume of buffer for Ba -stimulation experiments. This was used for
all subsequent experiments. In all cases vectors were prepared as detailed in 2.7.1.1
and appropriate restriction enzyme digests done at all stages, to ensure that the
correct DNA was present.
6.4.1 Transient transfection of AtT-20 cells with HGH-SEAP and SEAP-ctrl,
followed by detection using cytochemistry
AtT-20 cells were transfected as detailed for transient transfections in 2.7.1.4 using
DNA (pg):lipofectamine (pi) ratios of 1:10 and 5.88:10, along with a negative
control containing no DNA. Both vector types were used and the cells were then
cytochemically stained for alkaline phosphatase activity after 24-72 hours using the
kit described in 2.9.2.
On examination of the cells no staining for alkaline phosphatase could be seen, so the
chemiluminescence assay was used.
6.4.2 Transient transfection of AtT-20 cells with HGH-SEAP, followed by
detection using chemiluminescence
AtT-20 cells were transfected as detailed for transient transfections in 2.7.1.4 using
DNA (pg):lipofectamine (pi) ratios of 1:10 and 1:1 with a negative control
containing no DNA. Only the HGH-SEAP vector was used in this case (due to a
shortage of reagents) and the medium from the cells was assayed for SEAP activity
after 72 hours using the kit described in 2.9.1. The detection of the chemiluminescent
reaction was by exposure of 96 well plates, containing the reaction mixture, to X-ray
film for 30min. The results are shown in figure 6.2.
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6.4.3 Transient transfection of AtT-20 cells with HGH-SEAP and SEAP-ctrl,
followed by detection using an enzymatic assay
AtT-20 cells were transfected as detailed for transient transfections in 2.7.1.4 using a
DNA (pg): lipofectamine (pi) ratio of 1:1, with a negative control containing no
DNA. Both vector types were used and the medium from the cells was assayed after
72hours using the enzyme assay described in 2.9.3. The results for this are shown in
figure 6.3.
It was then necessary to assess whether the HGH-SEAP could be released in a
regulated manner, and whether the SEAP could be detected, and this was done by
• 94-
stimulating the transiently-transfected cells with Ba (as detailed in 2.5.1.1). The
SEAP-ctrl plasmid was used as an additional control in these experiments, as in this
94-
case the SEAP should be constitutively expressed and Ba -stimulation should have
no effect. The results for this are shown in figure 6.4.
Finally the transiently-transfected cells were stimulated with Ba2+ as before, and the
secreted ACTH measured by RIA, to check that the regulated secretion was normal.
The results for this are shown in figure 6.5.
All the results shown are for cells that had been transiently transfected for 72hours.
Cells transfected for different times were also assayed and very similar results
obtained.
6.5 Discussion
Cytochemistry was unsuccessful as a method of detection of alkaline phosphatase
secreted from transfected cells, probably due to a lack of sensitivity. The
chemiluminescence assay (figure 6.2) proved much more successful and indicated
that the optimal ratio of HGH-SEAP DNA (pg): lipofectamine (pi) was 1:1. This
was in contrast to the lacZ expression vector results which showed a DNA (pg):
lipofectamine (pi) ratio of 10:1 to be best, and demonstrated that the optimal ratio for
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transfection was dependent on the particular plasmid being used. The main problem
with chemiluminescence was that the reagents were very costly as they were
intended for use in a typical reporter gene assay, as opposed to an assay that requires
the processing of numerous samples. The spectophotometric assay used gave good
results in that it detected SEAP in the media of AtT-20 cells transiently transfected
for 72 hours (figure 6.3). The HGH-SEAP vector gave an increase in absorbance of
around 1.7 times that of non-transfected cells, whilst the SEAP-ctrl vector gave an
increase of nearly 2.3 times that of non-transfected cells. This shows a difference in
basal levels of secretion between the constitutively secreted SEAP (SEAP-ctrl) and
the SEAP in the regulated secretory pathway (HGH-SEAP). The enzyme assay was
then tested for its ability to detect SEAP secreted from AtT-20 cells stimulated with
9+ •
Ba (figure 6.4). In this instance the controls were non-transfected cells and cells
transfected with the SEAP-ctrl vector, and both gave very similar absorbance levels.
**> i
No detectable difference was seen between Ba -stimulated and non-stimulated cells,
or control and transfected cells, and absorbance levels obtained were background
levels. The same samples were assayed for ACTE1 secretion using the RIA, to ensure
that the transfection had not caused any disruption in normal regulated secretion
94-
(figure 6.5). The results showed that Ba -stimulated ACTH secretion was occurring
in AtT-20 cells transfected with both SEAP-ctrl and HGH-SEAP vectors. This
eliminates the possibility that SEAP was not detected due to a general transfection-
mediated failure of the AtT-20 cells to secrete normally, although it cannot be
excluded that the HGH-SEAP had not correctly entered the regulatory pathway.
Although the reporter gene assay appeared satisfactory, it did not permit the
measurement of regulated secretion in AtT-20 cells. It was decided to obtain stable
HGH-SEAP transfectants using selection with G418 as detailed in 2.7.1.4. The
reasoning behind this was to attempt to obtain a higher percentage of transfected
cells (i.e. 100%) thus increasing the signal, and allowing the detection of Ba2+-
stimulated SEAP secretion.
6.6 Selection of stable HGH-SEAP AtT-20 cell transfectants and
subsequent detection of SEAP
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AtT-20 cells were transfected with HGH-SEAP and SEAP-ctrl vectors at a DNA
(p.g): lipofectamine (pi) ratio of 1:1, with an additional control containing no vector
DNA. The transfection was done in the usual manner, followed by selection over a
period of 4-6 weeks using G418. Only wells transfected with HGE1-SEAP contained
surviving cells after 2-3weeks, and these were sub-cloned, grown up and a stock
frozen down for future use. The following experiments investigated two stably-
transfected cell lines, si and s2. Throughout these experiments the cells were
maintained in G418-containing medium to ensure that loss of expression did not
occur.
The spectrophotometric assay was first used to measure the amount of SEAP in the
medium after 72 hours, and the results are shown in figure 6.6. The cells were
i
stimulated to secrete using Ba , and secreted SEAP measured. Samples of cells were
also completely lysed, in order to detect total SEAP. The results for this are shown in
• 2+ •
figure 6.7. Finally the same samples were assayed for Ba -stimulated secretion of
ACTH using RIA to ensure that the stable transfectants were still able to secrete in a
regulated manner (results shown in figure 6.8).
6.7 Discussion
AtT-20 cell lines si and s2 were stably transfected with the HGH-vector and then
screened for SEAP activity using the standard spectrophotometric assay. Figure 6.6
shows the amount of SEAP constitutively secreted into the medium. The si cell line
secreted very large amounts (approximately 4.5 times the control levels), whilst the
s2 cell line secreted amounts around 1.5 times the control levels. These results
confirmed that stable transfectants had been obtained, that displayed both G418
resistance and SEAP activity.
The next stage was to assess whether SEAP release could be stimulated by Ba2+
(figure 6.7). An additional control of lysed cells was also used, in order to measure
the total SEAP content. The results indicated a problem in the sensitivity of the
system in that the A450 values for all samples (including the non-transfected control
cells) were very similar. Even the s2 cell line, which previously showed high levels
of SEAP activity, displayed no activity above basal levels. Interestingly, when the
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9+
same cells were stimulated to secrete ACTH using Ba , the s2 cells (which had been
shown to produce high levels of SEAP) displayed a significant reduction in the levels
9+
of Ba -stimulated secretion. This suggested that the HGH-SEAP was causing a
reduction in regulated secretion, because of the site of integration of the HGH-SEAP
vector DNA within the genomic DNA. Another possibility was that the HGH-SEAP
protein was expressed at very high levels, was entering the regulatory secretory
pathway and was interfering with the transport and release ofACTH.
6.8 Discussion and Conclusions (Section I)
These experiments showed that the HGH-SEAP vector could efficiently transfect
AtT-20 cells, and could be used to select G418-resistant clones. The selection
process was lengthy, and the number of clones surviving the 2-3week stage was
minimal, although plating the cells at low density improved this. The problem then
was to maintain these cells and grow up large enough numbers to passage and
eventually freeze. In this particular set of experiments only two stable cell lines
actually reached this stage. This indicates the advantages of using transiently-
transfected cells for initial stages of assessing the system.
It was found that SEAP could be detected in medium when cells had been grown in it
9 i
for around 72 hours. However on stimulation of the cells with Ba , no difference in
SEAP levels could be measured between basal and stimulated samples, in transiently
or stably-transfected cells. Even after total lysis of stably transfected cells SEAP was
still undetectable using the spectrophotometric assay. It was previously shown that
9+
Ba -stimulation caused a large fraction of total ACTH to be released, while
immunofluorescence revealed no significant granule depletion. This was presumed to
be due to the ACTH processing and release being rapid, or to degradation of ACTh
in the lysis buffer. These results in which the total SEAP in the cells cannot be
detected, but where SEAP released over 72 hours (at basal levels) can be detected,
suggests a similar scenario.
These results suggest that the HGH-SEAP vector and spectrophotometric assay do
not provide a sensitive enough method for the measurement of regulated exocytosis.
The next stage in the process would be to use transiently-transfected cells to study
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alternative methods of SEAP detection. A possible alternative to the /?-nitrophenyl
phosphate (pNPP) used in this enzyme assay for the detection of SEAP, was reported
by Huang et al., 1992. They showed that 3,6-fluorescein diphosphate could be used
as a fluorogenic substrate for alkaline phosphatase, and with a sensitivity of 50 times
that of the assay with pNPP.
If a detection method could be found in which the levels of sensitivity were such that
Ba2+-stimulated secretion of SEAP could be accurately monitored, stable cell lines
could then be produced. This would require the large-scale selection of a number of
stable cell lines, which could undergo detailed analysis. Immunofluorescence could
be used to detect the presence and whereabouts of the HGH-SEAP protein, and its
distribution could be compared to that of ACTH. The ACTH RIA could be used to
assess the effect (if any) on ACTH secretion. The new system of detection could then
be used to check that regulated secretion of HGH-SEAP had the same characteristics
as secretion ofACTH. This type of system would result in an assay that would be an
enormous improvement on the ACTH RIA, providing the sensitivity was high
enough. If it were, a far greater number of samples could be processed in a much
shorter period of time, without the constraints of product life-span. One of the main
future aims of this project would be to further develop this type of system.
Section II
This section describes a very small section of work that was done within the scope of
the project. It represents the beginning of a large project, in that it uses a completely
different method to try and further analyse Ca2+-regulated exocytosis in AtT-20 cells.
Transfection of AtT-20 cells with a mutated NSF gene should have a dominant
negative effect in the cell, regardless of whether vesicles are docked or undocked.
The intention was to mutate the NSF gene at the aforementioned site (see appendix)
using a plasmid template described in appendix (A) containing the NSF cDNA clone
from the Chinese Hamster Ovary cell line. Having done this it would be re-cloned
into a mammalian expression vector (along with the non-mutated control) and AtT-
20 cells transfected with it. Depending on the results of the transient transfection (i.e.
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how deleterious it was to the cells) the mutant NSF would then have been sub-cloned
into an expression vector which would allow NSF expression to be controlled.
6.9 Site-directed mutagenesis of the NSF gene
The first stage of the project was to attempt to mutate the NSF gene, and the method
used for this has been described in 2.8 and appendix (B). The primers flanking the
NSF gene are denoted as 5' and 3', whilst the primers in the centre of the gene
containing the point mutation have been denoted as 5'M and 3'M. The plan was to
mutate the first half of the gene leaving an overlap of single bases, and then to mutate
the other half of the gene and leave the complementary overlap of single bases, all
using PCR. These overhangs could then act as long primers, which should anneal to
the other overhang, followed by extension using PCR. This 4-primer method of site-
directed mutagenesis has previously been reported by Ho et al., 1989. The precise
method used in each of these experiments has been detailed in 2.8, but an outline of
the primers and enzymes used in the reaction is given below.
The first experiment used the 5'M primer only (as this was obtained first), as well as
the 5' and 3' primers. The 5' and 3' primers were used to assess whether the primers
would give a whole gene product (as this was to be used for control transfections)
and the 5'M and 3' primers were used to assess whether a 'mutant' half of the gene
could be obtained. The results for this are shown in figure 6.9, which is a gel of the
PCR product obtained with Taq polymerase. The same reaction was investigated
using VENT-polymerase as this enzyme improves fidelity of the reaction and the
results of this are shown in figure 6.10. Both mutated fragments were then produced
using the 5'M and 3' primers or the 3'M and 5' primers and VENT-polymerase.
Samples of these PCR products were run on agarose gels, and the results are shown
in figure 6.11. The next stage was the purification of the mutant fragments, in order
to remove any of the original NSF template, which would cause contamination of the
mutant product through the 5' and 3' primers causing amplification of non-mutated
NSF. This was done by running all of the PCR product on a polyacrylamide gel
system set up using a large-toothed comb. The bands were then excised and purified
using a Qiagen gel-purification kit, which also resulted in the concentration of the
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DNA. A sample of this DNA was run on an agarose gel and the results are shown in
figure 6.12. Figure 6.13 shows the results obtained when the 5' and 3' primers were
used to try to anneal the two fragments together, with VENT-polymerase and varying
Mg2+ concentrations.
6.10 Discussion and Conclusions
Figure 6.9 showed that the 5'M, 5' and 3' primers were functional with Taq
polymerase and gave bands that were of the expected size (i.e. 2200bp and 1 lOObp
for the whole NSF gene and the mutated fragment respectively). When experiments
were done using single primers only, no bands were obtained. Figure 6.10 showed
the same experiment with VENT polymerase, and although the bands were less
strong, they could easily be seen when run on a gel. Figure 6.11 showed the
production of both mutant fragments using VENT polymerase, and these PCR
products were then purified and concentrated which resulted in bands of the correct
size (around 1 lOObp for both fragments). However when PCR and the 5' and 3'
primers were used to try and join these fragments together and create a whole
mutated gene, the reaction was unsuccessful, and no bands of the correct size were
obtained. At this point the project had to be abandoned due to time constraints. The
fragments would also need to be sequenced to ensure that the correct point mutation
had been obtained. A possible problem with this end reaction was the size of the
fragments which were being joined together (1 lOObp). Previous work that reported
success using this type of mutagenesis was joining much smaller fragments together
(Ho et al., 1989), and it may be that we would have to look at an alternative method.
This section has been included as it represents the main body of work that would be
undertaken (along with the alternative assay work also included in this section), if the
project were to be continued. It offers a new approach that would yield information
that would greatly improve our understanding of the mechanisms involved in Ca2+-
regulated exocytosis in AtT-20 cells.
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Figure 6.1 Transfection of AtT-20 cells with lacZ expression vector
using lipofectamine
AtT-20 cells were transfected with the lacZ expressing vector, and then stained for (3-
galactosidase activity 12 hours after transfection. The dark, speckled staining
represents positively-stained areas of cells. Wells 1-6 contain cells transfected with
DNA (pg):lipofectamine (pi) ratios of 0:2, 1:4, 1:6, 1:8, 1:10, 1:12 (well 1
representing the negative with no lacZ expressing vector).
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Figure 6.2 Transient transfection of AtT-20 cells with HGH-SEAP
and subsequent detection using chemiluminescence
Chemiluminescence assay as a method to detect the transient transfection of AtT-20
cells with the HGH-SEAP vector. Duplicate samples were assayed and these are
shown in the same column. The columns are labelled 1-3 and these represent DNA
(pg):lipofectamine (pi) ratios of 0:1 (control), 1:1 and 10:1 respectively.
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Figure 6.3 Detection of SEAP in transiently-transfected AtT-20 cells
using a spectrophotometric assay
Medium from AtT-20 cells transfected 72hours previously with vectors SEAP-ctrl
and HGH-SEAP was assayed for SEAP using the spectrophotometric technique
described in 2.9.3. The ratios of DNA (pg) to lipofectamine (pi) were 1:1, except in
the control sample which contained the same volume of lipofectamine (5pi) but no
DNA. The figure below details the A450 values obtained when the samples were read




Figure 6.4 Stimulation of transiently-transfected AtT-20 cells with
2+
Ba , followed by spectrophotometric detection of SEAP
AtT-20 cells were transiently transfected with SEAP-ctrl and HGH-SEAP plasmids,
2_|_and then stimulated with Ba in the normal way after 72hours. The amount of SEAP
9+
secreted was then assessed by spectrophotometric assay. Cells incubated in Ba -
stimulation buffer are shown as (+) barium, whilst cells incubated in the control




Figure 6.5 Ba2+-stimulation of transiently-transfected cells and
measurement ofACTH secretion by radioimmunoassay
The usual ACTH RIA was used to measure ACTH secretion from transiently-
transfected AtT-20 cells. Cells incubated with Ba2+ are shown as Ba stim, whilst cells
incubated in control Locke's buffer are shown as Ba Ctrl.
hghseap seapctrl
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Figure 6.6 Detection of SEAP in stably-transfected AtT-20 cells
using spectrophotometry
Secreted SEAP was measured in the medium of AtT-20 cells stably transfected with
the HGH-SEAP vector, and grown in the medium for 72hours. Control represents
non-transfected cells grown under the same conditions, whilst si and s2 represent the




Figure 6.7 Ba -stimulation of stably-transfected cells and
measurement of SEAP secretion by spectrophotometry
AtT-20 cell lines stably transfected with HGH-SEAP vector were grown until 70-
80% confluent, at which point they were stimulated to secrete using Ba2+. The
secreted SEAP was measured by spectrophotometric assay. Normal represents non-
transfected AtT-20 cells grown and stimulated in the same way, whilst si and s2 are
• • 9+
the stable cell lines. The samples stimulated with Ba are shown as (+) barium,
those incubated in the control Locke's buffer as (-) barium, and total lysis samples as
total lysis.
(+) barium (-) barium total lysis
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Figure 6.8 Ba -stimulation of stably-transfected cells and
measurement of ACTH secretion by radioimmunoassay
AtT-20 cells stably transfected with HGH-SEAP vector were grown in 24-well plates
94-
until 80% confluent, and were then stimulated to secrete using Ba . The ACTH
secreted was measured using RIA. Cells stimulated with Ba2+ are shown as (+)
barium, whilst cells incubated in control Locke's buffer are shown as (-) barium.
Non-transfected control cells, treated in the same way are shown as normal, whilst




Figure 6.9 Optimisation of PCR reaction with Taq polymerase
The gel below represents the results obtained with varying amounts of template, Taq
polymerase, and combinations of the primers 5', 3' and 5'M. Lane 1 contains
molecular weight markers as shown on the left hand side (base pairs). The PCR
reaction in lanes 2-4 used the primers 5' and 3' and 2pl, 0.5pl and 0.2pl of NSF
template respectively. The PCR reaction in lanes 5-7 used the primers 5'M and 3'
and 2pl, 0.5pi and 0.2pl ofNSF template respectively. All PCR reactions were done






Figure 6.10 Optimisation of PCR reaction with VENT polymerase
The gel below shows the results obtained using VENT or Taq polymerase, and
combinations of the primers 5' and 3' or 3' and 5'M. Lane 1 and lane 6 contain a lkb
DNA ladder (shown in base pairs). Lane 2 used primers 5' and 3' with Taq-
polymerase, whilst lane 3 used the same primers but with VENT polymerase. Lane 4
used primers 5'M and 3' with Taq-polymerase, whilst lane 5 used the same primers
with VENT-polymerase. All VENT-polymerase reactions used 2mM MgSCb.
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Figure 6.11 Production of both mutant fragments
The gel below shows the results obtained using both mutagenic primers and the
appropriate flanking primer. Lanes 1 and 2, 5'M and 3' primers or 3'M and 5'
primers respectively and VENT polymerase with 2mM MgSCL. A lkb DNA ladder
is shown in base pairs.
240
6.12 Purification and concentration ofmutated fragments
The gel below represents the results obtained on purification of the fragments
obtained in figure 6.10. Lanes 1 and 2, purified bands obtained using the 3'M and 5'
primers or 5'M and 3' primers respectively. 15pi samples were run in each lane of
the gel. Arrows denote bands of 1 lOObp.
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Figure 6.13 Joining ofmutant fragments
Lane 1, lkb DNA ladder shown in base pairs. Lanes 2 and 3 show the results
obtained when the PCR reaction mixture contained the 5'M fragment and the 3'M
fragment, along with 2mM and 4mM MgSCL respectively and VENT polymerase.
Lanes 4 and 5 were controls with the 5'M fragment only and 2mM or 4mM MgSCL
respectively. Lanes 6 and 7 were controls with the 3'M fragment only and 2mM or
4mM MgSCL respectively. Lanes 8 and 9 represents both the 5'M and 3'M
fragments in a PCR reaction containing 2mM and 4mM MgSCL respectively,
however the mutated fragments were unpurified and taken straight from the PCR
reaction mixture. Lanes 2-8 all used VENT polymerase and the reaction mixture
contained 5' and 3' primers.







Ca -regulated exocytosis has been investigated in various cell types, and this
particular study uses the AtT-20 mouse anterior pituitary cell line. The most
commonly studied models have been neuroendocrine cells, such as chromaffin cells,
and neuronal cells, and these differ considerably from AtT-20 cells in terms of their
physiological functions. This project aimed to compare Ca2+-regulated exocytosis in
AtT-20 cells with that in neuronal and chromaffin cells, in order to assess whether
similar mechanisms were involved. The first aim was to characterise process in
molecular terms by elucidating which of the proteins currently believed to be
involved in exocytosis were present in AtT-20 cells, and to which part of the cell
they were localised. Having completed this section of the work some experiments on
2+the actual mechanism of Ca -regulated exocytosis in AtT-20 cells were performed.
The final section of this project investigated an alternative method for measuring
regulated secretion from AtT-20 cells.
Immunoblotting revealed the presence of synaptotagmin, aSNAP, SNAP-25, NSF,
synaptobrevin 2, syntaxin I, rab3A, cofilin, ADF and CAPS, for all of which there is
already strong evidence for an involvement in exocytosis in neuronal and chromaffin
cells. This localised synaptobrevin, syntaxin and synaptobrevin in membrane
fractions, CAPS, ADF and cofilin to cytosolic fractions and SNAP-25, aSNAP, NSF
and rab3A to both. The most interesting result here was the presence of aSNAP and
NSF in the membrane fraction, as they are soluble proteins with no method of
membrane attachment other than via other SNARE proteins.
Immunofluorescence microscopy revealed different staining patterns for each of
these proteins, aSNAP showing punctate, vesicular staining (very similar to that of
ACTH) and NSF showing plasma membrane staining, similar to that obtained for
SNAP-25. Cofilin displayed a distinct and very unusual staining pattern which was
punctate and vesicular, but different in nature from that of ACTH or aSNAP. These
cofilin rich bodies (CRBs) were larger and less abundant than secretory vesicles, and
were associated with the cortical actin of the cell. The ACTH vesicles did not co-
localise with the cortical actin structure nor with the CRBs, and existed within a
general network of actin at the plasma membrane ofAtT-20 cells. In this respect they
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differed from chromaffin cells, where the vast majority of vesicles lie below the
cortical actin layer. This forms two distinct phases of release on stimulation of
exocytosis: fast ATP-independent fusion of a minority of pre-docked vesicles and the
slower ATP-dependent release from undocked vesicles below the cortical actin
(ATP-dependent). This particular study did not permit the measurement of these
different time phases in AtT-20 cells, but if it were found to be true, the
morphological evidence would not suggest an actin barrier to be the cause. AtT-20
9+ •
cells stimulated with Ba displayed no great change in ACTH-containing vesicles or
actin distribution. When the total content of ACTH was measured, however, Ba2+
appeared to release about 70% of the total ACTH content, so it is surprising that no
granule depletion was noted. It is unlikely that this is due to dynamic replacement of
the granule pool as protein processing and membrane flow would not function on this
time scale. It is more likely that the ACTH, which is unstable and easily degraded,
was substantially lost during the lysis treatment, and total lysis values should be
treated with caution. The lack of actin re-distribution suggests that it does not play a
large part in Ca2+-regulated exocytosis in AtT-20 cells, or that the changes were not
detectable under these conditions.
• • • 9+
Permeabilised AtT-20 cells, stimulated to secrete with 10pM Ca , and an ACTH
derection by RIA, were used to investigate the mechanism of exocytosis in AtT-20
cells. Antibodies, directed against various proteins thought to be involved in
exocytosis, and introduced into permeabilised AtT-20 cells, had no effect on ACTH
release. The same result was obtained with recombinant cytoplasimc synaptotagmin I
(cytoplasmic domain), recombinant cofilin, phalloidin, cytochalasin and aSNAP.
These negative results can be interpreted in a number of ways, but the most general
explanation would be that the ACTH-containing vesicles exist in a pre-docked state
in the cells, with aSNAP already bound to the SNARE complex. This would prevent
antibodies or added recombinant proteins from having any effect on exocytosis, as
the fusion complex would already be formed. The role of NSF is more difficult to
understand as it appears to bind generally to the plasma membrane, with or without
the presence of vesicles (hence its non-punctate staining pattern). Cytosolic rundown
experiments in permeabilised chromaffin cells showed a decrease in Ca2+-stimulated
exocytosis, corresponding to the leakage of cytosolic components from the cells.
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This could be prevented on addition of cytosol or aSNAP, but the same results was
9+
not found in AtT-20 cells. Rundown of Ca -stimulated exocytosis was difficult to
obtain and although the introduction of cytosol reversed it to some extent, the
introduction of aSNAP had no effect, in support of this explanation. The lack of
effect on exocytosis in AtT-20 cells, seen on the introduction of phalloidin and
cytochalasin, again suggested that actin does not act as a major barrier to regulated
secretion in these cells. These negative results were validated by the use of
immunofluorescence microscopy to prove that proteins were able to enter and bind to
intracellular components, under these conditions. However although presumptions
could be made as yet there was no direct or functional evidence for the involvement
of the proteins tested in AtT-20 cell exocytosis. The introduction of botulinum
2d"neurotoxin D and tetanus toxin light chains caused a major decrease in Ca -
stimulated exocytosis in AtT-20 cells and proved that the mechanism of regulated
secretion in AtT-20 cells was similar to that seen in other cell types, in that
synaptobrevin had a major role. The addition of a-latrotoxin to intact AtT-20 cells
had an effect opposite to that seen in neuronal cells, in that a decrease in basal levels
of secretion were seen, again suggesting definite differences between cell types.
These results suggest that the mechanisms involved in the secretion of ACTH from
AtT-20 cells, are similar to those of exocytosis from neuronal and chromaffin cells.
They show the definite involvement of synaptobrevin, and thus the probable
involvement of aSNAP, NSF, synaptotagmin, syntaxin, SNAP-25, rab3A and CAPS.
They do not however offer any evidence of a rate-determining role for actin, ADF or
cofilin in exocytosis, although it would be interesting to elucidate the function of
cofilin, due to its very distinct staining pattern.
Because of time limitations this project failed to produce a mutant NSF, however an
alternative method for studying regulated secretion in AtT-20 cells was tested. AtT-
20 cells were stably transfected with a construct expressing a fusion protein
containing the SEAP reporter gene fused to the HGH gene. Basal secretion of the
fusion protein over 24-72 hours could be detected using a spectrophotometric assay,
however this assay was unable to detect the extra ACTH secreted during cell
9+
stimulation with Ba .
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Future work could involve further investigation of the effects of the other botulinum
neurotoxins (directed against SNAP-25 and syntaxin) to show a role for these
2+
proteins in Ca -regulated exocytosis in AtT-20 cells. Immunofluorescence
microscopy could be used for co-localisation studies of SNAP-25, NSF, ACTH and
aSNAP, as well as using new antibodies against other proteins thought to be
involved in exocytosis. The production of a mutant NSF expression construct would
be a major area of future work, as this should overcome the inability of proteins to
interfere with the exocytotic machinery. The final aim would be to develop the
SEAP-HGH assay for the detection of regulated secretion in AtT-20 cells, to avoid
having to use the laborious ACTH RIA. This would initially centre on transient
transfections of AtT-20 cells with the SEAP-HGH vector followed by the
identification of an assay method sensitive enough to accurately measure regulated
release of SEAP. Stable transfectants would then be selected and studied to ensure
that normal regulated secretion was occurring.
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